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Summary	
Background	
The	first	scientific	studies	on	negative	health	effects	of	passive	smoking	published	in	
the	1980s	 instigated	an	 intense	battle	between	 the	 tobacco	 industry,	who	 fear	 the	
loss	 of	 social	 acceptance	 of	 smoking	 and	 resultant	 financial	 damages,	 and	 diverse	
interest	 groups	 defending	 the	 health	 of	 the	 non‐smoking	 population.	 In	 2003	 the	
World	 Health	 Organisation	 issued	 a	 Framework	 Convention	 for	 Tobacco	 Control,	
which	was	signed	by	168	member	states	and	has	been	ratified	by	176.	
Since	 then,	 several	 countries	 have	 implemented	 smoking	 bans	 in	 public	 indoor	
spaces	 and	 workplaces.	 At	 the	 same	 time	 studies	 on	 second	 hand	 smoke	 (SHS)	
exposure	 and	 related	 health	 effects	 in	 hospitality	 workers	 have	 been	 conducted	
using	 various,	 albeit	 unreliable,	 methods.	 For	 example,	 exposure	 is	 typically	
assessed	 by	 means	 of	 a	 questionnaire	 or	 by	 measuring	 a	 proxy	 such	 as	 PM2.5.		
Likewise,	 measuring	 nicotine	 in	 biological	 samples	 such	 as	 urine,	 blood	 or	 saliva	
may	 be	 influenced	 by	 personal	 metabolism.	 Most	 health‐related	 studies	 focus	 on	
respiratory	 examinations	 and	 have	 completely	 neglected	 long‐term	 effects	 of	 SHS	
exposure	 on	 cardiovascular	 health.	 This	 study	 aims	 to	 address	 some	 of	 these	
knowledge	gaps.	
In	May	2010	Switzerland	implemented	the	first	national	smoking	ban	to	protect	the	
population	 from	passive	smoking.	Loose	regulation	 left	 room	for	exceptions;	 there	
remained	 a	 possibility	 to	 establish	 small	 smoking	 venues	 or	 separate	 smoking	
rooms	 of	 limited	 size.	 The	 COSIBAR	 study	 utilized	 the	 transition	 as	 a	 natural	
intervention	to	examine	exposure	and	the	cardio‐respiratory	health	of	non‐smoking	
hospitality	workers.	
Methods	
An	 intervention	group	 that	experienced	a	 change	 in	 smoking	regulation	was	 to	be	
compared	 with	 a	 control	 group	 that	 continued	 to	 work	 in	 a	 smoke‐exposed	
environment.	To	this	end,	the	air	was	measured	in	193	hospitality	venues	before	the	
ban	in	the	cantons	of	Basel	City,	Basel	County	and	Zurich.	92	workers	were	recruited	
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and	 invited	to	three	medical	examinations,	once	before	 implementation	of	 the	ban	
and	twice	afterwards.	Exposure	was	also	measured	each	 time,	and	at	 the	 first	and	
second	 time	 points	 a	 questionnaire	 on	 behaviour	 and	 acceptance	 was	 mailed	 to	
participants.	In	this	non‐medical	target	group	also	smokers	were	included.	
Exposure	was	measured	by	means	of	a	passive	nicotine‐specific	 sampler.	One	was	
placed	at	the	workplace	for	a	week	and	a	second	one	was	worn	by	the	participants	
for	a	personal	24‐hour	measurement.	In	addition,	we	took	a	salivary	sample	during	
the	 medical	 examination	 to	 determine	 nicotine	 and	 cotinine	 content.	 A	
questionnaire	contained	further	questions	on	personal	exposure.	
Height,	weight	 and	blood	pressure	were	measured	 in	 the	medical	 component.	We	
did	 an	 ECG	 to	 assess	 heart	 rate	 variability	 (HRV)‐	 a	 quantitative	 marker	 of	
autonomic	 activity	 of	 the	 nervous	 system.	We	 also	measured	 pulse	wave	 velocity	
(PWV)	 to	 determine	 arterial	 stiffness	which	 is	 an indicator	 of	 cardiovascular	 risk	
factors	 and	 atherosclerosis.	 Respiratory	 health	 was	 examined	 by	 measuring	 lung	
function	and	fractional	exhaled	nitric	oxide	(FeNO),	an	inflammatory	marker	in	the	
lungs.	Furthermore	we	did	an	allergy	 test	at	baseline	and	performed	an	extensive	
interview	at	each	appointment.	
To	analyse	the	health	data	we	developed	several	models;	exposure	was	compared	to	
all	 health	 parameters	 in	 a	 cross‐sectional	 baseline	 analysis.	 A	 longitudinal	 model	
correlated	exposure	at	every	time	point	with	corresponding	health	data	taking	into	
account	 within‐subject	 correlation.	 Finally,	 a	 pre/post	 comparison	 of	 health	
parameters	was	done	without	taking	exact	exposure	into	account.	All	models	were	
adjusted	for	appropriate	covariates.	
The	 behaviour	 and	 acceptance	 questionnaire	 contained	 questions	 on	 personal	
knowledge	and	attitude	 towards	 the	smoking	ban	and	 factors	 influencing	 these	as	
well	 as	 on	 smoking	 status	 and	 behaviour.	 Responses	were	 analysed	with	 suitable	
statistical	tests.	
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Results	
Average	 SHS	 exposure	 in	 the	 intervention	 group	 decreased	 by	 2.4	 cigarette	
equivalents/day	 (CE/d)	 after	 the	 smoking	 ban	 while	 the	 change	 in	 the	 exposed	
control	group	was	significantly	smaller.		
In	the	cross‐sectional	analysis	of	the	baseline	data	we	found	that	mean	lung	function	
of	 all	 exposed	 hospitality	workers	was	 below	 the	 recorded	 average	 for	 the	 Swiss	
population.	 FeNO	 values	 were	 directly	 associated	 with	 exposure,	 meaning	 we	
observed	decreased	inflammation	with	increased	exposure.	
In	the	longitudinal	model	that	compared	exposure	to	health	measures,	several	HRV	
parameters	significantly	correlated	with	exposure.	A	decrease	by	one	unit	CE/d	was	
linked	to	an	increase	in	the	root	mean	square	of	successive	differences	(RMSSD),	the	
standard	deviation	of	N‐N	 intervals	 (SDNN),	high	 frequency	(HF)	and	Total	Power	
(TP)	 as	 well	 as	 a	 decrease	 in	 PWV.	 These	 associations	 were	 consistent	 with	 the	
original	hypothesis	that	predicted	better	health	with	lower	exposure.	
In	 the	 pre/post	 model	 not	 taking	 exact	 exposure	 into	 account,	 there	 was	 a	
significantly	different	development	of	several	parameters	in	the	intervention	group	
compared	 to	 the	 control	 group.	 SDNN,	 RMSSD,	 HF	 and	 TP	 increased	 in	 the	
intervention	group	while	decreasing	in	the	control	group.	The	inverse	was	true	for	
the	 low	 frequency/HF	 ratio	 (LF/HF),	 an	 effect	 that	 also	 corresponded	 to	 our	
expectations.	 FeNO	 decreased	 in	 the	 intervention	 group,	 while	 the	 control	 group	
showed	 a	 significantly	 different	 slight	 increase.	 No	 changes	 could	 be	 observed	 in	
lung	function.	
Acceptance	 of	 the	 smoking	 ban	 was	 higher	 in	 non‐smokers	 than	 in	 smokers	
throughout	the	study.	It	rose	from	baseline	to	follow‐up	in	both	groups	in	the	canton	
of	Basel	Land	which	had	a	comprehensive	smoking	ban	in	place	but	not	in	the	two	
other	cantons	that	had	a	regulation	allowing	exceptions.	
Discussion	
In	 this	 study	 there	 were	 clear	 indications	 for	 an	 improvement	 of	 cardiovascular	
health	in	non‐smoking	hospitality	workers	after	 implementation	of	a	smoking	ban.	
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Risk	factors	for	myocardial	infarction	or	arteriosclerosis	had	significantly	decreased	
in	 the	 intervention	 group.	 No	 change	 in	 lung	 function	 was	 observed	 while	 FeNO	
showed	a	decrease	 that	cannot	be	considered	clinically	relevant.	Hence,	heart	rate	
variability	 and	 pulse	wave	 velocity	 seem	 to	 be	 the	most	 sensitive	markers,	while	
lung	function	may	take	longer	to	recover	or	may	remain	irreversibly	damaged.	FeNO	
is	influenced	by	many	factors	and	is	in	need	of	further	research.	
All	 these	 results	 speak	 for	 a	 comprehensive	 smoking	ban	without	 exceptions.	The	
higher	 acceptance	 that	we	 observed	with	 this	 type	 of	 regulation	 further	 supports	
this	recommendation.	
Nevertheless	 an	 initiative	 by	 the	 lung	 association	 demanding	 exactly	 this	
consolidation	 of	 the	 law	 was	 rejected	 in	 September	 2012.	 During	 the	 animated	
voting	 campaign,	 first	 study	 results	 were	 published.	 The	 failure	 of	 the	 campaign	
raises	 the	 question	 if	 health	 is	 an	 attractive	 political	 argument	 when	 personal	
freedom	 of	 decision	 is	 threatened.	 What	 more,	 the	 tobacco	 industry	 holds	 a	
powerful	 position	 as	 an	 important	 employer	 and	 tax	 payer	 in	 Switzerland	 and	 its	
role	 must	 be	 considered	 and	 moved	 into	 the	 people’s	 conscience.	 The	 alleged	
personal	 freedom	of	Swiss	citizens	to	decide	on	their	smoking	behaviour	seems	to	
be	an	illusion,	caused	by	concealed	brainwashing	by	the	world’s	most	manipulative	
industry.	
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Zusammenfassung	
Hintergrund	
Seit	 in	 den	 1980er	 Jahren	 erste	 wissenschaftliche	 Studien	 die	 negativen	
gesundheitlichen	 Folgen	 von	 Passivrauchen	 nachgewiesen	 haben,	 herrscht	 ein	
unerbittlicher	 Kampf	 zwischen	 der	 Tabaklobby,	 die	 den	 Verlust	 der	 sozialen	
Akzeptanz	des	Rauchens	und	damit	verbundene	finanzielle	Einbussen	fürchtet,	und	
verschiedenen	Interessengruppen,	die	sich	für	die	Gesundheit	der	nichtrauchenden	
Bevölkerung	 einsetzen.	 Die	 Weltgesundheitsorganisation	 erliess	 2003	 ein	
Rahmenübereinkommen	zur	Eindämmung	des	Tabakkonsums,	das	von	168	Staaten	
unterschrieben	 und	 inzwischen	 von	 176	 ratifiziert	 wurde.	 Seither	 wurden	 in	
mehreren	 Ländern	 Rauchverbote	 in	 öffentlichen	 Räumen	 und	 an	 Arbeitsplätzen	
eingeführt.	Dabei	wurden	oft	Studien	zu	Rauchexposition	und	Gesundheitsfaktoren	
von	 Gastgewerbemitarbeitern	 durchgeführt,	 mit	 unterschiedlichen	 Methoden.	 Die	
Exposition	wurde	meistens	 anhand	 von	 Fragebogen	 oder	 unter	 Anwendung	 eines	
Proxys	wie	PM2.5	eingeschätzt,	was	jedoch	ungenau	sein	kann.	Die	Nikotinmessung	
von	 biologischen	 Proben	 wie	 Urin,	 Blut	 oder	 Speichel	 kann	 ausserdem	 vom	
persönlichen	 Metabolismus	 beeinflusst	 werden.	 Bezüglich	 der	 Gesundheit	
konzentrierten	 sich	 die	 meisten	 Studien	 auf	 respiratorische	 Untersuchungen	 und	
vernachlässigten	kardiovaskuläre	Langzeitauswirkungen	der	Passivrauchexposition	
völlig.	Mit	dieser	Studie	sollten	einige	dieser	Lücken	gefüllt	werden.	
Im	 Mai	 2010	 wurde	 in	 der	 Schweiz	 das	 erste	 Bundesgesetz	 zum	 Schutz	 der	
Bevölkerung	 vor	 Passivrauchen	 eingeführt.	 Da	 die	 lose	 Regelung	 Raum	 für	
Ausnahmen	liess,	war	es	weiterhin	möglich,	kleine	Raucherlokale	oder	abgetrennte	
Rauchräume	 von	 begrenzter	 Grösse,	 zu	 führen.	 Die	 COSIBAR	 Studie	 nutzte	 die	
Umsetzung	 als	 natürliche	 Intervention	 für	 eine	 Untersuchung	 der	 Exposition	 und	
kardio‐respiratorischen	Gesundheit	bei	nichtrauchenden	Gastgewerbemitarbeitern.		
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Methoden	
Eine	Interventionsgruppe,	die	eine	Änderung	der	Rauchregel	erfuhr,	sollte	mit	einer	
Kontrollgruppe	verglichen	werden,	die	weiterhin	im	Rauch	arbeiten	musste.	
Dazu	wurde	vor	dem	Rauchverbot	die	Luft	in	193	Betrieben	in	den	Kantonen	Basel	
Stadt,	Basel	Land	und	Zürich	gemessen.	92	Mitarbeiter	konnten	rekrutiert	werden	
und	 wurden	 zu	 drei	 medizinischen	 Untersuchungen	 eingeladen,	 einmal	 vor	
Einführung	 des	 Rauchgesetzes	 und	 zweimal	 danach.	 Parallel	 wurde	 jeweils	 die	
Exposition	 gemessen,	 sowie	 beim	 ersten	 und	 zweiten	 Erhebungszeitpunkt	 ein	
Verhaltens‐und	 Akzeptanzfragebogen	 verschickt,	 in	 dessen	 Zielgruppe	 auch	
Raucher	eingeschlossen	wurden.	
Die	Exposition	wurde	mit	Hilfe	eines	passiven	Nikotinbadges	gemessen,	einerseits	
während	 einer	 Woche	 am	 Arbeitsplatz	 und	 andererseits	 mit	 einer	 persönlichen	
Messung,	bei	der	der	Proband	den	Badge	24	Stunden	auf	sich	trug.	Darüber	hinaus	
wurde	 während	 der	 medizinischen	 Untersuchung	 eine	 Speichelprobe	 genommen,	
um	 den	 Nikotin‐	 und	 Kotiningehalt	 festzustellen.	 Ein	 Fragebogen	 enthielt	
zusätzliche	Fragen	zur	Exposition.	
Im	 medizinischen	 Teil	 wurde	 neben	 Grösse,	 Gewicht	 und	 Blutdruck	 ein	 EKG	 zur	
Untersuchung	der	Herzrhythmusvariabilität	(HRV),	einem	quantitativen	Marker	des	
autonomen	 Nervensystems,	 durchgeführt.	 Anhand	 der	 Pulswellengeschwindigkeit	
(PWV)	wurde	die	arterielle	Steifheit	gemessen,	die	ein	Indikator	für	kardiovaskuläre	
Risikofaktoren	 und	 Arteriosklerose	 ist.	 Die	 respiratorische	 Gesundheit	 wurde	mit	
einer	Messung	des	ausgeatmeten	Stickstoffoxids	(FeNO),	einem	Entzündungsmarker	
in	der	Atemluft,	und	einem	Lungenfunktionstest	untersucht.	Darüber	hinaus	wurden	
beim	 ersten	 Termin	 ein	 Allergietest	 und	 jedes	 Mal	 ein	 ausführliches	 Interview	
durchgeführt.		
Für	 die	 Analyse	 der	 Gesundheitsdaten	 wurden	 mehrere	 Modelle	 entwickelt:	
Einerseits	wurde	die	Korrelation	der	Exposition	mit	den	verschiedenen	Parametern	
vor	 Einführung	 des	 Rauchverbots	 in	 einer	 Querschnittsuntersuchung	 angeschaut.	
Darüber	 hinaus	 wurde	 die	 Exposition	 in	 einem	 longitudinalen	 Modell	 zu	 jedem	
Zeitpunkt	mit	 den	 jeweiligen	Gesundheitsdaten	verglichen	unter	Berücksichtigung	
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der	 Tatsache,	 dass	mehrere	 Untersuchungen	 von	 einer	 Person	 stammen	 konnten.	
Als	 letztes	 wurde	 in	 einem	 Prä/Post‐Modell	 ein	 Vergleich	 der	 Gesundheits‐
parameter	 vor	 und	 nach	 dem	 Rauchgesetz	 gemacht	 ohne	 Berücksichtigung	 der	
genauen	 Exposition.	 Die	 Modelle	 wurden	 jeweils	 für	 geeignete	 Kovariablen	
adjustiert.	
Der	 Verhaltens‐	 und	 Akzeptanzfragebogen	 enthielt	 Fragen	 zum	 persönlichen	
Wissenstand	 und	 zur	 Einstellung	 zum	 Rauchverbot,	 zu	 Faktoren,	 die	 diese	
beeinflussen	 sowie	 zum	 Rauchstatus	 und	 –verhalten.	 Antworten	 wurden	 anhand	
von	angemessenen	statistischen	Tests	verglichen.	
Ergebnisse	
Die	 durchschnittliche	 Rauchexposition	 in	 der	 Interventionsgruppe	 sank	 um	 2.4	
Zigarettenäquivalente/Tag	nach	dem	Rauchverbot	während	die	Veränderung	in	der	
exponierten	Kontrollgruppe	signifikant	kleiner	war.	
In	einer	Querschnittsuntersuchung	der	Baseline	Daten	wurde	 festgestellt,	dass	die	
mittleren	Lungenfunktionswerte	der	exponierten	Gastgewerbemitarbeiter	unter	der	
schweizerischen	Durchschnittsbevölkerung	 lag.	 Die	 FeNO	Werte	waren	 direkt	mit	
der	Exposition	assoziiert,	wobei	eine	Erhöhung	der	Exposition	eine	Verminderung	
des	Entzündungsmarkers	bedeutete.		
Im	 longitudinalen	Modell,	das	die	Exposition	mit	den	Gesundheitsmassen	verglich,	
korrelierten	mehrere	HRV	Parameter	 signifikant	mit	der	Exposition.	Die	Abnahme	
um	 ein	 Zigarettenäquivalent/Tag	 war	 mit	 einer	 Erhöhung	 der	 RMSSD	
(Quadratwurzel	 der	 Summe	 der	 quadrierten	 Differenzen	 zwischen	 benachbarten	
RR‐Intervallen),	der	SDNN	(Standardabweichung	der	RR‐Intervalle),	der	HF‐	(High	
Frequency)	 und	 der	 TP‐	 (Total	 Power)	 Komponente	 verbunden,	 sowie	 mit	 einer	
Abnahme	 der	 Pulswellengeschwindigkeit.	 Diese	 Assoziationen	 entsprachen	 der	
ursprünglichen	Hypothese,	die	eine	bessere	Gesundheit	mit	niedrigerer	Exposition	
voraussagte.	
Im	 Prä/Post‐Modell	 ohne	 Berücksichtigung	 der	 genauen	 Exposition	 wurde	 bei	
mehreren	 Parametern	 eine	 signifikant	 unterschiedliche	 Entwicklung	 in	 der	
Interventionsgruppe	 im	 Vergleich	 zur	 Kontrollgruppe	 gestellt.	 So	 stiegen	 SDNN,	
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RMSSD,	 HF,	 und	 TP	 in	 der	 Interventionsgruppe	 alle	 an,	 während	 sie	 in	 der	
Kontrollgruppe	 absanken.	 Der	 HF/LF	 (High	 Frequency/Low	 Frequency)	 Quotient	
verhielt	sich	umgekehrt,	ein	Effekt,	der	auch	den	Erwartungen	entsprach.	FeNO	sank	
in	der	Interventionsgruppe	ab,	während	sich	die	Kontrollgruppe	mit	einem	kleinen	
Anstieg	 signifikant	 anders	 verhielt.	 Bei	 den	 Lungenfunktionsparametern	 konnte	
keine	Veränderung	beobachtet	werden.	
Die	Akzeptanz	des	Rauchverbots	war	von	Anfang	an	höher	bei	den	Nichtrauchern	
als	bei	den	Rauchern.	 Sie	 erhöhte	 sich	 jedoch	 in	beiden	Gruppen	 im	Kanton	Basel	
Land,	 in	dem	ein	umfassendes	Rauchverbot	eingeführt	wurde,	während	das	in	den	
andern	beiden	Kantonen,	die	Ausnahmen	zuliessen,	nicht	der	Fall	war.	
Diskussion	
In	 dieser	 Studie	 wurden	 klare	 Anzeichen	 einer	 verbesserten	 kardiovaskulären	
Gesundheit	 der	 nichtrauchenden	 Gastronomiemitarbeiter	 nach	 Einführung	 des	
Rauchverbots	 gefunden.	 Die	 Risikofaktoren	 für	 einen	 Herzinfarkt	 oder	 eine	
Arteriosklerose	hatten	 sich	 in	der	 Interventionsgruppe	 signifikant	 vermindert.	Bei	
der	 Lungenfunktion	 konnte	 keine	Veränderung	 festgestellt	werden	während	 beim	
FeNO	zwar	eine	Abnahme	beobachtet	wurde,	die	 jedoch	nicht	als	klinisch	relevant	
betrachtet	 werden	 kann.	 Somit	 scheinen	 die	 Herzrhythmusvariabilität	 und	 die	
Pulswellengeschwindigkeit	 die	 sensitivsten	 Marker	 zu	 sein,	 während	 die	
Lungenfunktion	 womöglich	 entweder	 länger	 braucht,	 um	 sich	 zu	 erholen	 oder	
dauerhaft	 geschädigt	 bleibt.	 FeNO	wird	 von	 sehr	 vielen	 Faktoren	 beeinflusst	 und	
sollte	daher	noch	weiter	erforscht	werden.		
All	diese	Resultate	sprechen	für	ein	umfassendes	Rauchverbot	ohne	Ausnahmen.	Die	
erhöhte	 Akzeptanz	 dieser	 Form	 der	 Regelung,	 die	 wir	 fanden,	 unterstützt	 diese	
Empfehlung	weiter.	
Trotzdem	wurde	 eine	 Initiative	der	 Lungenliga,	 die	 genau	diese	Vereinheitlichung	
des	 Gesetzes	 verlangte,	 im	 September	 2012	 abgelehnt.	 Während	 des	 lebhaften	
Abstimmungskampfes	 wurden	 auch	 erste	 Studienresultate	 publiziert.	 Der	
Misserfolg	 der	 Kampagne	 wirft	 die	 Frage	 auf,	 ob	 Gesundheit	 als	 politisches	
Argument	 attraktiv	 ist,	 wenn	 dabei	 eine	 Einschränkung	 der	 persönlichen	
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Entscheidungsfreiheit	droht.	Ausserdem	muss	die	Rolle	der	Tabakindustrie,	 die	 in	
der	Schweiz	als	wichtiger	Arbeitgeber	und	Steuerzahler	eine	übermächtige	Stellung	
hat,	 näher	 betrachtet	 und	 ins	 Bewusstsein	 der	 Bürger	 gerückt	 werden.	 Die	
vermeintliche	 persönliche	 Freiheit	 der	 Schweizer	 über	 ihr	 Rauchverhalten	 zu	
entscheiden	 scheint	doch	eher	 eine	Selbsttäuschung	 zu	 sein,	 herbeigeführt	mittels	
einer	verdeckten	Gehirnwäsche	durch	die	wohl	manipulativste	Industrie	der	Welt.	
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1 INTRODUCTION	
This	thesis	deals	with	the	effects	of	a	smoking	ban	on	
exposure	to	second	hand	smoke	(SHS)	and	cardio‐respiratory	
health	of	non‐smoking	hospitality	workers	as	well	as	
behaviour	and	acceptance	of	hospitality	workers	regarding		
smoking	bans	in	Switzerland.	
1.1 Tobacco	from	a	public	health	perspective	
Tobacco	 consumption,	 including	 active	 and	passive	 cigarette	 smoking,	was	 one	 of	
the	three	leading	risk	factors	for	the	global	burden	of	disease	in	1990	and	remained	
so	 in	 2010	 despite	 considerable	 shifts	 among	 other	 risk	 factors	 (1).	 In	 men	 it	
continues	to	be	the	number	one	risk	factor	while	climbing	from	rank	five	to	four	in	
women.	Tobacco	takes	up	this	position	in	large	parts	of	the	world	making	it	a	truly	
global	phenomenon.	
1.1.1 Active	smoking	
Around	 one	 billion	men	 and	 250	million	women	 smoke	worldwide.	 In	 developed	
countries	 this	 corresponds	 to	 a	 smoking	 prevalence	 of	 35%	 in	 men	 and	 22%	 in	
women.	 In	developing	countries	half	of	all	men	smoke	compared	to	9%	of	women	
who	 more	 often	 rather	 chew	 tobacco.	 The	 epidemic	 is	 slowly	 shifting	 to	 the	
developing	 world	 as	 the	 tobacco	 industry	 is	 reaching	 out	 to	 newer	 markets	 (2).	
Numbers	are	continuing	to	grow	in	these	regions	of	the	world	while	they	are	slowly	
decreasing	in	the	more	industrialized	parts.	
Apart	 from	 gender,	 education	 and	 socio‐economic	 status	 are	 major	 influencing	
factors	 on	 smoking	 status.	 Those	 least	 educated	 and	 people	 below	 the	 poverty	
levels,	two	groups	that	often	overlap,	show	the	highest	smoking	prevalence	(3).	
In	Switzerland	27%	of	the	population	smoked	in	2010,	6%	more	men	than	women	
(4).	Of	these,	19%	were	daily	smokers,	but	numbers	have	been	declining	since	the	
year	 2000.	 On	 average,	 less	 Swiss	 men	 and	 more	 Swiss	 women	 smoke	 in	
comparison	to	international	figures.	
“…with a general 
lengthening of the 
expectation of life 
we really need 
something for 
people to die of…” 
 
Report for Tobacco 
Advisory Council, 
1978 
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30‐50%	of	all	smokers	die	prematurely,	half	of	them	in	middle	life	between	the	age	
of	35	and	69.	This	means	that	an	average	smoking	death	reduces	life	by	20	years.	
Lung	cancer	is	the	second	most	common	type	of	cancer	in	both	men	and	women	and	
the	 most	 frequent	 cause	 of	 cancer‐related	 death.	 This	 makes	 tobacco	 the	 single	
greatest	preventable	cause	of	death	due	to	cancer.	However,	smoking	also	damages	
the	body	in	many	other	ways	(Figure	1‐1)	(5,	6).	It	promotes	chronic	diseases	such	
as	 heart	 disease,	 pneumonia,	 hardening	 of	 the	 arteries,	 chronic	 lung	 disease	 and	
asthma	(7).	A	 large	number	of	non‐communicable	diseases	moved	upwards	 in	 the	
ranking	 of	 global	 disability‐adjusted	 life	 years	 (DALYs)	 between	 1990	 and	 2010.	
DALYs	represent	 the	sum	of	years	of	 life	 lost	(YLL)	and	years	 lived	with	Disability	
(YLD),	 adjusted	 for	 the	 severity	 of	 disability.	 Smoking	 remains	 one	 of	 the	 major	
behavioural	 risk	 factors	 for	 many	 of	 these	 (8).	 Cardiovascular	 and	 circulatory	
diseases	are	the	largest	contributor	to	DALYS	relating	to	tobacco	(41%).	
The	risk	of	falling	ill	as	a	result	of	tobacco	consumption	is	strongly	influenced	by	the	
amount	of	cigarettes	smoked	as	well	as	the	age	at	which	the	habit	is	taken	up.	What	
	
	
Figure	1‐1	Body	parts	affected	by	smoking	(9)	
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makes	 it	 a	 habit	 is	 addiction,	 another	 devastating	 cause	 and	 consequence	 of	
smoking.	 50‐60%	 of	 all	 regular	 smokers	 develop	 a	 dependency	 on	 nicotine,	 a	
tobacco	specific	alkaloid	(10).	Though	not	a	direct	cause	of	tobacco‐related	diseases,	
nicotine	 is	 the	major	psychoactive	 component	of	 smoke.	 It	 leads	 to	 an	 increase	 in	
heart	 rate	 and	 blood	 pressure	 and	 directly	 affects	 the	 brain	 within	 seconds.	
Cessation	 of	 regular	 supply	 can	 lead	 to	 withdrawal	 symptoms	 such	 as	 anxiety,	
aggression,	lack	of	concentration,	depression,	unrest,	sleep	disorders	and	increased	
appetite	(11).	
The	 relationship	 between	 active	 smoking	 and	 a	wide	 array	 of	 detrimental	 health	
effects	are	largely	indisputable	but	these	harms	are	also	allegedly	self‐inflicted.	The	
topic	 of	 SHS	 and	 consequential	 involuntary	 tobacco	 smoking	 harming	 casual	
bystanders	brought	the	debate	to	a	whole	new	level	(12).	
1.1.2	 Second	hand	smoke	
Second	hand	smoke	(SHS),	also	often	referred	to	as	Environmental	Tobacco	Smoke	
(ETS),	is	made	up	of	15%	mainstream	smoke	which	the	smoker	inhales	and	exhales	
and	85%	sidestream	smoke	which	comes	off	 the	smouldering	end	of	 the	cigarette	
(13).	 The	 chemical	 constituents	 of	 these	 two	 types	 are	 similar,	 but	 undiluted	
sidestream	smoke	 is	 considered	more	dangerous	as	 components	are	 incompletely	
burned	due	to	lower	temperature.	The	concentration	of	toxins	in	sidestream	smoke	
is	up	to	10	times	higher	than	in	mainstream	smoke	and	toxicity	increases	the	longer	
the	smoke	lingers	in	the	air	(14).	
Broadly	 speaking,	 cigarette	 smoke	 aerosol	 consists	 of	 CO,	 other	 vapour‐phase	
components,	particulate	matter	(tar)	and	nicotine	(15).	It	is	a	complex	and	dynamic	
mixture	 containing	more	 than	4000	 chemicals,	 out	 of	which	 around	200	 are	 toxic	
and	at	least	60	are	carcinogenic	(15,	16).	The	hazardousness	further	increases	when	
components	 interact.	Especially	polycyclic	aromatic	hydrocarbons	 lead	to	tumours	
in	 the	 respiratory	 organs	 that	 are	 in	 direct	 contact	 with	 tobacco	 smoke	 (17).	
Furthermore	aromatic	amines	and	tobacco	specific	N‐Nitrosamines	as	well	as	other	
chemicals	 are	 carcinogenic.	 Other	 noteworthy	 components	 are	 hydrogen	 cyanide	
and	 Polonium	 210,	 a	 radioactive	 metal.	 SHS	 has	 been	 classified	 as	 a	 Group	 1	
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(human)	 carcinogen	 by	 the	 International	 Agency	 for	 Research	 on	 Cancer	 (IARC)	
(15).	 According	 to	 the	 Surgeon	 General’s	 Report	 from	 2006	 there	 is	 no	 risk‐free	
exposure	level	to	SHS	(18).	
The	amount	of	smoke	created	through	smoking	depends	on	the	quantity	of	tobacco	
being	 burnt.	 A	 large	 cigar	 may	 produce	 as	 much	 smoke	 as	 an	 entire	 packet	 of	
cigarettes	(19).	Despite	 filtration	and	ventilation,	SHS	can	be	detected	in	the	air	of	
any	room	in	a	building	if	smoking	is	allowed	in	a	part	of	the	building(20).		
1.1.3	 Passive	smoking	
Passive	 smoking	 is	 the	 inhalation	 of	 SHS	 by	 persons	 other	 than	 the	 one	 actively	
smoking,	most	prominently	in	closed	spaces,	such	as	homes,	workplaces	or	cars.	In	
1990,	 DALYs	 attributable	 to	 passive	 smoking	 worldwide	 corresponded	 to	
approximately	 38	 million,	 in	 2010	 this	 number	 had	 decreased	 to	 20	 million	 (1).	
Nevertheless,	600	000	people	still	die	from	exposure	to	SHS	each	year	(21).	
The	 most	 vulnerable	 groups	 are	 women	 (47%	 of	 all	 attributable	 deaths),	 and	
children	 (28%)	 (22).	 Children	 are	 often	 exposed	 to	 SHS	 at	 home	 by	 smoking	
parents,	a	trend	that	is	significantly	heightened	in	socioeconomically	disadvantaged		
households	(23).	These	children	may	suffer	from	acute	otitis	media,	bronchitis	and	
pneumonia	 (16).	 Child	 mortality	 related	 to	 SHS	 exposure	 is	 often	 caused	 by	
infections	of	the	lower	respiratory	tract	or	asthma.	A	non‐smoking	mother	exposed	
to	 SHS	 during	 pregnancy	 increases	 the	 risk	 of	 stillbirth,	 low	 birth	 weight	 and	
congenital	anomalies	while	postnatal	exposure	to	SHS	increases	the	risk	of	sudden	
infant	death	syndrome	(SIDS)	(24‐26).	
The	 main	 causes	 of	 death	 from	 passive	 smoking	 in	 adults	 are	 ischaemic	 heart	
disease,	 asthma	 and	 lung	 cancer.	 If	 exposed	 on	 a	 regular	 basis	 these	 risks	 can	 be	
elevated	by	20‐30%	(16).	
Passive	 smoking	 is	 involuntary	 and	 health	 damages	 affect	 the	 most	 vulnerable	
groups.	The	tobacco	industry	soon	identified	the	issue	of	passive	smoking	as	more	
threatening	 to	 business	 than	 any	 former	 regulation	 or	 prohibition	 had	 been.	
Smoking	 was	 in	 danger	 of	 losing	 its	 social	 acceptability	 and	 potential	 economic	
damages	were	to	be	expected	(27).	
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1.1.4	 Cardiovascular	and	respiratory	health	
The	 list	 of	 illnesses	 related	 to	 tobacco	 consumption	 has	 continuously	 been	
expanded.	The	cardiovascular	as	well	as	the	respiratory	system	are	among	the	most	
susceptible	to	the	effects	of	air	pollutants	such	as	SHS.		
Cardio‐respiratory	health	factors	were	central	to	this	thesis.	Below	the	markers	we	
examined	are	introduced.	
Respiratory	 diseases	 account	 for	 18%	 of	 all	 tobacco	 related	 deaths	 (28).	 Studies	
indicate	 a	 linear	 dose‐response	 relationship	 between	 both	 active	 and	 passive	
smoking	and	lung	cancer	(29).	A	large	number	of	pack	years1		correspondingly	leads	
to	an	increase	in	lung	cancer	risk.	
Spirometry	
Spirometry	(the	measuring	of	breath)	is	the	most	common	pulmonary	function	test.	
It	measures	lung	function,	specifically	the	amount	(volume)	and/or	speed	(flow)	of	
air	 that	 can	 be	 inhaled	 and	 exhaled	 (30).	 In	 common	 practice	 it	 may	 be	 used	 to	
diagnose	asthma	and	obstructive	or	restrictive	lung	diseases	(31).	
Fractional	exhaled	nitric	oxide		
Fractional	 exhaled	 nitric	 oxide	 (FeNO)	 is	 an	 inflammatory	 marker	 mainly	
originating	 in	 the	 respiratory	 epithelium	 (32).	 Active	 smoking	has	 been	 shown	 to	
reduce	FeNO	 levels	 in	exhaled	air	but	knowledge	on	effects	of	passive	smoking	as	
well	 as	 reliable	 reference	 values	 are	 scarce	 (33,	 34),	 therefore	 our	 research	
regarding	cessation	of	SHS	exposure	and	FeNO	was	more	explorative	than	with	the	
other	outcomes.	
Cardiovascular	 health	 examinations	 suggest	 a	 different	 association	 pattern	 to	
smoking	 than	 respiratory	 studies.	 The	 risk	 of	myocardial	 infarction	 and	 coronary	
heart	 diseases	 increases	 steeply	 at	 low	 doses	 of	 SHS	 exposure	 or	 by	 actively	
smoking	1‐2	cigarettes	per	day	(Figure	1‐2).	This	is	in	contrast	to	other	substances	
such	 as	 reduced	 high	 density	 lipoprotein	 cholesterol	 or	 increases	 in	
                                                 
1Quantification	of	cigarette	smoking:	Number	of	pack	years	=		(packs	smoked	per	day)	×	(years	as	a	
smoker)	
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carboxyhaemoglobin	 concentrations	 that	 show	 a	 more	 linear	 dose‐response	
relationship	with	heart	disease	(35).	
 
Figure	1‐2	Non‐linear	dose‐response	association	between	exposure	to	tobacco	smoke	
toxins	and	ischaemic	heart	disease	(36).	
Heart	Rate	Variability	
The	 electrocardiogram	 (ECG)	 is	 a	 standard	 diagnostic	 tool	 in	 cardiology.	 It	 is	
painless,	 non‐invasive	 and	 reproducible	 under	 standardized	 conditions	 (37).	 It	
records	 the	 electrical	 activity	 of	 the	 heart	 and	 sheds	 light	 on	 the	 status	 of	 the	
Autonomic	 Nervous	 System	 (ANS).	When	measuring	 heart	 rate	 variability	 (HRV),	
the	temporal	pattern	between	heart	beats	(RR‐	or	NN‐interval)	is	the	focus	(Figure	
1‐3).	
 
Figure	1‐3	Peaks	and	RR	interval	of	an	ECG	signal	(38)	
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Even	when	 at	 rest,	 spontaneous	 variation	 is	 desirable	 indicating	 the	 ability	 of	 the	
heart	to	adapt	to	changes	in	stress	(Figure	1‐4).	In	smokers,	this	ability	to	adapt	is	
restricted,	shown	in	decreased	variation	(39).	Decreased	HRV	is	associated	with	an	
elevated	risk	for	cardiovascular	disease	(40,	41)and	overall	mortality	(42,	43).		
	
Figure	1‐4	Heart	Rate	Variability	of	a	normal	subject	(39)	
 
One	 simple	 statistical	 parameter	 to	 analyse	 the	 temporal	 domain	 of	 HRV	 is	 the	
Standard	Deviation	of	N‐N	Intervals	(SDNN).	Apart	from	the	temporal	domain,	there	
is	 a	 frequency	 domain	 which	 can	 give	 more	 detailed	 information	 on	 the	 exact	
composition	 of	 frequency	 shares	 that	make	 up	 the	HRV.	 Parameters	 include	High	
Frequency	(HF)	or	Low	Frequency	(LF).		
Arterial	Stiffness	
Measuring	 pulse	 wave	 velocity	 (PWV)	 is	 a	 non‐invasive	 method	 for	 assessing	
arterial	 stiffness.	 It	 involves	 measurement	 of	 two	 quantities:	 transit	 time	 of	 the	
arterial	pulse	along	the	analysed	arterial	segment	and	distance	on	the	skin	between	
both	recording	sites	(44).	The	pulse	wave	 that	 is	generated	by	the	 left	ventricle	 is	
transferred	 along	 the	 vascular	 wall	 with	 a	 velocity	 depending	 on	 the	 vascular	
elasticity	(Figure	1‐5).	PWV	inversely	correlates	with	arterial	elasticity:	a	high	PWV	
means	 that	 arterial	 stiffness	 is	 high	 and	 elasticity	 is	 low.	 PWV	 is	 an	 independent	
predictor	of	adverse	cardiovascular	events	such	as	arteriosclerosis	(45).	
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Figure	1‐5	Physiological	principle	of	pulse	wave	velocity	
1.2	 Tobacco	from	a	historical	and	political	perspective	
The	20th	century	belonged	to	the	cigarette.	It	experienced	several	decades	of	rising	
popularity	before	becoming	the	object	of	an	intense	debate	between	several	parties,	
each	gaining	the	upper	hand	at	different	stages.		The	increasing	number	of	smoking	
bans	worldwide	testifies	to	the	growing	success	of	the	anti‐tobacco	movement.	But	
along	the	way	it	had	to	experience	many	set‐backs.	
1.2.1	 The	rise	and	fall	of	the	cigarette	
When	 tobacco	 was	 first	 imported	 to	 Europe	 in	 the	 16th	 century,	 foreseeing	 King	
James	 I	 of	 England	 declared	 that	 smoking	 was	 “a	 custom	 loathsome	 to	 the	 eye,	
hateful	 to	 the	 nose,	 harmful	 to	 the	 brain,	 dangerous	 to	 the	 lungs…”	 (46).	
Nevertheless	this	plant	came	into	vogue	during	the	centuries	to	come,	first	mainly	in	
the	form	of	snuff	and	later	as	a	cigar.	Following	the	1883	invention	of	the	cigarette	
machine,	the	first	modern	cigarette	was	produced	in	the	USA	by	RJ	Reynolds	in	1913	
just	in	time	for	the	First	World	War.	Cigarettes	were	freely	distributed	to	the	troops	
and	at	times	even	used	as	commodity	money	(47).	The	Second	World	War	generated	
another	 surge	 in	 popularity;	 in	 those	 years	 tobacco	 companies	 still	 claimed	 that	
smoking	 was	 beneficial	 to	 health	 and	 families	 actually	 believed	 they	 were	 doing	
soldiers	 a	 favour	by	 supplying	 them	with	 cigarettes.	Today,	 cigarettes	 account	 for	
96%	of	the	value	of	all	tobacco	products	sold	globally	(48).	
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At	the	beginning	of	the	20th	century	lung	cancer	was	virtually	non‐existent,	but	rates	
suddenly	 started	 to	 rise	 steeply	 in	 the	 1940s,	 due	 to	 the	 long	 lag	 phase	 of	 20‐30	
years.	In	1939	Ochsner	and	DeBakey	first	suspected	the	link	between	smoking	and	
lung	 cancer	 (49).	 In	 1950	 tobacco	 advertising	 on	 television	 began	 and	 often	 used	
celebrities	 to	 appeal	 to	 youths.	 In	 the	 same	 year,	 A.	 Bradford	 Hill	 released	 a	
preliminary	 report	 proving	 that	 lung	 cancer	 was	 caused	 by	 smoking	 (50),	 a	
publication	that	soon	reached	legendary	status.	 It	denoted	the	start	of	a	 long	term	
cohort	study	on	mortality	related	to	smoking	habits	of	British	doctors,	a	study	that	
was	 continued	until	2001	and	would	ultimately	earn	 the	authors	knighthood.	The	
main	findings	were	that	persons	who	give	up	smoking	before	the	age	of	30	do	not	
die	prematurely	while	10	years	of	life	are	lost	if	smoking	is	continued	until	70	(51‐
55).	
The	 1950s	 therefore	 represented	 the	 starting	 point	 of	 a	 public	 health	 battle	 that	
soon	reached	global	status	and	continues	to	be	fought	to	the	present	day.	It	involves	
a	powerful	industry,	politicians,	health	advocates	and	innumerable	interest	groups.	
When	the	Surgeon	General’s	Report	stated	in	1964	that	smoking	causes	lung	cancer	
in	men	 this	had	 to	be	communicated	 in	a	 secured	press	conference	(56).	Smoking	
prevalence	dropped	by	20%	after	this,	but	only	transiently,	and	finally	peaked	in	the	
US	in	1965	(57).	
In	response	to	criticism,	the	industry	developed	a	low‐tar,	“light”	and	a	low‐nicotine	
cigarette	 which	 were	 promoted	 as	 less	 dangerous	 and	 less	 addictive	 (58).	 It	
organized	a	worldwide	network	of	scientific	consultants	 to	mislead	the	media,	 the	
public	 and	 healthcare	 advocates	 (59).	 Scientific	 results	 were	 downplayed,	
questioned	and	denied	(60‐63).	These	measures	helped	buy	the	industry	time,	and	
significantly	delayed	 the	 introduction	of	 smoking	bans.	However,	 in	 the	1970s	 the	
first	cigarette	advertising	bans	on	TV	and	radio	were	implemented	(64).	
The	 discussion	 on	 smoking	 bans	 in	 public	 places	 emerged	 when	 the	 dangers	 of	
involuntary	 tobacco	 smoking	 came	 into	 play.	 The	 first	 reports	 on	 adverse	 health	
effects	 of	 passive	 smoking	 were	 published	 in	 1981	 by	 the	 Japanese	 scientist	
Hirayama	who	observed	that	non‐smoking	wives	of	heavy	smokers	had	a	higher	risk	
of	lung	cancer	(65).	By	1986	it	was	widely	accepted	among	scientific	circles	that	SHS	
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indeed	also	caused	lung	cancer.	Even	before	this	the	World	Health	Assembly	(WHA),	
the	 decision‐making	 body	 of	 the	 World	 Health	 Organisation	 (WHO),	 released	 a	
report	expressing	 for	the	 first	 time	the	need	for	a	 framework	for	effective	tobacco	
control.	 	 Finally,	 recognizing	 the	 trans‐national	 character	 of	 the	 industry	 and	 the	
need	for	a	global	response	to	the	growing	worldwide	tobacco	epidemic,	in	1997	the	
WHO	initiated	its	first	international	treaty,	the	Framework	Convention	on	Tobacco	
Control	(FCTC).	
1.2.2	 The	WHO	Framework	Convention	on	Tobacco	Control	(FCTC)	
The	FCTC	was	the	first	treaty	to	be	negotiated	by	the	WHO.	It	is	an	evidence‐based	
treaty	resting	upon	the	WHO	constitution	from	1946	that	stated	the	objective	of	the	
WHO	 is	 the	 attainment	 of	 the	 highest	 possible	 level	 of	 health	 by	 all	 peoples	 (66).	
Negotiations	on	the	FCTC	started	in	1999	and	it	took	four	years	until	the	treaty	was	
unanimously	approved	by	the	WHO	assembly.	It	came	into	force	in	2005	as	one	of	
the	globally	most	recognised	treaties	with	168	signature	states.	To	date	it	has	been	
ratified	by	176	states.	
The	most	important	obligations	of	the	treaty	are	the	following	(67):	
•	product	declarations	and	warnings	on	all	tobacco	products;	
•	restrictions	in	tobacco	marketing	and	sponsoring;	
•	control	of	cigarette	smuggling,	of	 illegal	 fabrication	and	counterfeiting	of	tobacco	
products;	
•	prohibition	of	selling	tobacco	products	to	minors.	
Article	8	deals	with	protection	from	exposure	to	SHS:	treaty	members	are	obliged	to	
undertake	measures	to	protect	people	from	SHS	at	the	workplace,	in	closed	spaces	
and	in	public	transportation,	facilities	and	places.	
Additionally	 price	 and	 tax	 measures	 are	 to	 be	 taken	 to	 reduce	 the	 demand	 for	
tobacco	(68).		The	FCTC	is	supported	by	the	Department	of	Tobacco	Free	Initiative	
(TFI),	a	project	by	the	WHO	designated	to	reduce	the	global	burden	of	disease	and	
death	caused	by	tobacco.	It	supports	member	states	in	 legal,	political	and	financial	
matters	concerning	tobacco	control	and	coordinates	international	activities	(69).	
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Switzerland	signed	 the	FCTC	 in	2004	but,	 like	 the	USA	and	seven	other	 countries,	
never	 ratified	 it.	 This	 exemplifies	 the	 attitude	 assumed	 by	 Switzerland	 when	 it	
comes	to	tobacco	control.	
1.2.3	 The	smoking	ban	
A	smoking	ban	can	either	be	aimed	at	public	or	private	areas	and	may	be	mandated	
by	 law	or	be	voluntarily	adopted	(59).	While	 the	 first	smoke‐free	 initiatives	 in	 the	
18th	 century	 were	 designed	 to	 reduce	 fire‐risks	 (70)	 smoking	 bans	 in	 the	 21st	
century	are	mainly	a	consequence	of	health‐related	initiatives.	
Even	 before	 workplace	 smoking	 bans	 became	 legally	 binding,	 many	 companies	
voluntarily	implemented	smoking	restrictions.	A	serious	debate	on	detrimental	SHS	
exposure	at	the	workplace	was	launched	by	flight	attendants	who	prior	to	a	ban	on	
aircrafts	were	the	most	affected	occupational	group	(59).	Today,	in	many	countries,	
bars	 and	 restaurants	 are	 primarily	 regarded	 as	 recreational	 sites,	 not	 as	 work	
places,	and	therefore	hospitality	venues	are	often	excluded	from	smoking	bans.	This	
represents	 a	major	 issue	 in	 the	 controversies	 regarding	 new	 smoking	 regulations	
and	 exceptions	 therein	 (71).	Many	 countries	 have	 only	 implemented	 partial	 laws,	
either	 leaving	 room	 for	exceptions	or,	depending	on	 the	political	 system,	 covering	
just	parts	of	a	country.	
In	parallel	to	this	wave	of	smoking	bans,	national	anti‐tobacco	movements	launched	
a	forceful	campaign	against	tobacco	advertising.	Adverse	health	effects	and	risks	of	
addiction	 are	 the	main	 arguments	 in	 these	 advances.	 Opponents	 of	 smoking	 bans	
argue	that	the	government	interferes	with	personal	lifestyle,	hospitality	venues	may	
incur	 economic	 losses,	 adequate	 ventilation	 sufficiently	 reduces	 SHS	 or	 that	
smoking	 will	 be	 moved	 to	 private	 homes	 where	 children	 could	 be	 increasingly	
exposed	(71,	72).	
In	 2004,	 the	 Republic	 of	 Ireland	 was	 the	 first	 ever	 country	 to	 implement	 a	
comprehensive	smoking	ban	to	protect	 the	population	 from	SHS	at	 the	workplace,	
even	before	 ratifying	 the	FCTC	(73).	Within	a	 few	years	other	European	countries	
such	as	Italy	in	2005	and	the	UK	in	2007	followed	(74,	75).	
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To	date	87	nations	have	enacted	some	sort	of	100%	smoke	free	law,	and	59	include	
both	 restaurants	 and	 bars	 (76).	 Though	 first	 initiated	 in	 industrialized	 countries,	
smoking	 bans	 have	 also	 spread	 to	 the	 developing	 world.	 Several	 Latin‐American	
countries	have	a	 comprehensive	 smoking	ban.	Asia	 still	 lags	 far	behind,	but	 so	do	
many	parts	of	Europe,	particularly	in	the	East.	
1.3	 Tobacco	from	a	Swiss	perspective	
1.3.1	 The	smoking	ban	in	Switzerland	
Switzerland	 is	 a	 country	 with	 a	 strong	 democratic	 and	 highly	 devolved	 federal	
tradition.	A	large	amount	of	laws	are	implemented	on	a	cantonal	level.	Switzerland	
is	 divided	 into	 26	 cantons	 that	 are	 separate,	 largely	 autonomous	 administrative	
zones.	The	first	canton	to	vote	on	a	smoking	ban	was	Ticino	(TI)	in	2006:	79%	of	the	
population	 approved	 a	 smoke	 free	 hospitality	 sector.	 Other	 cantons	 followed,	 but	
many	 had	 incorporated	 exceptions	 into	 the	 law,	 leaving	 the	 possibility	 open	 for	
small	venues	to	remain	smoking	or	for	separate	smoking	rooms.	The	first	national	
smoking	 ban,	 that	 had	 been	 initiated	 in	 2004	 and	 was	 passed	 by	 the	 federal	
government	 on	 3	 October	 2008,	 was	 to	 be	 implemented	 on	 1	 May	 2010.	 The	
parliament	 had	 incorporated	 some	 exceptional	 rules	 stating	 that	 venues	 smaller	
than	80m2	could	continue	 to	 run	as	 smoking	venues	and	separate	smoking	rooms	
not	 larger	 than	 1/3	of	a	venue	should	also	be	allowed	(77,	78).	This	quickly	 led	 to	
around	 45	 organizations	 dealing	 with	 health,	 prevention,	 consumer	 and	 worker	
protection	 as	 well	 as	 youth	 and	 parenting	 to	 join	 forces	 in	 May	 2009,	 one	 year	
before	the	 federal	act	was	 implemented.	They	 launched	an	 initiative	 for	a	national	
comprehensive	 smoking	 ban.	 This	 initiative	 was	 submitted	 in	 May	 2010	 shortly	
after	the	original	ban	had	come	into	force.	It	was	rejected	on	23	September	2012	as	
recommended	by	the	government	after	a	lively	public	debate.	
To	 date	 Switzerland	 remains	 a	 patchwork	 of	 smoking	 regulations,	 with	 sporadic	
advances	by	different	interest	groups	to	either	weaken	or	tighten	the	cantonal	laws.	
In	Basel	Stadt	(BS)	where	parts	of	the	research	work	for	this	thesis	was	performed,	
there	 was	 a	 vote	 in	 November	 2011	 to	 downgrade	 the	 law	 to	 the	 degree	 of	 the	
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national	 law.	 This	 action	was	 supported	 by	 the	 so‐called	 “Fümoar	 Club”	 that	 had	
been	 founded	 on	 22	 January	 2010	 in	 anticipation	 of	 the	 national	 law.	 Owners	 of	
roughly	185	hospitality	venues	that	continue	as	smoking	venues	are	members	of	the	
club.	All	guests	are	required	to	buy	a	card	for	passive	membership	for	10	CHF	per	
year,	non‐members	are	not	allowed	to	visit	 these	venues.	A	 juristic	evaluation	has	
declared	this	type	of	club	as	a	clear	contravention	of	the	law	but	to	date	attempts	for	
legal	action	have	been	pushed	to	higher	courts	delaying	any	definite	action	(79).	A	
similar	 attempt	 to	 circumvent	 the	 law	 in	 another	 canton	 was	 recently	 declared	
illegal,	 and	 therefore	 the	 end	 of	 the	 “Fümoar	 Club”	 in	 BS	 appears	 to	 be	 solely	 a	
question	of	time.		
The	 most	 recent	 initiative	 on	 a	 federal	 level	 was	 submitted	 for	 preliminary	
examination	by	the	“Swiss	committee	against	passive	smoking”	from	Geneva	to	the	
federal	 chancellery	 in	 May	 2012.	 It	 demands	 “protection	 of	 health	 from	 passive	
smoking	–	for	an	effective	and	non‐discriminatory	protection	along	the	lines	of	the	
WHO”,	 expanding	 demand	 to	 include,	 for	 the	 first	 time,	 regulation	 of	 private	
settings.	The	18	month	long	signature	collection	for	the	initiative	to	be	approved	for	
a	national	vote	will	end	on	19	December	2013	(80).	
1.3.2	 The	economic	significance	of	tobacco	for	Switzerland	
Switzerland	 is	of	particular	 interest	 to	 the	 tobacco	 industry.	 International	 tobacco	
companies	 such	 as	 Japan	 Tobacco	 (JT)	 and	 British	 American	 Tobacco	 (BAT)	 have	
their	biggest	branch	office	outside	of	the	US	in	Switzerland	and	Philipp	Morris	has	
its	 global	 headquarters	 in	 Lausanne.	 All	 three	 companies	 hold	 large	 cigarette	
manufacturing	factories	in	this	country	and	are	therefore	important	employers	and	
tax	payers.	
An	average	package	of	cigarettes	currently	costs	7.90	CHF,	adjusted	for	purchasing	
power	 this	 is	 among	 the	 cheapest	 in	 high	 income	 countries	 (81).	 54%	 of	 the	
revenues	are	 taxes	 that	are	entirely	used	 for	 the	Old‐Age	and	Survivors	 Insurance	
(AHV)	and	the	Disability	Insurance	(IV).	 	The	Swiss	government	earned	2.2	Billion	
CHF	from	tobacco	sales	taxes	in	2011.	0.3%	of	the	revenues	from	cigarette	sales	are	
used	 in	 support	 of	 local	 tobacco	 growers,	 the	 same	 amount	 that	 goes	 into	 the	
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tobacco	 prevention	 fund	 (TPF)	 (82).	 The	 fund	 was	 set	 up	 to	 finance	 prevention	
strategies,	 keep	 people	 from	 taking	 up	 tobacco	 smoking,	 support	 quitting	 and	
protect	the	population	from	SHS	(83).	
Tobacco	consumption	costs	the	Swiss	economy	around	10	billion	CHF/year.	Medical	
treatment	accounts	for	1.2	billion	of	these,	while	costs	related	to	working	hours	lost	
to	 illness	and	 invalidity	 contribute	3.8	billion	 (84).	The	 remaining	5	billion	are	an	
estimate	 for	 loss	of	quality	of	 life.	Direct	health	costs	 from	SHS	exposure	 in	public	
places	have	been	estimated	at	330	m	CHF/year	(85).		
In	 Switzerland	 smoking	 is	 the	 leading	 preventable	 cause	 of	 death	 (86),	 which	
provides	the	main	motivation	for	this	research	as	described	in	the	aims	below.	
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2 AIMS	AND	OBJECTIVES	OF	THIS	THESIS	
2.1	 Research	gaps	
Despite	the	large	number	of	studies	that	have	been		
performed	in	numerous	countries	surrounding	the		
implementation	of	a	public	smoking	ban,	several		
issues	regarding	exposure	assessment	and	health		
effects	 remain	unresolved.	Reliable	methods	 to	 assess	personal	 SHS	exposure	and	
the	most	appropriate	markers	 to	observe	 the	 influence	of	 SHS	on	health	 risks	 are	
still	 to	 be	 evaluated.	 Moreover,	 most	 former	 smoking	 ban	 study	 designs	 did	 not	
permit	the	 inclusion	of	a	control	group	as	the	bans	were	usually	 introduced	in	the	
entire	study	region.	The	COSIBAR	(Cohort	Study	on	Smoking	Interventions	in	Bars	
and	 Restaurants)	 aimed	 to	 illuminate	 many	 of	 these	 open	 questions	 by	 applying	
several	methods	to	measure	SHS	exposure,	examining	a	variety	of	health	outcomes	
and	by	including	a	control	group.	
Exposure	to	second	hand	smoke	
Previous	 studies	 usually	 used	 a	 single	 measure	 to	 determine	 exposure.	 This	 was	
often	 a	 proxy	 for	 SHS	 such	 as	 PM2.5	 or	 even	 more	 commonly	 self‐reported	
estimations.	 The	 COSIBAR	 study	 compared	 and	 evaluated	 several	 objective	
exposure	measurement	methods	in	parallel,	all	of	them	specific	to	tobacco.	Exposure	
results	are	discussed	in	Article	1,	Section	4	of	this	thesis.	
Cardiovascular	health	outcomes	
Although	 SHS	 is	 a	 widely	 recognized	 risk	 factor	 for	 heart	 disease,	 there	 are	 still	
ample	knowledge	gaps	on	cardiovascular	effects	of	a	smoking	ban,	in	particular	with	
respect	to	long	term	exposure.	This	study	examined	cardiovascular	health	by	means	
of	 two	methods	assessing	HRV,	a	quantitative	marker	of	autonomic	activity	of	 the	
nervous	 system,	 and	 PWV,	 a	 marker	 of	 arterial	 stiffness.	 Results	 on	 these	
measurements are addressed in Article 2 in Section 5 of this thesis.	
“We will continue to use 
all necessary resources… 
and where necessary 
litigation, to actively 
challenge unreasonable 
regulatory proposals.” 
 
Louis Camilleri, 
Chairperson and CEO, 
Philip Morris 
International, 2010 
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Respiratory	health	outcomes	
Fractioned	Exhaled	Nitric	Oxide	(FeNO),	an	 inflammatory	marker	of	 the	 lungs,	has	
not	been	investigated	in	most	smoking	ban	studies.	Previous	publications	on	FeNO	
in	 smokers	 and	 asthmatics	 suggested	 this	 could	 be	 a	 further	 interesting	 though	
complex	marker	in	assessing	airway	inflammation	in	connection	with	SHS	exposure.	
Results	on	this	topic	are	summarized	in	Article	3	in	Section	6	of	this	thesis.	
Research	on	 lung	 function	developments	 in	non‐smokers	 after	 a	 smoking	ban	has	
delivered	contradictory	results	as	to	which	parameters	undergo	a	change	and	how	
long	it	takes	for	potential	improvements	to	come	about.	We	included	spirometry	to	
further	 clarify	 these	 issues.	 To	 complement	 these	 findings	 we	 also	 asked	 several	
questions	on	respiratory	symptoms	 in	 the	 interview.	Corresponding	results	are	 to	
be	found	in	Article	3	in	Section	6	of	this	thesis.	
Behaviour	towards	and	acceptance	of	the	smoking	ban	
It	 is	 still	 uncertain	 how	 different	 levels	 of	 smoking	 regulations	 are	 accepted	 by	
hospitality	 workers	 and	 if	 rules	 are	 complied	 with.	 Results	 from	 other	 countries	
examining	 behaviour	 and	 acceptance	 after	 a	 complete	 smoking	 ban	 cannot	 be	
directly	 applied	 to	 the	 heterogeneous	 situation	 in	 Switzerland	 with	 different	
regulations	 in	 a	 small	 geographic	 area.	 In	 the	 COSIBAR	 study	 a	 questionnaire	
assessing	 these	 issues	 was	 distributed	 to	 smoking	 and	 non‐smoking	 hospitality	
workers.	The	analyses	and	interpretation	are	summarized	in	Article	4	in	Section	7	of	
this	thesis.	
2.2	 Questions	and	objectives	
The	overall	aim	of	this	study	was	to	compare	changes	in	SHS	exposure	and	cardio‐
respiratory	 health	 in	 non‐smoking	 hospitality	workers	 that	 experience	 a	 smoking	
ban	 at	 their	 workplace	 to	 a	 control	 group	 that	 did	 not	 undergo	 any	 changes	 in	
exposure.	 In	 addition,	 potential	 changes	 in	 behaviour	 and	 acceptance	 in	 smoking	
and	non‐smoking	hospitality	workers	were	assessed.	
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On	the	basis	of	our	results	the	following	methodological	questions	and	wider	policy	
relevant	issues	are	addressed	in	the	discussion	in	Section	9	of	this	thesis:	
1) Our	findings	in	context:	How	do	they	fit	in	with	other	studies?		
2) Methodological	Issues:	What	are	the	strengths	and	limitations?	
3) Hospitality	workers:	Is	this	a	suitable	study	population?		
4) From	research	to	policy:	How	could	our	results	impact	policy‐making?		
5) Future	tobacco	research:	What	are	key	issues	and	goals?	
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3 STUDY	SETTING	AND	METHODS	
3.1	 Study	Design		
COSIBAR	(Cohort	Study	on	Smoking	Interventions		
in	Bars	and	Restaurants)	is	a	prospective	cohort	study		
that	used	the	implementation	of	a	nationwide	
smoking	ban	in	May	2010	as	an	intervention	to		
create	a	quasi‐experimental	research	setting.	Several		
cantons	–	administrative	zones	in	Switzerland	–	had	already	issued	a	smoking	ban	
before	 the	 federal	 law	 on	 second	 hand	 smoke (Bundesgesetz	 zum	 Schutz	 vor	
Passivrauchen,	 SR	 818.31)	 was	 implemented	 but	 these	 regulations	 varied	 in	
strictness	(Figure	3‐1).	The	federal	law	prohibited	smoking	in	closed	spaces	that	are	
either	public	or	serve	as	a	workplace.	Hospitality	venues	below	80	m2	in	size	were	
still	 allowed	 to	 be	 run	 as	 smoking	 venues	 if	 adequately	 ventilated	 (77).	 An	
amendment	added	 that	 smoking	rooms	 that	do	not	exceed	 1/3	of	 the	entire	venue	
should	also	remain	optional	(78).	Cantons	continued	to	be	free	to	implement	more	
stringent	laws.		
	
Figure	3‐1	Heterogeneity	in	smoking	legislation	across	different	cantons	in	Switzerland	
“A few weeks before the 
ban came into force in 
Ireland, Dublin banker 
Jimmy Fogarty asked the 
barman at his local pub: 
‘What are you going to do 
when the ban comes in?’ 
‘Breathe’, the barman 
replied.” 
 
Bulletin of the World 
Health Organization, 
Ireland, 2006 
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COSIBAR	was	to	be	carried	out	in	three	cantons	that	did	not	have	any	ban	in	place	
before	1	May	2010:	Basel	City	(BS),	Basel	County	(BL)	and	Zurich	(ZH).		
While	the	population	in	BS	and	BL	had	voted	for	the	most	stringent	version	of	the	
regulation	in	Switzerland,	only	allowing	unattended	smoking	rooms,	ZH	added	one	
amendment	 to	 the	 basic	 national	 law	 by	 additionally	 prohibiting	 small	 smoking	
venues	below	80m2	but	permitting	owners	to	arrange	a	smoking	room	according	to	
the	 national	 law.	 BS	 already	 implemented	 the	 new	 law	 on	 1	 April	 2010,	 so	 there	
were	no	further	changes	in	this	canton	on	1	May	2010	and	baseline	measurements	
of	the	study	needed	to	be	finalized	one	month	earlier.	
Due	 to	 these	 heterogeneous	 regulations	 the	 COSIBAR	 study	 had	 the	 unique	
opportunity	of	comparing	a	group	of	hospitality	workers	experiencing	a	strict	new	
law	to	a	group	that	remained	exposed	to	SHS	at	different	degrees	after	1	May	2010.	
Prior	to	implementation	of	the	ban	we	performed	baseline	measurements	of	SHS	in	
all	complying	venues	and	invited	eligible	participants	to	the	medical	examination.		
	
 
Figure	3‐2	Overview	of	the	study	design	
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The	behaviour	and	acceptance	questionnaire	was	sent	to	all	hospitality	workers	that	
gave	us	their	address	irrespective	of	smoking	status.	
Participants	of	the	medical	examination	were	invited	to	two	follow‐up	examinations,	
six	and	twelve	months	after	the	ban.	Exposure	data	was	collected	collaterally	each	
time.	At	 baseline	 the	number	of	 venues	 far	 exceeded	participants.	After	 the	ban	 a	
convenience	 sample	 was	 measured	 again,	 including	 all	 that	 were	 participants’	
workplaces.	 The	 behaviour	 and	 acceptance	 survey	was	 repeated	 after	 six	months	
(Figure	3‐2).	
3.2	 Recruitment	
		
Figure	3‐3	Recruitment	procedure	
 
After	 ethical	 clearance	 had	 been	 received	 from	 the	 EKBB	 in	 December	 2009,	
recruitment	 started	 in	 January	 2010	 according	 to	 the	 scheme	 in	 Figure	 3‐3.	 A	
comprehensive	 list	 of	 hospitality	 venues	 was	 drawn	 from	 the	 digital	 Swiss	
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phonebook	2009	①	and	invitation	letters	containing	information	on	the	study	and	a	
form	to	schedule	a	visit	were	sent	to	all.	Non‐responders	were	followed‐up	by	phone	
and	 direct	 personal	 visits	②.	Whenever	 we	 got	 permission	 from	 the	 owner	 of	 a	
smoking	 venue	 ③,	 we	 deposited	 MoNIC	 badges	 for	 SHS	 measurements	 and	
distributed	screening	questionnaires	to	the	staff.	 	After	one	week	we	went	back	to	
pick	 up	both	④.	Eligible	 study	participants	were	 invited	 to	 a	 health	 examination,	
which	 was	 carried	 out	 in	 one	 of	 the	 two	 study	 centres	 in	 Basel	 and	 Zurich	⑦.	
Hospitality	 workers	 that	 were	 not	 eligible	 for	 the	 health	 study	 received	 the	
behaviour	and	acceptance	questionnaire	by	post.		
Due	 to	 the	 poor	 response	 rate	 several	 amendments	were	made	 to	 the	 procedure	
during	the	whole	recruitment	period:	
 Control	group	members	were	 further	recruited	after	 implementation	of	 the	
new	law.		
 We	 visited	 hospitality	 venues	 directly	 without	 prior	 arrangement,	
emphasized	 the	 possibility	 of	 expressing	 their	 opinion	 in	 the	 acceptance	
questionnaire,	we	shortened	and	adapted	the	screening	questionnaire,	added	
a	 support	 letter	 from	 the	 cantonal	 physician	 and	 also	directly	 enclosed	 the	
acceptance	questionnaire	in	the	mailing.		
 We	placed	 an	 advertisement	 in	 the	 20	minutes	 newspaper	 in	 ZH,	 the	most	
popular	free	newspaper,	and	in	the	gastronomy	paper	“Expresso”	and	placed	
a	link	on	the	website	of	the	Swiss	gastronomy	association.		
 We	 hired	 someone	 solely	 to	 recruit	 more	 participants	 and	 extended	 the	
control	group	to	non‐exposed	hospitality	workers	that	had	always	worked	in	
a	smoke‐free	environment.		
 We	also	looked	for	non‐hospitality	workers	exposed	to	SHS	on	a	regular	basis	
by	means	of	an	online	advertisement	to	further	expand	the	exposed	control	
group	⑤. 
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3.3	 Study	Sample	
At	 baseline,	 225	 badges	 were	 placed	 in	 193	 hospitality	 venues	 consisting	 of	 126	
restaurants,	31	cafés	and	36	bars.	At	follow‐up	1,	we	measured	51	venues	with	52	
badges	and	at	follow‐up	2,	42	badges	were	placed	in	36	venues.	
Eligibility	criteria	for	the	medical	examination	were	being	between	18	and	65	years	
of	 age,	 working	 at	 least	 half‐time,	 having	 worked	 for	 at	 least	 one	 year	 in	 the	
hospitality	sector	and	having	been	a	non‐smoker	for	at	least	5	years.	Persons,	who	
intended	 to	 leave	 the	 job	 within	 the	 next	 three	 months	 or	 were	 pregnant,	 were	
excluded.	
The	medical	survey	was	conducted	with	92	participants	at	baseline,	57	women	and	
35	men	with	an	average	age	of	40.3	(95%‐CI:	37.6	to	43.0).	56	came	back	at	follow‐
up	 1	 (60.9%)	 and	 48	 at	 follow‐up	 2	 (52.2%).	 44	 persons	 attended	 all	 three	
examinations	 (47.8%).	 Participants	 were	 divided	 into	 four	 groups:	 a)	 the	
Intervention	group,	hospitality	workers	 that	experienced	a	 change	 in	exposure,	b)	
Control	group	I,	hospitality	workers	that	remained	exposed	to	SHS	after	the	ban,	c)	
Control	 group	 II,	 hospitality	 workers	 that	 had	 always	 worked	 in	 a	 smoke‐free	
environment	 and	 d)	 Control	 group	 III,	 that	 consisted	 of	 people	 that	 were	 SHS	
exposed	on	a	regular	basis	without	being	employed	in	the	hospitality	sector	(Figure	
3‐4).	 Control	 groups	 I	 and	 III	 were	 merged	 for	 analysis	 (referred	 to	 as	 exposed	
control	group).	
The	 behaviour	 and	 acceptance	 survey	 that	 included	 smoking	 and	 non‐smoking	
hospitality	workers	had	109	participants	at	baseline	and	83	at	 follow‐up	 (76.1%).	
71	persons	filled	in	the	questionnaire	twice.	Non‐smoking	respondents	were	mainly	
participants	from	the	medical	examination.	
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Figure	3‐4	Study	sample:	Hospitality	venues	and	participants	of	the	medical	examination	
3.4	 Exposure	Measurements	
In	this	study,	exposure	to	SHS	was	measured	using	three	different	methods	resulting	
in	five	parameters:	
 The	newly	developed	MoNIC	(Monitor	of	nicotine)	badge,	a	passive	sampler,	
is	a	glass	fibre	filter	that	is	washed	with	distilled	water,	methanol	and	CH2Cl2	
(Dichloromethane)	and	 impregnated	with	5mg	sodium	bisulphate	per	 filter	
(87).	 It	 is	 transported	 in	 an	 air‐tight	 plastic	 case	 between	 the	 lab	 and	
measurement	 sites.	 It	may	be	placed	 in	 a	 room	 for	up	 to	 a	week	or	 can	be	
worn	as	a	brooch	near	 the	respiratory	organs	 for	a	personal	measurement.	
The	amount	of	nicotine	on	the	badge	is	assessed	by	gas	chromatography	and	
used	to	calculate	the	number	of	passively	smoked	cigarettes	per	day	(CE/d)	
assuming	a	nicotine	 content	of	0.2	mg/cigarette	and	an	average	ventilation	
rate	of	10	L/min	(88).		
Participants	were	 asked	 to	wear	 badges	 on	 themselves	 (Figure	 3‐5)	 for	 24	
hours	 for	a	personal	measurement	and	to	 fill	 in	a	badge	protocol	providing	
details	on	the	exact	times	and	locations	of	measurement.	
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Figure	3‐5	The	MoNIC	badge	and	its	application	
	
1‐2	badges,	depending	on	the	number	of	smoking	and	non‐smoking	sections,	
were	placed	in	the	hospitality	venues	for	one	week,	often	near	the	bar	where	
waiting	personnel	spend	much	of	their	working	time.	We	calculated	a	time‐
weighted	average	for	workplace	exposure	taking	into	account	work	load	and	
regular	work	time.	The	24h	badge	value	was	multiplied	by	1.75	considering	
that	 nicotine	 levels	 decrease	 when	 the	 venue	 is	 closed.	 This	 factor	 was	
estimated	 from	 a	 previous	 study	 of	 continuous	 PM2.5	 measurements	 in	
smoking	 environments	 (20).	 For	 a	 full‐time	 employee	 the	 obtained	
concentration	was	divided	by	 three	 to	 calculate	 average	CE/d	 assuming	 an	
eight	 hour	 shift/day.	 The	 value	 for	 part‐time	 employees	 was	 derived	 by	
further	 dividing	 according	 to	 the	 workload.	 	 For	 non‐hospitality	 workers	
average	SHS	exposure	was	obtained	from	a	personal	badge	that	participants	
wore	on	themselves	on	a	typical	day.	
 A	saliva	sample	was	taken	at	each	medical	examination	to	determine	current	
nicotine	and	cotinine	concentration.	
 A	questionnaire	provided	self‐reported	exposure	information.	
3.5	 Health	Examinations	
Health	examinations	were	performed	in	one	of	our	study	centres	in	either	Zurich	or	
Basel.		The	following	outcomes	were	recorded:	
 Height	and	weight		
 Hip	and	waist	circumference	
3	Study	Setting	and	Methods	
26 
 
 Heart	Rate	Variability	(HRV),	a	quantitative	marker	of	autonomic	activity	of	
the	 nervous	 system	 that	 is	 associated	 with	 cardiovascular	 morbidity	 and	
mortality		
 Pulse	 wave	 velocity	 (PWV),	 a	 measure	 of	 arterial	 stiffness	 which	 is	 an	
important	indicator	of	cardiovascular	risk	factors	and	atherosclerosis	
 Blood	pressure	
 A	skin	prick	test	on	the	forearm	to	diagnose	allergies	
 Fractional	exhaled	nitric	oxide	(FeNO),	a	marker	of	inflammation	in	the	lungs	
 Spirometry	to	measure	lung	function	
 An	extensive	questionnaire	including	information	on	respiratory	symptoms,	
cardio‐vascular	medical	history,	medicine	intake,	allergy	symptoms,	smoking	
and	 alcohol	 consumption,	 quality	 of	 life,	 sleeping	 habits,	 physical	 activity,	
living	 conditions	 and	 noise	 exposure.	 This	 was	 partly	 conducted	 as	 a	
computer	based	interview	and	partly	on	paper.	
3.6	 Behaviour	and	Acceptance	Survey	
The	 written	 questionnaire	 contained	 83	 questions	 about	 current	 smoking	
regulations	at	the	workplace	and	their	compliance.	It	covered	cognitive	acceptance	
issues	 such	 as	 personal	 relevance	 and	 knowledge	 about	 the	 law,	 social	 factors	
(perception	of	non‐smoking	as	a	social	norm	and	perception	of	relevant	peers)	and	
proactive	 acceptance	 and	 perceived	 annoyance	 at	 the	 workplace	 and	 as	 a	 guest.	
Smoking	status	and	behaviour	(smokers	only)	were	assessed	according	to	the	WHO	
definition	(89).	
3.7	 Data	Analysis	
We	 developed	 statistical	 association	 models	 to	 answer	 the	 different	 research	
questions.	 All	 analyses	 were	 adjusted	 for	 the	 appropriate	 covariates	 that	 were	
determined	 for	 each	 outcome.	 Further	 details	 and	 results	 can	 be	 found	 in	 the	
corresponding	articles	in	sections	4	to	7	of	this	thesis.	
	
3	Study	Setting	and	Methods	
27 
 
Is	cardio‐respiratory	health	in	non‐smoking	hospitality	workers	affected	by	long‐term	
SHS	exposure	before	implementation	of	a	smoking	ban?	
A	cross‐sectional	analysis	of	 the	outcome	data	at	baseline	was	done	using	 linear	
regression	with	the	estimated	work	place	SHS	exposure	as	explanatory	variable	and	
adjusting	for	appropriate	covariates.	Data	from	all	study	participants	were	used	for	
this	model.	
	
Is	 there	 a	 dose‐response	 relationship	 between	 SHS	 exposure	 and	 cardio‐respiratory	
health	markers	before	and	after	a	smoking	ban?	
Covariate‐adjusted	 exposure	 response	 associations	 were	 calculated	 with	 a	
random	intercept	model	using	the	estimated	work	place	SHS	exposure	at	the	time	of	
the	 health	 examination	 as	 explanatory	 variable.	 Data	 from	 all	 study	 participants	
were	used	for	this	model.	
	
Does	 cardio‐respiratory	 health	 improve	 in	 an	 intervention	 group	 of	 non‐smoking	
hospitality	workers	that	experiences	a	smoking	ban	in	comparison	to	a	control	group	
that	remains	exposed?	
In	 this	 model,	 the	 two	 follow‐up	 measures	 were	 merged	 into	 one	 post‐ban	 to	
increase	 statistical	 power.	 Changes	 in	 the	 outcome	 were	 compared	 between	 the	
intervention	 and	 the	 control	 group	 irrespective	 of	 exact	 exposure.	 For	 the	
intervention	group	and	the	exposed	control	group	a	pre/post	ban	exposure	variable	
was	derived	although	in	the	control	group	no	ban	was	introduced.	For	each	outcome	
a	linear	mixed	effects	model	with	a	random	subject	intercept	was	fit	including	a	
(study	group	*	pre/post	ban)	 interaction	term.	Then,	crude	and	adjusted	values	of	
the	health	outcomes	prior	 and	after	 the	ban	 for	both	groups	were	 calculated.	The	
unexposed	control	group	was	excluded	in	this	model.	
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Do	replies	in	the	questionnaires	change	in	the	course	of	the	study?		
Categorical	 answers	 before	 and	 after	 the	 ban	were	 compared	 by	means	 of	 a	Chi2	
test.	The	Kruskal	Wallis	Test	was	used	for	numerical	data.	
These	tests	were	applied	for	the	evaluation	of	the	behaviour	and	acceptance	survey	
as	well	as	other	self‐reported	outcomes	such	as	respiratory	symptoms.	
	
All	 data	 were	 analysed	 using	 STATA	 10.1	 and	 STATA	 12	 (StataCorp	 LP,	 College	
Station,	TX).	Graphs	were	created	with	R	3.0.0.	
3.8	 Ethical	Clearance	
Ethical	approval	was	obtained	 from	the	Ethics	committee	of	both	cantons	of	Basel	
(EKBB)	 on	 25	 November	 2009	 (Ref.	 No.	 EK	 317/09).	 All	 participants	 signed	 an	
informed	consent	before	every	examination.	
	
Methodological	issues	are	discussed	in	Section	9.2	of	this	thesis.	
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ABSTRACT	
Background.	In	May	2010,	Switzerland	introduced	a	heterogeneous	smoking	ban	in	
the	hospitality	sector.	While	the	law	leaves	room	for	exceptions	in	some	cantons,	it	
is	 comprehensive	 in	 others.	 This	 longitudinal	 study	 uses	 different	 measurement	
methods	 to	examine	airborne	nicotine	 levels	 in	hospitality	venues	and	the	 level	of	
personal	 exposure	 of	 non‐smoking	 hospitality	 workers	 before	 and	 after	
implementation	of	the	law.	
Methods.	Personal	exposure	 to	second	hand	smoke	(SHS)	was	measured	by	 three	
different	 methods.	 We	 compared	 a	 passive	 sampler	 called	 MoNIC	 (Monitor	 of	
NICotine)	 badge,	 to	 salivary	 cotinine	 and	 nicotine	 concentration	 as	 well	 as	
questionnaire	data.	Badges	allowed	the	number	of	passively	smoked	cigarettes	to	be	
estimated.	They	were	placed	at	the	venues	as	well	as	distributed	to	the	participants	
for	personal	measurements.	To	assess	personal	exposure	at	work,	a	time‐weighted	
average	of	the	workplace	badge	measurements	was	calculated.	
Results.	Prior	to	the	ban,	smoke‐exposed	hospitality	venues	yielded	a	mean	badge	
value	of	4.48	(95%‐CI:	3.7	to	5.25;	n	=	214)	cigarette	equivalents/day.	At	follow‐up,	
measurements	in	venues	that	had	implemented	a	smoking	ban	significantly	declined	
to	 an	 average	 of	 0.31	 (0.17	 to	 0.45;	 n	 =	 37)	 (p	 =	 0.001).	 Personal	 badge	
measurements	also	significantly	decreased	 from	an	average	of	2.18	(1.31‐3.05	n	=	
53)	 to	 0.25	 (0.13‐0.36;	 n	 =	 41)	 (p	 =	 0.001).Spearman	 rank	 correlations	 between	
badge	 exposure	measures	 and	 salivary	measures	 were	 small	 to	 moderate	 (0.3	 at	
maximum).	
Conclusions.	 Nicotine	 levels	 significantly	 decreased	 in	 all	 types	 of	 hospitality	
venues	after	 implementation	of	 the	 smoking	ban.	 In‐depth	analyses	demonstrated	
that	 a	 time‐weighted	 average	 of	 the	workplace	 badge	measurements	 represented	
typical	 personal	 SHS	 exposure	 at	 work	 more	 reliably	 than	 personal	 exposure	
measures	such	as	salivary	cotinine	and	nicotine.	
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BACKGROUND	
Banning	 smoking	 at	workplaces	 and	 restaurants	 is	widely	 recommended	as	 a	 key	
intervention	 for	protecting	people	 from	exposure	 to	second	hand	smoke	(SHS)	(1‐
3).	 Although	 the	 hospitality	 sector	 had	 been	 previously	 excluded	 from	 smoking	
bans,	 this	 omission	 has	 been	 amended	 in	many	 countries	 over	 the	 past	 10	 years.	
Today,	28	countries	have	comprehensive	policies	banning	smoking	in	all	workplaces	
(4).	 This	 trend	 is	 in	 alignment	with	 the	 recommendations	 from	 the	World	Health	
Organization’s	Framework	Convention	for	Tobacco	Control	(FCTC),	stating	in	Article	
8	 that	all	workplaces	 in	closed	rooms	should	be	protected	 from	SHS	(5).	Although	
Switzerland	signed	the	WHO	Convention	in	2004,	it	was	never	ratified.		
There	 is	 no	 comprehensive	 smoking	 ban	 protecting	 hospitality	 staff	 from	 SHS	 in	
Switzerland.	 In	 May	 2010,	 a	 national	 smoking	 ban	 based	 on	 a	 fairly	 unrestricted	
regulation	which	permitted	certain	exceptions	was	 implemented	 (6).	According	 to	
the	national	law,	venues	could	allow	smoking	if	they	were	less	than	80m2	in	size	or	if	
smoking	 rooms	 did	 not	 exceed	 one	 third	 of	 the	 total	 venue	 size.	 Switzerland	 is	
divided	 into	 26	 administrative	 zones	 called	 cantons,	 and	 each	 was	 permitted	 to	
implement	its	own	stricter	legislation	on	top	of	the	national	law.	This	has	resulted	in	
a	patchwork	of	different	laws	within	a	small	geographical	area.	
It	has	been	shown	that	a	partial	law	can	actually	lead	to	an	increase	in	SHS	levels	in	
venues	 that	 continue	 to	 allow	 smoking	 (7).	 In	 a	 global	 cross‐sectional	 study	
measuring	 smoking	 and	 non‐smoking	 Irish	pubs,	 Connolly	 et	 al.	 found	particulate	
matter	less	than	2.5	μm	in	diameter	(PM2.5)	to	be	93%	lower	in	smoke‐free	pubs	(8).	
According	 to	Villarroel	 et	 al.,	 PM2.5	 levels	 are	 five	 times	higher	 in	 smoking	venues	
than	 in	 non‐smoking	 venues	 (9).	 Interestingly,	 several	 studies	 found	 that	 spatial	
separation	 of	 rooms	 where	 smoking	 is	 allowed	 does	 not	 prevent	 exposure	 to	
environmental	 tobacco	 smoke	 in	 nearby	 non‐smoking	 areas.	 In	 2004,	 Cains	 et	 al.	
found	 that	 spatially	 separated	 non‐smoking	 rooms	 had	 only	 marginally	 reduced	
particulate	matter	less	than	10	μm	in	diameter	(PM10)	and	nicotine	air	levels	when	
compared	to	a	non‐	smoking	area	in	direct	confluence	with	a	smoking	area	(10).	A	
Swiss	 study	 showed	 that	 PM2.5	 in	 non‐smoking	 rooms	 of	 venues	 that	 allowed	
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smoking	 elsewhere	 in	 the	 building	 was	 more	 than	 double	 the	 PM2.5	 levels	 of	
completely	 smoke‐free	 hospitality	 venues	 (11).	 Several	 longitudinal	 studies	
examined	 changes	 in	 SHS	 levels	 before	 and	 after	 introduction	 of	 smoking	 bans.	
While	Semple	et	al.	 found	an	average	PM2.5	 reduction	of	86%	in	Scottish	pubs	 two	
months	after	 implementation	of	 the	 law,	Lee	et	al.	 came	up	with	a	 slight	decrease	
resulting	from	a	partial	law	compared	to	a	large	decrease	from	a	comprehensive	law	
(12,	 13).	 These	 effects	 were	 reproduced	 in	 other	 places	 such	 as	 Minnesota	 or	
Guatemala	(14,	15).	
The	present	study	is	part	of	COSIBAR	(Cohort	Study	on	Smoke‐Free	Interventions	in	
Bars	and	Restaurants),	a	longitudinal	quasi‐experimental	study	examining	exposure	
of	 hospitality	 workers	 who	 were	 non‐smokers,	 and	 their	 health	 status	 at	 three	
different	 time	 points	 before	 and	 after	 implementation	 of	 the	 new	 law.	 There	 are	
several	established	methods	to	determine	personal	SHS	exposure,	all	of	which	have	
their	advantages	and	disadvantages.	The	most	common	and	simple	way	is	through	a	
questionnaire	 (16).	Other	 options	 include	 taking	biological	 samples	 such	 as	urine,	
saliva,	blood	or	hair.	While	drawing	blood	is	invasive,	both	urine	and	saliva	sampling	
are	simple	and	quick.	Commonly	the	cotinine	content	is	measured,	as	it	is	the	most	
specific	and	sensitive	biomarker	(17).	A	hair	sample	provides	cumulative	exposure	
over	 time,	with	 the	 last	 centimetre	 of	 hair	 usually	 corresponding	 to	 the	 previous	
month’s	exposure	(18),	but	this	method	needs	to	be	further	refined	(19).	In	order	to	
determine	 the	 SHS	 exposure	 within	 a	 room,	 PM2.5	 levels	 in	 air	 are	 often	 used	 as	
proxies	 (11).	 In	 this	 study,	 SHS	exposure	of	 the	participants	was	determined	with	
three	different	methods.	Firstly,	by	the	MoNIC	(Monitor	of	Nicotine)	badge,	a	passive	
sampling	device,	secondly,	by	salivary	samples	and	thirdly,	by	a	personal	interview	
relating	to	duration	of	SHS	exposure	at	work	and	outside	of	working	hours.		
The	 aim	 of	 the	 present	 study	 was	 to	 analyse	 the	 effect	 of	 different	 smoking	
regulations	 on	 SHS	 exposure	 in	 bars,	 cafés	 and	 restaurants	 and	 of	 non‐smoking	
hospitality	 workers	 employed	 therein.	 In	 addition,	 we	 aimed	 to	 evaluate	 the	
different	methods	of	SHS	exposure	assessment	and	to	determine	the	most	accurate	
proxy	for	SHS	exposure	at	work.		
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METHODS	
Study	design	
This	is	a	quasi‐experimental,	longitudinal	study	(Figure	4‐1)	comparing	two	groups:	
i)	hospitality	venues	and	non‐smoking	employees	for	whom	smoking	was	banned	as	
a	result	of	a	new	smoking	regulation	(intervention	group);	ii)	hospitality	venues	and	
non‐smoking	 employees	 that	 did	 not	 undergo	 any	 change	 in	 exposure	 (control	
groups).	The	intervention	group	of	the	venue	study	consisted	of	hospitality	venues	
where	smoking	was	either	partially	or	completely	allowed	prior	to	the	introduction	
of	the	smoking	ban.	All	compliant	venues	were	included	in	the	study.	Participants	of	
the	personal	study	had	worked	in	such	a	venue	for	at	least	one	year	prior	to	the	ban,	
and	 were	 therefore	 exposed	 to	 SHS.	 Additional	 eligibility	 criteria	 were	 being	
between	18	and	65	years	of	age,	working	at	least	half‐time	and	having	been	a	non‐
smoker	for	at	least	5	years.	After	introduction	of	the	smoking	ban,	the	intervention	
group	 were	 no	 longer	 exposed	 to	 SHS	 at	 work.	 The	 primary	 comparison	 group	
(Control	Group	I,	Figure	4‐1)	were	employees	who	were	exposed	to	SHS	both	before	
and	after	 the	 implementation	of	 the	smoking	ban	because	of	 the	exceptional	 rules	
described	above.	As	hospitality	workers	who	were	non‐smokers	were	found	to	only	
rarely	work	in	such	venues,	two	additional	comparison	groups	were	included	in	the	
COSIBAR	study.	Control	Group	II	consisted	of	non‐smoking	hospitality	workers	who	
worked	in	a	smoke‐free	environment	at	all	times,	and	Control	Group	III	were	non‐
smokers	 that	 were	 regularly	 exposed	 to	 SHS	 without	 being	 employed	 in	 the	
hospitality	sector.	
In	 the	 intervention	 group,	 a	 baseline	 examination	 was	 conducted	 within	 the	 3	
months	prior	 to	 the	 introduction	of	 the	smoking	ban.	Subsequently,	 two	 follow‐up	
examinations	were	conducted	at	3‐6	months	and	9‐12	months	after	the	smoking	ban	
introduction	 (Figure	 4‐1).	 Study	 participants	 of	 Control	 Group	 II	 were	 examined	
only	 once	 for	 a	 cross‐sectional	 baseline	 analysis.	 Control	 Groups	 I	 and	 III	 were	
examined	three	times,	unrelated	to	the	smoking	ban.	Most	of	the	study	participants	
worked	 in	 the	cantons	of	Basel	City,	Basel	County	and	Zurich.	Smoking	bans	were	
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introduced	on	1st	April	2010	in	Basel	City	and	on	1st	May	2010	in	Basel	County	and	
Zurich.		
Recruitment	procedure,	study	population	and	data	collection	
A	list	of	all	hospitality	venues	in	the	cantons	of	Zurich,	Basel	City	and	Basel	County	
was	 created	using	 the	digital	 Swiss	phonebook	 from	2009.	Each	 venue	 received	 a	
letter	with	information	about	the	study,	including	a	request	to	distribute	screening	
questionnaires	 to	 staff	 serving	 at	 tables	 or	 at	 the	 bar	 (waiting	 staff)	 and	 for	 air	
measurements	to	be	performed	by	the	study	team.	These	letters	were	followed	with	
phone	calls	and	visits	two	weeks	later.	For	those	venues	that	agreed	to	participate,	
an	 interview	with	 the	 owner	was	 conducted	 in	 order	 to	 obtain	 basic	 information	
relating	 to	 the	 current	 smoking	 regulations,	 the	 venue	 size,	 other	 sources	 of	
environmental	PM2.5	and	the	number	of	staff.	At	least	one	MoNIC	badge	was	placed	
in	 the	 venue,	 often	 near	 the	 bar	 where	 waiting	 personnel	 spend	 much	 of	 their	
working	 time	 (hereafter	 referred	 to	 as	 “workplace	 badge”).	 Where	 there	 were	
separate	 smoking	 and	 non‐smoking	 rooms	 or	 sections,	 one	 badge	 was	 placed	 in	
each.	 After	 one	 week,	 badges	 were	 collected	 and	 evaluated.	 For	 the	 intervention	
group,	 air	measurements	were	 performed	 in	 167	 hospitality	 venues	 that	 allowed	
smoking	at	 least	partly	before	 implementation	of	the	national	smoking	ban	in	May	
2010.	 Follow‐up	 measurements	 were	 only	 conducted	 in	 those	 venues	 where	
personal	 study	 participants	worked.	 The	 26	 control	 group	 venues	were	 recruited	
and	measured	by	the	same	procedures	between	2010	and	2011.		
For	 the	 personal	 study,	 screening	 questionnaires	 were	 distributed	 to	 the	 waiting	
staff,	 providing	 information	 on	 age,	 workload	 (hours/week),	 number	 of	 years	
worked,	 smoking	 status,	 current	 health	 and	 personal	 details.	 Eligible	 study	
participants	were	invited	to	a	health	examination,	which	was	carried	out	 in	one	of	
two	 study	 centres	 in	Basel	 City	 and	Zurich.	 Prior	 to	 the	 visit,	 a	MoNIC	badge	was	
sent	to	the	study	participants	which	they	were	asked	to	attach	near	their	shirt	collar	
for	 a	 period	 of	 24	 hours	 and	 bring	 to	 the	 study	 centre	 (hereafter	 referred	 to	 as	
“personal	 badge”).	 A	 protocol	 stating	 the	 exact	 measurement	 time	 and	 location	
accompanied	each	badge.	During	 the	visit	at	 the	study	centre,	 saliva	was	collected	
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for	nicotine	and	cotinine	analyses.	A	questionnaire,	part	of	which	was	conducted	as	
a	 face‐to‐face	 interview,	 was	 completed	 relating	 to	 smoking	 behaviour	 and	 SHS	
exposure	 over	 the	 previous	 12	 months	 at	 work	 and	 outside	 of	 work.	 The	
participants	 were	 asked	 at	 the	 baseline	 visit	 and	 at	 the	 first	 follow‐up	 visit	 how	
many	hours	per	day	they	were	exposed	to	SHS	at	work	and	during	their	leisure	time.	
Categorical	responses	were	required	for	both	questions:	0‐0.5	hours,	0.5‐2	hours,	2‐
5	hours	and	more	than	5	hours.	
Members	of	Control	Group	III	were	recruited	by	means	of	an	online	advertisement	
looking	 for	 non‐smokers	 that	 were	 exposed	 to	 SHS	 on	 a	 regular	 basis,	 either	
privately	or	at	work.	In	this	group,	no	workplace	badge	data	was	collected.	
Ethical	approval	was	obtained	from	the	EKBB	(Ethics	committee	of	both	cantons	of	
Basel)	 and	 all	 participants	 signed	 an	 informed	 consent	 before	 every	 examination	
(Reference	no.	EK:	317/09).	
Laboratory	analyses	
MoNIC	badges	are	glass	fibre	filters	that	are	washed	with	distilled	water,	methanol	
and	dichloromethane	(CH2Cl2),	impregnated	with	about	5mg	sodium	bisulphate	per	
filter	and	placed	in	an	air‐tight	plastic	case	(20).	This	method	was	developed	by	the	
Institute	of	Work	and	Health	in	Lausanne	(20)	and	adapted	from	that	proposed	by	
Hammond	 and	 Ogden	 (21,	 22).	 Badges	 were	 always	 transported	 between	 study	
centres,	 participants,	 and	 the	 laboratory	 in	 these	 air‐tight	 cases.	 The	 amount	 of	
nicotine	 on	 the	 badge	 was	 determined	 by	 gas	 chromatography.	 The	 extracted	
nicotine	from	the	filter,	known	to	take	in	air	at	a	rate	of	10	ml/min,	was	multiplied	
by	 1000	 to	 mimic	 an	 average	 respiration	 rate	 of	 10	 l/min	 which	 corresponds	 to	
normal	sedentary	behaviour	(23).	The	number	of	passively	smoked	cigarettes	was	
calculated	by	assuming	0.2	mg	nicotine	per	cigarette.		
Salivary	cotinine	and	nicotine	levels	were	obtained	during	the	medical	examination	
without	 any	 stimulation	using	a	plastic	 straw,	 and	quantified	by	 liquid‐liquid	 (liq‐
liq)extraction	with	CH2Cl2	 and	GC‐NPD	 (gas	 chromatography‐nitrogen‐phosphorus	
detector;	working	range:	0.1‐500	ng/ml.	limit	of	quantification:	0.1	ng/ml)	(20,	24).	
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The	final	batch	of	saliva	samples	from	control	group	members	were	excluded	from	
the	data	analysis	due	to	inconsistencies	in	lab	procedures.	
Data	analysis	
Data	 were	 analysed	 using	 Stata	 10.1.	 Workplace	 exposure	 of	 participants	 was	
calculated	 from	 the	 MoNIC	 badge	 placed	 at	 the	 workplace.	 If	 two	 badges	 were	
placed	in	a	venue,	we	used	the	value	from	the	section	where	the	buffet	was	located	
for	our	calculations	as	waiting	staff	spends	more	of	their	time	there.	We	used	a	time‐
weighted	average,	based	on	a	shift	of	8	hours/day	for	full‐time	employees.	Average	
workplace	 concentration	 was	 multiplied	 by	 workload	 *0·6	 taking	 into	 account	
holidays	 and	 considering	 the	 fact	 that	 nicotine	 levels	 decrease	 when	 a	 venue	 is	
closed	 and	 staff	 is	 absent.	 This	 factor	 was	 estimated	 from	 a	 previous	 study	 of	
continuous	 PM2.5	 measurements	 in	 smoking	 environments	 (11).	 Longitudinal	
comparisons	 were	 conducted	 by	 means	 of	 the	 Kruskal‐Wallis	 equality‐of‐
populations	 rank	 test	 that	 compares	 three	 or	 more	 unmatched	 groups.	 In	 cross‐
sectional	 comparisons	 between	 different	 venue	 types,	 the	 non‐parametric	 Mann‐
Whitney	test	for	two	unpaired	groups	was	applied.		
RESULTS	
We	performed	225	badge	measurements	in	193	hospitality	venues	during	baseline	
visits.	First	follow‐up	visits	were	conducted	199	days	later,	on	average,	in	51	venues	
with	58	badges.		At	the	second	follow‐up,	42	badges	were	placed	in	36	venues.	The	
intervention	group	comprised	56	persons	at	baseline,	44	persons	at	follow‐up	1	(79	
%)	 and	 42	 at	 follow‐up	 2	 (75	%).	 These	were	 compared	 to	 the	 control	 groups:	 6	
persons	working	in	smoking	venues	that	did	not	change	their	rule	(control	group	I),	
14	 hospitality	 workers	 that	 had	 always	 worked	 in	 smoke‐free	 environments	
(Control	Group	II)	and	16	persons	that	are	regularly	exposed	to	SHS	privately	or	at	
work	 without	 being	 employed	 in	 the	 hospitality	 sector	 (Control	 Group	 III).	 Two	
members	 of	 Control	 Group	 I	 returned	 for	 a	 second	 examination	 (33%),	 while	 10	
(62.5%)	 and	 5	 (31.3%)	 participants	 in	 Control	 Group	 III	 underwent	 second	 and	
third	examinations,	respectively	(Figure	4‐1).		
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Figure	4‐1	Study	design	with	number	of	venues	and	study	participants	
 
At	 baseline,	 badge	 analysis	 of	 all	 smoke‐exposed	 hospitality	 venues	 yielded	 an	
average	value	of	4.48	(95%‐CI:		3.7	to	5.25;	n=214)	cigarette	equivalents	(CE)/day.	
This	means	 that	 a	 person	 present	 in	 a	 smoke‐exposed	 venue	 for	 24	 hours	would	
inhale	 a	 similar	 amount	 of	 smoke	 as	 a	 person	 actively	 smoking	 4.48	 cigarettes.	
Badges	 from	 smoking	 venues	 from	 where	 at	 least	 one	 study	 participant	 was	
included	in	the	study	(n=50),	yielded	an	average	exposure	of	4.00	(95%‐CI:	2.48	to	
5.51)	 CE/day.	 The	 other	 164	 badges	 from	 venues	without	 study	 participants	 had	
average	 values	 of	 4.62	 (95%‐CI:	 3.72	 to	 5.53)	 CE/day.	 The	 type	 of	 smoking	
regulation	in	place	clearly	influenced	SHS	exposure,	with	smoking	venues	reaching	
an	 average	 of	 6.12	 (4.71	 to	 7.53;	 n=82)	 CE/day	 (Figure	 4‐2).Levels	 in	 smoking	
sections	 yielded	 4.39	 (3.24	 to	 5.54;	 n=93)	 CE/day,	 venues	with	 a	 time	 regulation	
that	 prohibited	 smoking	 during	mealtimes	 1.95	 (0.45	 to	 3.45;	 n=11)	 CE/day	 and	
open,	non‐smoking	sections	averaged	0.92	(0.5	to	1.35;	n=28)	CE/day.	This	was	still	
significantly	higher	 than	values	 in	completely	non‐smoking	venues	(Control	Group	
II)	at	0.13	(0.01	to	0.24;	n=11)	CE/day	(p<0.001).	There	was	only	one	non‐smoking	
section	in	our	sample	that	was	separated	by	a	door.		
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Figure	4‐2	Cross‐sectional	 comparison	of	SHS	 levels	 in	different	 types	of	hospitality	venues	
(n=193)	with	different	smoking	policies	at	baseline	(n=225)	
1	time	regulation	refers	to	venues	with	temporal	ban,	ex.	during	mealtimes	
2	A	Cigarette	equivalent	(CE)/day	 is	the	equivalent	amount	of	smoke	of	one	actively	smoked	cigarette	
that	a	smoke‐exposed	person	inhales		
	
There	were	 also	 substantial	 differences	 in	 SHS	 exposure	 according	 to	 the	 type	 of	
hospitality	 venue.	 At	 baseline,	 the	 highest	 exposure	 was	 found	 in	 bars	 with	 9.99	
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(7.06‐12.92;	n=36)	CE/day,	 followed	by	cafés	 (4.54;	95%	CI:	3.12‐5.96;	n=31)	and	
restaurants	(3.28;	2.53‐4.02;	n=126)	(Figure	4‐2).		
At	 the	 time	 of	 the	 first	 follow‐up,	 the	 exposure	 had	 significantly	 decreased	 to	 0.3	
(0.21	 to	 0.38;	 n=37)	 in	 all	 venues	 that	 had	 introduced	 a	 smoking	 ban	 (i.e.	
intervention	group),	irrespective	of	venue	type	(p<0.001).	The	type	of	venue	was	no	
longer	an	influential	factor.	Six	months	later,	at	follow‐up	2,	levels	remained	low	at	
0.33	 (0.17	 to	0.49;	n=33)	CE/day.	 In	venues	 that	had	not	 implemented	a	 smoking	
ban	(Control	Group	I),	smoke	 levels	at	 follow	up	1	were,	on	average,	3.37	(1.29	to	
5.44;	n=14)	CE/day.	
Table	 4‐1	 shows	 the	 results	 of	 the	 personal	 study.	 At	 follow‐up,	 personal	 badges	
showed	significant	decreases	in	exposure	(p<0.001),	although	this	decrease	was	not	
as	pronounced	as	for	workplace	badges.	Restricting	the	pre/post	ban	comparison	of	
the	 intervention	 group	 to	 only	 the	 33	 persons	 who	 participated	 in	 all	 three	
examinations	 gave	 similar	 results	 (mean	 time‐weighted	 average	 of	 workplace	
exposure	at	baseline:	2.67	(1.38	to	3.96)	CE/day,	at	first	follow‐up:	0.14	(0.1	to	0.18)	
CE/day,	and	at	second	follow	up:	0.19	(0.09	to	0.28)	CE/day).	Participants	that	were	
lost	 to	 follow‐up	 had	 lower	 workplace	 exposure	 at	 baseline	 (p=0.004),	 in	 the	
personal	 badges	 this	 difference	 was	 less	 pronounced	 (p=0.171).	 In	 the	
questionnaire,	 14.7%	 of	 the	 intervention	 group	 reported	 the	 same	 length	 of	
exposure	per	day	at	 follow‐up	as	 at	baseline,	while	 the	 remainder	 reported	 lower	
values	 (85.3%).	 Regarding	 exposure	 in	 their	 leisure	 time,	 30.3%	 stated	 a	 lower	
number	of	 exposed	hours,	 66.7%	remained	 the	 same	and	one	person	 reported	an	
increase	in	exposed	hours.		
Addressing	the	second	aim	of	the	study,	the	personal	badge	results	were	compared	
with	salivary	nicotine	and	cotinine	 levels.	Spearman’s	rank	correlation	coefficients	
were	0.17	for	badge	versus	nicotine	(p‐value:	0.04;	n=137)	and	0.3	for	badge	versus	
cotinine	(p‐value<0.001;	n=137).	Nicotine	and	cotinine	showed	a	correlation	of	0.41	
(p‐value:	 <0.001;	 n=140).	 The	 time‐weighted	 average	 of	 the	 workplace	 badge	
yielded	correlation	coefficients	of	0.17	with	salivary	nicotine	(p‐value:	0.07;	n=116),	
0.23	with	salivary	cotinine	(p‐value:	0.01;	n=116)	and	0.56	with	the	personal	badge	
(p‐value<0.001;	n=142).		
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DISCUSSION	
The	smoking	ban	 led	 to	a	significant	decrease	 in	exposure	 for	all	participants	 that	
worked	in	an	environment	where	a	new	law	was	introduced.	SHS	levels	in	all	types	
of	 venues	 dropped	 to	 nearly	 zero	 after	 the	 ban.	 At	 baseline,	 the	 current	 smoking	
policy	in	the	venue	and	the	type	of	venue	clearly	influenced	the	number	of	passively	
smoked	 cigarettes	 per	 day,	 as	 calculated	 from	 air	 measurements	 in	 hospitality	
venues.	Venues	where	participants	worked	did	not	significantly	differ	from	venues	
from	where	there	were	no	participants.	Bars	had	higher	values	than	cafés,	which	in	
turn	yielded	a	higher	exposure	than	restaurants.	Some	restaurants	had	special	time	
regulations	 such	 as	 smoke‐free	 mealtimes,	 which	 led	 to	 a	 further	 decrease	 in	
average	levels.	Badge	readings	from	smoking	rooms	were	only	slightly	higher	than	
those	 from	 smoking	 sections	 in	mixed	 rooms,	 i.e.	 rooms	 containing	 both	 smoking	
and	 non‐smoking	 sections.	 Although	 non‐smoking	 sections	 had	 lower	 levels,	 they	
were,	nevertheless,	significantly	higher	than	in	entirely	smoke‐free	locations.	These	
results	 are	 in	 line	 with	 previous	 studies	 that	 found	 that	 designated	 non‐smoking	
sections	 were	 inadequate	 measures	 for	 protecting	 people	 from	 SHS	 (10,11,25).	
Moreover,	studies	have	shown	that	only	the	implementation	of	a	comprehensive	law	
results	in	widespread	acceptance	by	the	population	(26,27).	
Comparison	of	various	exposure	proxies	
In	 this	 study,	 salivary	 data	 were	 compared	 with	 personal	 and	 workplace	 badge	
measurements	as	well	as	questionnaire	data.	There	was	poor	correlation	between	
these	indicators.	The	personal	and	the	workplace	badges	had	the	highest	correlation	
coefficient:	 0.56	 (p‐value	 <	 0.001;	 n	 =	 142).	 One	 drawback	 of	 personal	 badge	
measurements	is	that	participants	did	not	always	clearly	state	where	the	badge	was	
worn,	 be	 it	 at	 home,	 work	 or	 both.	 The	 personal	 badge	 measurement	 was	 also	
greatly	affected	by	 the	behaviour	on	 that	given	day,	e.g.	whether	 the	wearer	went	
out	to	a	place	where	smoking	was	allowed.	In	some	instances,	the	personal	badges	
captured	only	exposure	outside	of	the	workplace,	as	some	study	participants	did	not	
work	 during	 the	 24	 hours	 prior	 to	 the	 health	 examination.	 The	 results	 of	 these	
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badges	are,	therefore,	specific	to	a	given	day	and	should	be	treated	with	caution.	The	
workplace	badge,	however,	was	exposed	for	a	period	of	one	week,	thus	representing	
the	average	exposure	environment	in	the	workplace.	
Salivary	measurements	are	subject	to	variations	in	individual	metabolism,	as	are	all	
biomarkers.	Cotinine	reflects	exposure	to	nicotine	and	is,	therefore,	very	specific	for	
tobacco	exposure	(28).	Timely	sampling	 is	crucial,	due	 to	the	rapid	degradation	of	
the	compound,	and	results	also	depend	on	how	recently	the	exposure	occurred	(29).	
They	would	have	been	more	likely	to	reflect	workplace	SHS	exposure	if	participants	
were	sampled	immediately	after	leaving	the	workplace.	Unfortunately,	this	was	not	
possible	 in	 the	 context	 of	 this	 study.	 But	 other	 studies	 face	 similar	 problems,	 in	
particular	if	the	exposure	is	not	as	clearly	specified	as	in	hospitality	workers.	
Our	 salivary	 samples	 do,	 however,	 allow	 us	 to	 identify	 potential	 smokers	 from	 a	
supposedly	non‐smoking	sample.	The	Society	for	Research	on	Nicotine	and	Tobacco	
(SRNT)	 subcommittee	 suggests	 that	 smokers	 are	 likely	 to	 have	 salivary	 cotinine	
values	of	>	15	ng/ml	(30).	Thus,	salivary	measurements	will	be	useful	to	ensure	that	
future	 health	 analyses	 are	 restricted	 to	 non‐smokers	 only.	 Self‐reported	 data	 in	
questionnaires	 are	 prone	 to	 recall	 bias	 and	 risk	 imprecision	 (28).	 Nevertheless,	
participants	confirmed	their	overall	declining	exposure	at	work	with	the	responses	
given	 in	 the	questionnaire.	Concerning	exposure	out	of	working	hours,	a	declining	
tendency	was	observed,	but	two	thirds	reported	unchanging	conditions.	
We	 calculated	 a	 time‐weighted	 average	 for	 the	 workplace	 badge	 to	 better	
approximate	 the	 true	 exposure	 at	 work,	 taking	 into	 account	 the	 participants’	
individual	 workload.	 For	 this	 reason,	 workplace	 badges	 likely	 provided	 the	most	
relevant	 measure	 of	 changes	 in	 exposure	 after	 the	 smoking	 ban	 introduction.	
Consequently,	 these	measurements	were	 used	 to	 assess	 the	 relationship	 between	
changes	in	workplace	exposure	and	cardio	respiratory	outcomes.	
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Strengths	and	limitations	
A	key	strength	of	our	study	is	that	different	methods	were	applied	and	compared	in	
order	 to	assess	 the	personal	exposure	of	 the	study	participants.	 In	addition	 to	 the	
more	 standard	methods	of	 salivary	nicotine	and	cotinine	and	questionnaire‐based	
data,	 the	MoNIC	badge	was	used.	This	passive	 sampler	 is	 very	 simple	 and	easy	 to	
use,	providing	a	specific	value	for	nicotine	without	a	proxy.	Although	SHS	is	the	most	
important	 contributor,	 PM2.5	measurements	 can	 be	 confounded	 by	 other	 sources	
such	 as	 candles,	 kitchen	 fumes	 or	 other	 air	 pollutants	 (31,32).	 A	 large	 number	 of	
venues	were	measured	before	the	smoking	ban,	representing	a	range	of	venue	types	
and	 smoking	 policies.	 Some	 limitations	 to	 our	 study	 have	 been	 identified.	 The	
recruitment	process	was	long,	taking	place	both	before	and	after	implementation	of	
the	 new	 law,	 and	 this	 could	 have	 led	 to	 a	 selection	 bias.	 Presumably,	 venues	 less	
willing	 to	 participate	 would	 have	 had	 higher	 exposure	 levels.	 Restaurants	 were	
overrepresented	 in	 our	 study	 compared	 to	 bars,	 and	 restaurants	 had	 lower	 SHS	
levels	than	bars.	Consequently,	an	underestimation	of	the	true	average	SHS	levels	in	
Swiss	hospitality	workers	is	highly	likely.	A	similar	situation	can	be	assumed	in	the	
recruitment	of	participants.	Heavily	exposed	workers	were	often	determined	to	be	
smokers,	 and	 were	 not	 eligible	 to	 participate.	 Those	 workers	 that	 consented	 to	
participate	were	probably	more	health	conscious	and	more	likely	to	work	in	venues	
with	lower	exposures.	
CONCLUSIONS	
These	 results	 support	 previous	 findings	 that	 a	 smoking	 ban	 leads	 to	 significantly	
lower	SHS	levels	in	hospitality	venues,	provided	that	the	venue	is	completely	smoke‐
free.	 A	 time‐weighted	 average	 of	 the	workplace	 badge	 turned	 out	 to	 be	 the	most	
reliable	method	 to	determine	changes	 in	personal	SHS	exposure	at	 the	workplace.	
The	 personal	 exposure	 of	 hospitality	 workers	 was	 shown	 to	 decline	 after	 the	
implementation	 of	 a	 smoking	 ban.	 A	 comprehensive	 national	 law	 is	 needed	 in	
4	Exposure	
 
43 
 
hospitality	venues	in	Switzerland	in	order	to	fully	protect	the	population	from	SHS,	
particularly	hospitality	personnel	in	their	professional	environment.	
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Table	4‐1	Different	personal	measurement	methods	at	baseline,	follow‐up	1	and	follow‐up	2	
	
	 Baseline Follow‐up	1 Follow‐up	2 	n2 Arithmetic	mean	(95%	CI) n Arithmetic	mean	(95%	CI) n Arithmetic	mean	(95%	CI) p‐Value	
Personal	badge	(cigarette	
equivalents/day)		
Intervention	group	 53 2.18	(1.31	to	3.05) 41 0.53	(0.39	to	0.67) 41 0.25	(0.13	to	0.36) <0.001	
Control	Groups	I+III 20 1.69	(0.74	to	2.64) 11 1.17	(0.57	to	1.77) 5 1.22	(0.10	to	2.34) 0.892	
Control	Group	II	 14 0.41	(0.25	to	0.57) 	
Work	place	badge	
(cigarette	
equivalents/day)*	
Intervention	group	 50 4.82	(3.14 to	6.50) 40 0.27	(0.19 to	0.34) 36 0.31	(0.17 to	0.46) <0.001	
Control	Groups	I	 6 3.85	(‐0.51	to	8.21) 2 2.15	(‐23.66	to	27.96) 1 0.22 0.561	
Control	Group	II	 12 0.27	(0.08	to	0.47) 	
Time	weighted	average	of	
work	badge	(cigarette	
equivalents/day)*	
Intervention	group	 50 2.65	(1.69 to	3.62) 40 0.15	(0.11 to	0.20) 36 0.18	(0.10 to	0.27) <0.001	
Control	Groups	I	 6 2.24	(‐0.30	to	4.79) 2 1.25	(‐13.80	to	16.31) 1 0.30 0.561	
Control	Group	II	 12 0.14	(0.03	to	0.25) 	
	
Salivary	nicotine	(ng/ml)		
	
Intervention	group	 44 1.99	(0.98 to	3.00) 35 2.42	(‐0.01 to	4.86) 36 2.81	(‐0.12 to	5.75) 0.227	
Control	Groups	I+III 14 1.45	(‐0.05	to	2.95) 5 4.24	(‐5.49	to	13.97) 1 7.80 0.699	
Control	Group	II	 5 2.38	(‐3.95	to	8.71) 	
Salivary	cotinine	(ng/ml)	
Intervention	group	 44 0.67	(0.04 to	1.30) 35 2.75	(0.32	to	5.17) 36 0.81	(0.00 to	1.61) 0.243	
Control	Groups	I+III 14 1.54	(‐0.43	to	3.51) 5 3.84	(‐2.56	to	10.24) 1 0.13 0.329	
Control	Group	II	 5 2.82	(‐4.73	to	10.37) 	
	
*no	data	for	control	group	III	
                                                 
2 if	two	persons	worked	in	the	same	venue,	this	badge	was	counted	double	
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ABSTRACT	
Objectives.	 To	 investigate	 the	 effect	 of	 a	 change	 in	 second	 hand	 smoke	 (SHS)	
exposure	on	heart	rate	variability	(HRV)	and	pulse	wave	velocity	(PWV),	this	study	
utilized	a	quasi‐experimental	setting	when	a	smoking	ban	was	introduced.	
Methods.	HRV,	a	quantitative	marker	of	autonomic	activity	of	the	nervous	system,	
and	 PWV,	 a	 marker	 of	 arterial	 stiffness,	 were	 measured	 in	 55	 non‐smoking	
hospitality	workers	before	and	3	to	12	months	after	a	smoking	ban	and	compared	to	
a	 control	 group	 that	 did	 not	 experience	 an	 exposure	 change.	 SHS	 exposure	 was	
determined	 with	 a	 nicotine	 specific	 badge	 and	 expressed	 as	 inhaled	 cigarette	
equivalents	per	day	(CE/d).	
Results.	 PWV	 and	 HRV	 parameters	 significantly	 changed	 in	 a	 dose	 dependent	
manner	 in	 the	 intervention	 group	 compared	 to	 the	 control	 group.	 A	 one	 CE/d	
decrease	was	associated	with	a	2.3%	(95%	CI:	0.2	to	4.4;	p=0.031)	higher	root	mean	
square	 of	 successive	 differences	 (RMSSD),	 a	 5.7	%	 (95%	 CI:	 0.9	 to	 10.2;	 p=0.02)	
higher	high	frequency	(HF)	component	and	a	0.72%	(95	%	CI:	0.40	to	1.05;	p<0.001)	
lower	PWV.		
Conclusions.	 PWV	 and	 HRV	 significantly	 improved	 after	 introducing	 smoke‐free	
workplaces	indicating	a	decreased	cardiovascular	risk.	
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INTRODUCTION	
Several	 epidemiological	 studies	 from	 various	 countries	 have	 shown	 the	 beneficial	
effects	 of	 a	 public	 indoor	 smoking	 ban	 on	 cardiovascular	 health,	 especially	 acute	
myocardial	 infarction	 (AMI).	 In	 Indiana,	 USA,	 hospital	 admission	 rates	 for	 AMI	
declined	 by	 50%	 primarily	 among	 non‐smokers	 (1).	 In	 Helena,	 Montana	 rates	
decreased	 by	 40%,	 but	 returned	 to	 former	 levels	 after	 ban	 suspension	 (2),	 while	
decreased	levels	stayed	low	in	Pueblo	County	after	a	longer	enforcement	period	(3).	
Studies	in	European	cities	suggest	less	pronounced	decreases	(4).	In	Scotland,	AMI	
rates	decreased	by	17%	after	 the	ban	compared	to	a	4%	decrease	 in	England	that	
did	 not	 have	 a	 ban	 (5).	 A	 recent	 meta‐analysis	 including	 45	 studies	 calculated	
significantly	 lower	 hospital	 admission	 rates	 for	 both	 coronary	 events	 (RR:	 0.848;	
95%	CI:	0.816‐0.881)	as	well	as	for	other	heart	diseases	(RR:	0.610;	95%	CI:	0.440‐
0.847)	after	 introducing	a	comprehensive	smoking	ban	(6).	However,	most	studies	
lack	a	control	group	as	well	 as	exact	 information	on	smoking	status	and	exposure	
because	they	were	conducted	on	a	population	level	only.	To	assess	the	mechanistic	
public	health	impact	of	public	smoking	bans,	population‐based,	sensitive	measures	
beyond	AMI	are	needed.	
Heart	 rate	 variability	 (HRV)	 is	 a	 quantitative	marker	 of	 autonomic	 activity	 of	 the	
nervous	system	and	lower	HRV	is	associated	with	higher	cardiovascular	morbidity	
and	mortality	(7).	The	main	influencing	factors	are	sex,	age,	physical	activity,	blood	
pressure	and	 smoking	 status	 (8).	 In	 a	 study	by	Pope	et	 al.,	 acute	 exposure	 to	SHS	
alternating	 with	 non‐exposed	 periods	 led	 to	 consistently	 lower	 HRV	 measures	
during	exposure	(9).	A	cross‐sectional	analysis	showed	that	long‐term	SHS	exposed	
persons	for	>2h/day	have	higher	High	Frequency	(HF),	lower	total	power	(TP),	Low	
Frequency	 (LF)	 and	 a	 lower	 LF/HF	 ratio	 than	 unexposed	 people	 (10)	 .	 These	 are	
important	 frequency‐domain	 HRV	 measures	 providing	 further	 insight	 on	
fluctuations	of	HR	(11).	Chen	et	al.	showed	that	HRV	was	lower	in	mice	during	and	
after	 exposure	 to	 second‐hand	 smoke	 (SHS)	 (12).	 No	 longitudinal	 study	 on	 long‐
term	SHS	exposure	and	HRV	has	been	conducted	so	far.	
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Pulse	wave	velocity	(PWV)	provides	a	measure	of	arterial	stiffness	(13)	which	is	an	
important	 indicator	 of	 cardiovascular	 risk	 and	 atherosclerosis	 (14).	 In	 addition	
arterial	stiffness	is	a	powerful	predictor	of	all‐cause	mortality	(13,	15).	An	increase	
of	 PWV	 was	 observed	 after	 acute	 exposure	 to	 SHS	 (16)	 and	 after	 smoking	 one	
cigarette	 (17).	 Arteries	 such	 as	 the	 aorta	 and	 the	 femoral	 artery	 are	 composed	of	
different	 amounts	 of	 smooth	 muscle	 cell	 layers	 and	 acute	 changes	 in	 arterial	
stiffness	 may	 reflect	 changes	 in	 arterial	 tone	 due	 to	 autonomic	 innervation	 or	
changes	in	endothelial	function	(18).	
In	another	study	PWV	was	found	to	be	higher	among	smokers	than	non‐smokers	but	
smoking	cessation	did	not	lead	to	any	significant	changes	(19).	A	prospective	cohort	
study	found	a	significant	relationship	between	the	number	of	cigarettes	smoked	per	
day	and	the	annual	rate	of	change	in	PWV	(20).	Long‐term	exposure	to	SHS	and	its	
impact	on	arterial	stiffness	have	not	been	examined	as	yet.	
When	 Switzerland	 introduced	 a	 smoking	 ban	 in	 May	 2010,	 the	 national	 law	 left	
room	 for	 exceptions	 (21).	 While	 several	 cantons	 –	 administrative	 zones	 in	
Switzerland	 ‐	 completely	 banned	 smoking	 venues	 and	 rooms,	 in	 other	 cantons	
either	 small	 smoking	venues	or	 separated	 smoking	 rooms	were	 still	 allowed.	This	
unique	 situation	 served	as	a	quasi‐experimental	 setting	 for	our	prospective	 study.	
The	 aim	was	 to	 directly	 relate	 SHS	 exposure	 in	 non‐smoking	 hospitality	 workers	
before	and	after	 introduction	of	the	smoking	ban	to	HRV	and	arterial	stiffness.	We	
further	compared	possible	changes	in	the	intervention	group	which	was	subject	to	
the	 introduction	 of	 smoke	 free	 workplaces	 to	 the	 control	 group	 that	 did	 not	
experience	any	changes	in	SHS	exposure	at	the	work	place.	
METHODS	
Study	population	
This	 is	 a	 quasi‐experimental	 	 study	 comparing	non‐smoking	 employees	 for	whom	
second	hand	smoke	exposure	at	work	was	eliminated	as	a	result	of	the	new	smoking	
regulations	(intervention	group)	with	non‐smoking	employees	that	did	not	undergo	
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any	 change	 in	 exposure	 (control	 groups).	 The	 intervention	 group	 consisted	 of	
participants	who	had	worked	for	at	least	1	year	in	venues	where	smoking	was	either	
partially	or	completely	allowed	prior	to	the	introduction	of	the	smoking	ban	(n=55).	
After	 introduction	 of	 the	 smoking	 ban,	 the	 intervention	 group	 was	 no	 longer	
exposed	 to	 SHS	 at	 work.	 The	 control	 group	 consisted	 of	 individuals	 who	 were	
exposed	 to	 SHS	 both	 before	 and	 after	 the	 implementation	 of	 the	 smoking	 ban	
because	of	the	exceptional	rules	described	above	(n=7)	and	non‐smokers	that	were	
regularly	 exposed	 to	 SHS	 at	 work	 or	 in	 private	 without	 being	 employed	 in	 the	
hospitality	 sector	 (n=16).	 Due	 to	 difficulties	 in	 recruitment	 of	 non‐smoking	
hospitality	 workers,	 we	 additionally	 included	 a	 supplementary	 group	 of	 14	 non‐
smoking	hospitality	workers	at	baseline,	who	worked	in	a	smoke‐free	environment	
at	all	times	(labelled	supplementary	group).		
In	 the	 intervention	 group,	 a	 baseline	 examination	 was	 conducted	 within	 the	 3	
months	prior	 to	 the	 introduction	of	 the	smoking	ban.	Subsequently,	 two	 follow‐up	
examinations	were	conducted	at	3‐6	months	and	9‐12	months	after	the	smoking	ban	
introduction.	 The	 unexposed	 study	 participants	 constituting	 the	 supplementary	
group	were	 examined	 once;	 all	 others	were	 invited	 for	 examinations	 three	 times.	
Intervals	between	examinations	were	also	about	six	months.		
Recruitment	procedure	
A	list	of	hospitality	venues	in	the	cantons	of	Zurich,	Basel	City	and	Basel	County	was	
created	using	the	digital	Swiss	phonebook	from	2009.	Each	venue	received	a	letter	
that	was	followed‐up	by	a	phone	call	and	a	visit	two	weeks	later.		
Screening	 questionnaires	 were	 distributed	 to	 the	 waiting	 staff,	 for	 providing	
information	on	the	eligibility	criteria	which	were	being	between	18	and	65	years	of	
age,	working	at	least	half‐time,	having	worked	for	at	least	one	year	in	the	hospitality	
sector	and	having	been	a	non‐smoker	for	at	least	5	years.	Eligible	study	participants	
were	invited	to	a	health	examination,	which	was	carried	out	in	one	of	the	two	study	
centres	in	Basel	City	and	Zurich.		
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The	non‐hospitality	workers	were	 recruited	by	means	of	 an	 online	 advertisement	
looking	 for	 non‐smokers	 that	 were	 exposed	 to	 SHS	 on	 a	 regular	 basis,	 either	
privately	or	at	work.		
Health	examinations	
The	health	examinations	comprised	cardiovascular	and	respiratory	tests	as	well	as	a	
computer‐based	 interview.	 About	 20	 minutes	 into	 the	 health	 examination,	
electrocardiograms	(ECG)	were	continuously	recorded	for	10	minutes	with	a	7‐lead	
digital	recorder	(SEER	Light,	GE	Healthcare,	Freiburg,	Germany)	with	participants	in	
the	 supine	 position.	 ECGs	were	 stored	 and	 subsequently	 analysed	 on	 a	 PC	MARS	
workstation	(GE	Healthcare).	Beat	annotations	were	automatically	assigned	by	the	
GE	 software	 and	 manually	 reviewed	 by	 an	 investigator	 blinded	 to	 the	 exposure	
status	of	participants	to	ensure	proper	annotation	of	non‐sinus	beats	and	artefacts.	
Only	normal	sinus	beats	were	used	in	the	calculation	of	HRV	metrics.	The	duration	
between	 the	 R	 waves	 of	 consecutive	 normal	 sinus	 beats	 (N‐N	 intervals)	 was	
identified	 and	 only	 beats	 with	 an	 N‐N	 interval	 between	 0.4	 and	 2.0	 s	 and	 ratio	
between	0.8	and	1.2	were	included	in	the	analysis.	
Calculations	 for	 time	domain	 [standard	deviation	of	N‐N	 intervals	 (SDNN);	 square	
root	 of	 the	 mean	 squared	 differences	 of	 successive	 N‐N	 intervals	 (rMSSD)]	 and	
frequency	domain	 [low‐frequency	 (LF)	power	 (0.04‐0.15	Hz),	high‐frequency	 (HF)	
power	(0.04‐0.15	Hz),	and	their	ratio	(LF/HF)]	HRV	parameters	were	evaluated	on	
non‐overlapping	5‐min	intervals	of	ECG	data	using	standard	techniques	(Task	Force	
of	the	European	Society	of	Cardiology	1996).	Only	5	minute	intervals	with	a	ratio	of	
N‐N/R‐R	intervals	>90%	were	included	in	our	analyses.		
Subsequently,	 PWV	 and	 blood	 pressure	were	measured	 using	 a	 VaSera	 VS‐1500N	
device	(Fukuda	Denshi	Co.,	Tokyo,	Japan).	Participants	were	in	supine	position	and	
at	rest	for	at	least	10	minutes	beforehand.	If	the	first	two	measures	were	more	than	
0.5	m/s	apart,	a	third	measurement	was	taken.	For	analysis	the	average	of	the	two	
more	similar	measurements	was	used.	
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Exposure	measurements	
SHS	was	measured	using	newly	developed	MONIC	passive	sampling	badges	made	of	
glass	 fibre.	 The	 amount	 of	 nicotine	 on	 a	 badge	 was	 determined	 by	 gas	
chromatography	 and	 used	 to	 calculate	 the	 number	 of	 passively	 smoked	
cigarettes(CEs)/day	assuming	a	nicotine	content	of	0.2	mg/cigarette	and	an	average	
ventilation	rate	of	10	L/min	(22),(23).	
In	 the	hospitality	venues	 that	agreed	to	participate,	at	 least	one	MoNIC	badge	was	
placed	 for	 one	week,	 often	 near	 the	 bar	where	waiting	 personnel	 spend	much	 of	
their	 working	 time.	 We	 calculated	 for	 each	 hospitality	 worker	 a	 time‐weighted	
average	 workplace	 exposure	 (24)	 by	 multiplying	 their	 average	 workplace	
concentration	by	their	workload	(in	percentage	of	full	time	equivalent)	and	by	0.6,	
which	 	 represents	 presence	 time	 at	 the	 work	 place	 including	 	 holidays	 and	
considering	the	fact	that	nicotine	levels	decrease	when	a	venue	is		unattended(24).	.	
For	 non‐hospitality	workers	 average	 SHS	 exposure	was	 obtained	 from	 a	 personal	
badge	that	participants	wore	on	themselves	at	work	and	in	private	on	a	typical	day.	
Statistical	Analysis	
Longitudinal	analyses	were	conducted	with	two	statistical	approaches.	First,	for	the	
intervention	 group	 and	 the	 control	 group	 a	 pre/post	 ban	 exposure	 variable	 was	
derived	by	defining	baseline	data	of	both	groups	as	pre‐ban	and	the	two	follow‐up	
examinations	as	post	ban	although	in	the	control	group	no	ban	was	 introduced.	 In	
order	 to	 increase	 statistical	power	we	did	not	differentiate	between	 the	 follow‐up	
examinations	and	calculated	an	overall	effect.	For	each	 log‐transformed	outcome	a	
linear	mixed	effects	model	with	a	random	subject	intercept	was	fit	including	a	study	
group	by	pre/post	ban	 interaction	 term.	HRV	analyses	were	adjusted	 for	age,	 sex,	
BMI	 and	 season,	 PWV	 additionally	 for	 time	 of	 day	 and	 systolic	 blood	 pressure	 as	
continuous	variables.	Systolic	blood	pressure	was	adjusted	for	age,	sex,	BMI,	season	
and	 self‐reported	 asthma.	 Finally,	we	 calculated	 crude	 and	 adjusted	 values	 of	 the	
health	 outcomes	 prior	 and	 after	 the	 ban	 for	 both	 groups.	 Secondly,	 covariate‐
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adjusted	exposure	 response	associations	were	 calculated	with	 a	 random	 intercept	
model	 using	 the	 estimated	 work	 place	 SHS	 exposure	 at	 the	 time	 of	 each	 health	
examination	 as	 explanatory	 variable	 using	 data	 from	 all	 study	 participants,	
including	the	unexposed	supplementary	group.		
Data	were	analysed	using	Stata	10.1	(StataCorp	LP,	College	Station,	TX).	
RESULTS	
Exposure	of	the	study	population	
Our	study	sample	comprised	92	participants,	55	in	the	intervention	group,	23	in	the	
control	group	and	14	in	the	supplementary	group.	Groups	did	not	differ	in	terms	of	
sociodemographic	factors	or	health	status,	except	for	age,	self‐reported	asthma	and	
physical	 activity	 (Table	 5‐1).	 There	 were	 no	 diabetics	 in	 our	 sample.	 Average	
exposure	 in	 the	 intervention	 group	 at	 baseline	 was	 2.56	 (95%	 CI:	 1.70	 to	 3.44)	
cigarette	equivalents	per	day	 (CE/day)	and	0.16	 (95%	CI:	0.13	 to	0.20)	CE/day	at	
follow‐up	 resulting	 in	 an	 exposure	 reduction	 of	 2.40	 CE/day	 (Table	 5‐1).	 In	 the	
exposed	control	group	exposure	at	baseline	was	2.07	(95%	CI:	0.96	to	3.18)	CE/day	
and	1.59	(95%	CI:	0.67	to	2.50)	CE/day	at	follow‐up.		
Heart	Rate	Variability	
From	the	HRV	analyses	2	observations	from	the	intervention	group	and	5	from	the	
control	group	were	excluded	due	to	missing	data	(n=1)	or	insufficient	quality	(n=6).	
At	baseline,	adjusted	HRV	parameters	did	not	differ	between	 the	 intervention	and	
the	exposed	 control	 group	 (Table	5‐2).	After	 the	 introduction	of	 the	 smoking	ban,	
SDNN,	 RMSSD,	 HF,	 LF/HF	 and	 Total	 Power	 significantly	 diverge	 between	 the	 two	
groups	(Figure	5‐1).	All	 these	parameters	 increase	 in	the	 intervention	group	while	
decreasing	in	the	control	group	except	the	LF/HF	ratio	which	goes	 in	the	opposite	
direction,	 leading	 to	 a	 significant	 change	 in	 the	 intervention	 group	 relative	 to	 the	
exposed	 control	 group	 after	 implementation	 of	 the	 smoking	 ban.	 The	 exposure‐
response	model	(Table	5‐3)	shows	significant	increases	of	2.3%	(95%	CI:	0.2	to	4.4;	
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p=0.031)	and	5.7	%	(95%	CI:	0.9	to	10.2;	p=0.02)	per	decrease	in	CE/day	for	RMSSD	
and	HF,	respectively.	SDNN	and	Total	Power	are	associated	with	an	increase	of	1.8	
%	(95%	CI:	 ‐0.1	 to	3.8;	p=0.069)	and	4.1%	(95%	CI:	0.0	 to	8.0;	p=0.51),	while	 the	
LF/HF	 ratio	 significantly	 decreases	 by	 ‐5.7%	 (95%	CI:	 ‐9.1	 to	 ‐2.4);	 p=0.001)	 per	
decrease	in	CE/day.	LF	does	not	change	materially.	For	comparison,	age‐dependent	
changes	in	HRV	parameters	obtained	from	the	same	model	are	shown	in	Table	5‐3.	
	
Figure	5‐1	Covariate‐adjusted	Heart	Rate	Variability	parameters	at	baseline	and	follow‐up,	
Switzerland	2010/2011	
P‐values	refer	to	the	change	in	the	intervention	group	relative	to	the	control	group.		
SDNN=	standard	deviation	of	NN	intervals;	RMSSD=root	mean	square	of	successive	difference	
Pulse	Wave	Velocity	
For	 the	arterial	 stiffness	analyses	 two	participants	had	missing	data	and	 technical	
problems	 resulted	 in	 the	 loss	 of	 five	 observations	 for	 the	 PWV	measurements	 (4	
intervention,	1	control).	Table	5‐2	shows	crude	and	adjusted	values	of	PWV	for	the	
intervention	and	control	group.	Figure	5‐2	illustrates	the	changes	in	adjusted	values	
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comparing	 the	 intervention	 and	 control	 groups.	 Differences	 in	 PWV	 are	 not	
significant	although	the	intervention	group	shows	a	steady	decrease	over	the	year,	
an	effect	not	observed	in	the	control	group.	Systolic	blood	pressure	decreases	in	the	
intervention	group	and	increases	in	the	control	group.	
According	 to	 the	 exposure‐response	 model	 (Table	 5.3)	 PWV	 declines	 with	 each	
CE/day	decrease	by	0.72%	(95%	CI:	0.40	to	1.05;	p<0.001)	whereas	the	decrease	for	
systolic	blood	pressure	is	not	statistically	significant.		
	
Figure	5‐2	Covariate‐adjusted	Pulse	Wave	Velocity	and	systolic	blood	pressure	at	baseline	and	
follow‐up,	Switzerland	2010/2011	
P‐values	refer	to	the	change	in	the	intervention	group	relative	to	the	control	group	
	
DISCUSSION	
The	 smoking	 ban	 implementation	 led	 to	 statistically	 significant	 improvements	 in	
HRV	 parameters	 in	 non‐smoking	 hospitality	 workers	 within	 12	 months.	 HRV	
increased	 in	 the	 intervention	 group	 and	 PWV	 decreased	 compared	 to	 the	 control	
group	that	did	not	experience	any	changes	in	SHS	exposure.		
This	 study	 addresses	 several	 research	 gaps	 that	 the	 Institute	 of	 Medicine	 2010	
report	 on	 SHS	 exposure	 and	 cardiovascular	 effects	 identified	 (25):	 It	 directly	
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examines	 the	 exposure‐response	 relationship	 of	 individual‐level	 SHS	 exposure	 to	
HRV	and	arterial	 stiffness	 and	accounts	 for	potential	 confounders,	 including	other	
risk	 factors	 for	 cardiovascular	 events.	 It	 also	 compares	 possible	 changes	 in	 an	
intervention	 group	 where	 smoke	 free	 workplaces	 were	 introduced	 to	 a	 control	
group	that	did	not	experience	a	change	in	SHS	exposure.	
Comparison	with	the	literature	
Our	 results	 on	 HRV	 are	 in	 line	 with	 the	 only	 other	 study	 looking	 into	 long‐term	
effects	of	SHS	on	HRV		reporting	trends	of	lower	levels	in	SDNN,	Total	Power	and	HF	
in	subjects	that	were	exposed	to	SHS	for	>2h/d	compared	to	unexposed	subjects	in	a	
cross‐sectional	 setting	 (10).	Our	 findings	 are	 also	 supported	by	other	 studies	 that	
looked	at	acute	effects	of	SHS	on	HRV	and	 found	consistent	decreases	 in	SDNN	as	
soon	 as	 subjects	were	 exposed	 (9)	 or	 right	 after	 exposure	 (26,	 27).	 The	 effect	 of	
active	smoking	on	heart	rate	variability	has	been	studied	extensively.	While	several	
studies	found	diminished	HRV	in	heavy	smokers	(28‐30),	others	did	not	confirm	this	
(31,	 32).	 A	 study	 examining	 the	 effect	 of	 smoking	 cessation	 on	 HRV	 recorded	 a	
significant	 increase	 one	 day	 after	 cessation	 in	 heavy	 smokers	 that	 although	
diminished,	 persisted	 one	 month	 after	 cessation	 (33).	 This	 effect	 is	 in	 line	 with	
another	study	looking	at	regular	smokers	(34).		
Interpretation	of	our	results	
No	 significant	 difference	 in	 HRV	 parameters	 between	 the	 intervention	 and	 the	
exposed	 control	 group	 could	 be	 detected	 at	 baseline.	 SDNN,	 reflecting	 the	 overall	
variability	of	HRV,	 increased	by	1.8%	per	decrease	 in	CE/day,	which	 is	more	 than	
the	1.5%	decrease	of	SDNN	per	year	of	life	according	to	the	same	exposure‐response	
model.	Applying	the	average	exposure	reduction	of	2.4	CEs/day	that	we	estimated	in	
this	 study,	 this	 effect	 corresponds	 to	 a	 delay	 of	 roughly	 three	 years	 in	 HRV	
reduction.	 RMSSD	 and	 HF	 describing	 parasympathetic	 activity	 both	 increased	
significantly.	 LF	 did	 not	 change	 measurably	 while	 the	 LF/HF	 ratio	 significantly	
decreased.	 These	 alterations	 support	 former	 published	 evidence	 suggesting	 that	
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passive	 smoking	 increases	 the	 sympathetic	 drive	 and	 reduces	 parasympathetic	
modulation	as	well	as	overall	HRV	(35).	
PWV	was	higher	at	baseline	 in	 the	 intervention	group	than	 in	 the	exposed	control	
group.	During	the	study	the	two	groups	drew	closer	together	although	the	ban	effect	
was	not	significant.	In	the	exposure‐response	model,	PWV	significantly	declined	by	
0.72%	per	decrease	in	CE/day,	which	corresponds	to	a	ban	effect	of	about	2.5	years	
of	 life.	The	somewhat	discordant	result	of	 the	exposure‐response	model	compared	
to	the	pre/post	model	means	that	PWV	was	strongly	correlated	with	SHS	exposure	
at	 the	workplace	 but	 changes	within	 one	 year	were	 small.	 This	 pattern	would	 be	
consistent	with	a	more	 chronic	effect	of	 SHS	assuming	 that	measured	exposure	at	
the	workplace	at	baseline	is	representative	for	chronic	exposure.	
Strengths	and	limitations	
To	 the	 best	 of	 our	 knowledge	 this	 is	 the	 first	 study	 to	 prospectively	measure	 the	
effect	 of	 a	 smoking	 ban	 on	 subclinical	 outcomes	 related	 to	 cardiovascular	
physiology.	A	major	asset	of	this	study	is	the	quasi	experimental	setting	that	allowed	
comparing	the	effects	in	workers	where	a	smoke	free	workplace	was	introduced	to	a	
control	group	without	an	exposure	change.	A	further	strength	is	that	exposure	data	
was	collected	at	the	same	time	as	the	health	outcomes.	A	prospective	study	avoids	
the	 dangers	 of	 a	 possible	 recall	 bias	 and	 mixed	 linear	 models	 allow	 for	 within‐
subject	clustering.	By	using	the	MoNIC	badge,	SHS	exposure	was	directly	quantified	
by	 measuring	 nicotine	 without	 using	 a	 surrogate	 measure	 such	 as	 airborne	
particulate	matter.		
Although	exposure	misclassification	cannot	be	excluded,	in	particular	for	individuals	
of	 the	 control	 group	 without	 a	 workplace	 badge,	 the	 consistency	 of	 the	 results	
between	 the	 pre/post	 models	 with	 the	 exposure‐response	 model	 suggests	 that	
exposure	misclassification	is	unlikely	to	bias	our	results.	Due	to	limited	sample	size	
we	could	not	differentiate	between	the	two	follow‐up	examinations	in	our	analysis	
but	 this	 should	not	have	caused	any	bias.	Recruitment	of	eligible	participants	was	
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unexpectedly	 tedious	 as	 restaurant	 owners	 were	 worried	 about	 financial	 losses	
caused	 by	 the	 smoking	 ban,	 a	 concern	 that	 was	 shown	 to	 be	 baseless	 (36).	 The	
exposed	 control	 group	 was	 younger,	 physically	 more	 active	 and	 reported	 more	
asthma.	 This	 might	 have	 influenced	 the	 results.	 However,	 they	 are	 unlikely	 to	
explain	 the	 full	 pattern,	 since	 we	 have	 considered	 these	 factors	 in	 the	 exposure‐
response	model.	The	pre/post	model	is	mainly	a	within‐subject	comparison	where	
group	differences	are	less	relevant.	
Conclusions	
This	 study	 indicates	 that	 introduction	 of	 smoke‐free	 workplaces	 in	 hospitality	
venues	substantially	 lowers	cardiovascular	 risk	 factors	 in	non‐smoking	hospitality	
workers	 and	 emphasizes	 the	 need	 for	 authorities	 worldwide	 to	 implement	
comprehensive	policies	in	order	to	prevent	adverse	health	effects.	
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Table	5‐1	Study	population,	Switzerland	2010/2011	
	 Intervention	group	
(n=55)	 Control	group	(n=23)	
Supplementary	group	
(n=14)	 p‐Value‡	
Female	sex	 33	(60%)	 13	(57%)	 11	(79%)	 0.37	
Age	(years)	 42.2	(95%	CI:	39.0‐45.4)	 31.8	(95%	CI:	26.4‐37.2)	 46.8	(95%	CI:	41.1‐52.5)	 0.001	
BMI	(kg/m2)	 26.0	(95%	CI:	24.9‐27.2)	 25.0	(95%	CI:	22.7‐27.2)	 25.0	(95%	CI:	23.3‐26.7)	 0.23	
Overweight	(BMI>25)	 28	(50.1	%)	 11	(47.8	%)	 5	(35.7	%)	 0.60	
Smoking	status	
Never‐smokers	 40	(72.7	%)	 21	(91.3	%)	 12	(85.7	%)	
0.15	
Ex‐smokers	 15	(27.3	%)	 2	(8.7	%)	 2	(14.3	%)	
Self‐reported	asthma		 4	(7.3	%)	 8	(34.8	%)	 1	(7.1)	 0.01	
Systolic	blood	pressure	(mmHg)	 125.0	(95%	CI:	121.2‐128.7)	
122.3	(95%	CI:	115.6‐
129.1)	
128.6	(95%	CI:	122.7‐
134.4)	 0.16	
Diastolic	blood	pressure	(mmHg)	 81.5	(95%	CI:	78.8‐84.1)	 77.8	(95%	CI:	73.3‐82.3)	 82.3	(95%	CI:	77.9‐86.6)	 0.24	
Hypertension#	 15	(27.3	%) 11	(4.4	%) 4	(28.6	%) 0.07
Self‐reported	diabetes	mellitus	 0	(0	%) 0	(0	%) 0	(0	%)
Coronary	disease§	 1	(1.8	%) 0	(0	%) 1	(7.1	%) 0.34
Betablocker	intake	 6	(10.9	%) 1	(4.4	%) 2	(14.3	%) 0.56
Allergic*	 38	(69.1	%) 16	(69.6	%) 6	(42.9	%) 0.30
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Self‐reported	physical	activity†	 19	(34.6	%) 16	(69.6	%) 10	(71.4	%) 0.02
Average	workload	(%)	 93.8	(n=55) 100.0	(n=7) 84.3	(n=14) 0.20
Type	of	workplace	
bar	 5	(9.1	%)	 2	(88.7	%)	 0	(0	%)	
0.007	café	 18	(32.7	%) 0	(0	%) 0	(0	%)restaurant	 32	(58.2	%) 5	(21.7	%) 14	(100	%)
other	 0	(0	%) 16	(69.6	%) 0	(0	%)
Pre‐ban	workplace	exposure	(cigarette	
equivalents/day)	
2.56	(95%	CI:	1.70‐3.44)	 2.07	(95%	CI:	0.96‐3.18)	 0.12	(95%	CI:	0.03‐0.21)	 	
Post‐ban	workplace	exposure	(cigarette	
equivalents/day)	
0.16	(95%	CI:	0.13‐0.20) 1.59	(95%	CI:	0.67‐2.50)	 NA	 	
Values	shown	are	arithmetic	means	at	baseline	except	where	indicated	
‡	Kruskal	Wallis	Test	for	numerical	data,	Chi	square	for	proportion	
#	defined	as	positive	if	diastolic	blood	pressure>90	mmHg	OR	systolic	blood	pressure>140	mmHg	
§	defined	as:	has	taken	medication	for	coronary	heart	disease	during	the	past	7d	
*reacted	positively	to	at	least	one	skin	prick	test	
†deϔined	as:		answered	yes	to:	do	you	sweat	at	least	once/week	due	to	physical	activity?	
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Table	5‐2	Heart	Rate	Variability	and	Pulse	Wave	Velocity:	pre/post	model,	Switzerland	2010/2011	
	
	 	 Pre‐Ban	 Post‐Ban	
	 	 Intervention	Group	 Control	Group	 p‐Value#	 Intervention	Group	 Control	Group	
p‐
Value‡	
	 	 n	 Geometric	Mean	(95%	CI)	 n	
Geometric	Mean	
(95%	CI)	
	 n	 Geometric	Mean	(95%	CI)	 n	
Geometric	Mean	
(95%	CI)	
	
SDNN	
[ms]*	
unadjusted	 53	 42.1	(37.8‐47.0)	 21	 48.0	(37.5‐61.5)	 	 84	 46.2	(42.3‐50.4)	 19	 41.4	(33.4‐51.3)	 	
adjusted	 53	 42.4	(38.2‐47.1) 21 43.6	(37.0‐51.4) 0.79 84	 47.6	(43.3‐52.2) 19 38.6	(32.3‐46.2) 0.02	
RMSSD	
[ms]*	
unadjusted	 53	 28.9	(24.9‐33.5) 21 36.2	(25.8‐50.8) 84	 32.5	(28.8‐36.7) 19 31.1	(22.2‐43.6) 	
adjusted	 53	 30.5	(26.7‐34.8) 21 29.7	(24.1‐36.7) 0.86 84	 34.2	(30.2‐38.6) 19 26.7	(21.2‐33.4) 0.04	
LF/HF*	 unadjusted	 53	 1.5	(1.2‐1.9) 21 1.0	(0.6‐1.6) 84	 1.3	(1.1‐1.5) 19 1.3	(0.8‐2.0) 	
adjusted	 53	 1.4	(1.1‐1.7) 21 1.2	(0.9‐1.7) 0.48 84	 1.2	(1.0‐1.5) 19 1.6	(1.2‐2.3) 0.01	
HF	[ms2]*	 unadjusted	 53	 341.4	(240.8‐483.8)	 21	 556.3	(265.3‐1166.3)	 	 84	 450.4	(342.7‐591.9)	 19	 377.8	(179.3‐796.2)	 	
adjusted	 53	 376	(280‐505) 21 362	(226‐582) 0.92 84	 514	(390‐677) 19 258	(155‐430) 0.01	
LF	[ms2]*	 unadjusted	 53	 522.6	(408.7‐668.2) 21 555.9	(336.5‐918.2) 84	 558.1	(461.7‐674.7) 19 458.8	(287.2‐ 732.7) 	
adjusted	 53	 535	(424‐674) 21 444	(310‐636) 0.39 84	 605	(494‐741) 19 395	(266‐588) 0.28	
Total	
Power	
[ms2]*	
unadjusted	 53	 1797.2	(1439.4‐2243.9)	 21	 2348.0	(1399.6‐3939.0)	 	 84	
2188.8	(1832.1‐
2614.9)	 19	
1739.1	(1118.8‐
2703.2)	 	
adjusted	 53	 1807	(1454‐2247) 21 1951	(1387‐2745) 0.73 84	 2323	(1915‐2819) 19 1517	(1042‐2207) 0.02	
5	Heart	Rate	Variability	and	Pulse	Wave	Velocity	
 
65	
 
PWV	
[m/s]**	
unadjusted	 52	 11.2	(10.8‐11.6) 19 9.8	(8.9‐10.8) 83	 10.8	(10.5‐11.1) 18 9.8	(9.2‐10.5) 	
adjusted	 52	 11.1	(10.8‐11.4) 19 10.5	(10.1‐11.0) 0.03 83	 10.8	(10.5‐11.1) 18 10.5	(10.0‐11.0) 0.12	
Systolic	
blood	
pressure	
[mmHg]§	
unadjusted	 55	 124.3	(120.7‐127.9) 23 121.3	(114.7‐128.4) 85	 123.4	(120.5‐126.4) 19 124.3	(119.8‐128.9) 	
adjusted	 55	 124.1	(120.7‐127.5)	 23	 125.9	(120.4‐131.4)	 0.90	 85	 122.8	(119.5‐126.1)	 19	 128.3	(122.3‐134.3)	 0.13	
*Adjusted	for	age,	sex,	bmi	and	season	
**Adjusted	for	age,	sex,	bmi,	systolic	blood	pressure,	circadian	rhythm	and	season	
§Adjusted	for	age,	sex,	bmi,	season	and	asthma	
#Covariate	adjusted	p‐value	for	the	baseline	difference	according	to	the	mixed	linear	model	
‡Covariate	adjusted	p‐value	for	the	intervention	effect	based	on	the	interaction	term	of	the	mixed	linear	model	
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Table	5‐3	Heart	Rate	Variability	and	Pulse	Wave	Velocity:	Exposure‐Response	model,	Switzerland	2010/2011	
	 Coefficient#	(95%	CI)	 p‐Value	 Age	coefϐicient‡	(95%	CI)	 p‐Value	
SDNN*	 1.8	(‐0.1	to	3.8)	 0.069	 ‐1.5	(‐2.1	to	‐0.9)	 <0.001	
RMSSD*	 2.3	(0.2	to	4.4) 0.031 ‐2.6	(‐3.4	to	‐1.9)	 <0.001
LF/HF*	 ‐5.7	(‐9.1	to	‐2.4) 0.001 3.2	(2.1	to	4.4)	 <0.001
HF*	 5.7	(0.9	to	10.2) 0.020 ‐5.9	(‐7.5	to	‐4.2)	 <0.001
LF*	 0.6	(‐4.1	to	5.1) 0.802 ‐2.9	(‐4.2	to	‐1.7)	 <0.001
Total	Power*	 4.1	(0.0	to	8.0) 0.051 ‐3.0	(‐4.1	to	‐1.8)	 <0.001
PWV**	 ‐0.72	(‐0.40	to	‐1.05) <0.001 0.69	(0.54	to	0.85)	 <0.001
Systolic	blood	
pressure***	 ‐0.07	(‐0.32	to	0.47)	 0.722	 0.28	(0.13	to	0.43)	 <0.001	
#change	in	%	per	unit	decrease	in	cigarette	equivalents	
‡change	in	%	per	1y	increase	in	age	
*adjusted	for	age,	sex,	bmi	and	season	
**adjusted	for	age,	sex,	bmi,	season,	systolic	blood	pressure	and	circadian	rhythm		
***Adjusted	for	age,	sex,	bmi,	season	and	asthma	
5	Heart	Rate	Variability	and	Pulse	Wave	Velocity	
 
67	
 
References	
1.	 Seo	DC,	Torabi	MR.	Reduced	 admissions	 for	 acute	myocardial	 infarction	 associated	with	 a	
public	smoking	ban:	matched	controlled	study.	Journal	of	drug	education.	2007;37(3):217‐26.	
2.	 Sargent	 RP,	 Shepard	 RM,	 Glantz	 SA.	 Reduced	 incidence	 of	 admissions	 for	 myocardial	
infarction	associated	with	public	smoking	ban:	before	and	after	study.	BMJ.	2004;328(7446):977‐80.	
3.	 Bartecchi	 C,	 Alsever	 RN,	 Nevin‐Woods	 C,	 Thomas	 WM,	 Estacio	 RO,	 Bartelson	 BB,	 et	 al.	
Reduction	 in	 the	 incidence	 of	 acute	 myocardial	 infarction	 associated	 with	 a	 citywide	 smoking	
ordinance.	Circulation.	2006;114(14):1490‐6.	
4.	 Goodman	 PG,	 Haw	 S,	 Kabir	 Z,	 Clancy	 L.	 Are	 there	 health	 benefits	 associated	 with	
comprehensive	smoke‐free	laws.	International	journal	of	public	health.	2009;54(6):367‐78.	
5.	 Pell	JP,	Haw	S,	Cobbe	S,	Newby	DE,	Pell	AC,	Fischbacher	C,	et	al.	Smoke‐free	legislation	and	
hospitalizations	 for	 acute	 coronary	 syndrome.	 The	 New	 England	 journal	 of	 medicine.	
2008;359(5):482‐91.	
6.	 Tan	 CE,	 Glantz	 SA.	 Association	 between	 smoke‐free	 legislation	 and	 hospitalizations	 for	
cardiac,	cerebrovascular,	and	respiratory	diseases:	a	meta‐analysis.	Circulation.	2012;126(18):2177‐
83.	
7.	 Heart	 rate	variability.	 Standards	of	measurement,	physiological	 interpretation,	 and	clinical	
use.	Task	Force	of	the	European	Society	of	Cardiology	and	the	North	American	Society	of	Pacing	and	
Electrophysiology.	European	heart	journal.	1996;17(3):354‐81.	
8.	 Felber	Dietrich	D,	Schindler	C,	Schwartz	J,	Barthelemy	JC,	Tschopp	JM,	Roche	F,	et	al.	Heart	
rate	 variability	 in	 an	 ageing	 population	 and	 its	 association	 with	 lifestyle	 and	 cardiovascular	 risk	
factors:	 results	 of	 the	 SAPALDIA	 study.	 Europace	 :	 European	 pacing,	 arrhythmias,	 and	 cardiac	
electrophysiology	:	journal	of	the	working	groups	on	cardiac	pacing,	arrhythmias,	and	cardiac	cellular	
electrophysiology	of	the	European	Society	of	Cardiology.	2006;8(7):521‐9.	
9.	 Pope	 CA,	 3rd,	 Eatough	 DJ,	 Gold	 DR,	 Pang	 Y,	 Nielsen	 KR,	 Nath	 P,	 et	 al.	 Acute	 exposure	 to	
environmental	 tobacco	 smoke	 and	 heart	 rate	 variability.	 Environmental	 health	 perspectives.	
2001;109(7):711‐6.	
10.	 Felber	 Dietrich	 D,	 Schwartz	 J,	 Schindler	 C,	 Gaspoz	 JM,	 Barthelemy	 JC,	 Tschopp	 JM,	 et	 al.	
Effects	of	passive	smoking	on	heart	rate	variability,	heart	rate	and	blood	pressure:	an	observational	
study.	International	journal	of	epidemiology.	2007;36(4):834‐40.	
11.	 Bilchick	KC,	 Berger	RD.	Heart	 rate	 variability.	 Journal	 of	 cardiovascular	 electrophysiology.	
2006;17(6):691‐4.	
12.	 Chen	 CY,	 Chow	D,	 Chiamvimonvat	N,	 Glatter	 KA,	 Li	 N,	He	 Y,	 et	 al.	 Short‐term	 secondhand	
smoke	 exposure	 decreases	 heart	 rate	 variability	 and	 increases	 arrhythmia	 susceptibility	 in	 mice.	
American	journal	of	physiology	Heart	and	circulatory	physiology.	2008;295(2):H632‐9.	
5	Heart	Rate	Variability	and	Pulse	Wave	Velocity	
 
68	
 
13.	 Vlachopoulos	 C,	 Aznaouridis	 K,	 Stefanadis	 C.	 Prediction	 of	 cardiovascular	 events	 and	 all‐
cause	 mortality	 with	 arterial	 stiffness:	 a	 systematic	 review	 and	 meta‐analysis.	 Journal	 of	 the	
American	College	of	Cardiology.	2010;55(13):1318‐27.	
14.	 McEniery	CM,	Cockcroft	 JR.	Does	arterial	 stiffness	predict	atherosclerotic	coronary	events?	
Advances	in	cardiology.	2007;44:160‐72.	
15.	 Vlachopoulos	C,	Aznaouridis	K,	Terentes‐Printzios	D,	Ioakeimidis	N,	Stefanadis	C.	Prediction	
of	 cardiovascular	 events	 and	 all‐cause	mortality	 with	 brachial‐ankle	 elasticity	 index:	 a	 systematic	
review	and	meta‐analysis.	Hypertension.	2012;60(2):556‐62.	
16.	 Barnoya	 J,	 Glantz	 SA.	 Cardiovascular	 effects	 of	 secondhand	 smoke:	 nearly	 as	 large	 as	
smoking.	Circulation.	2005;111(20):2684‐98.	
17.	 Kubozono	 T,	 Miyata	 M,	 Ueyama	 K,	 Hamasaki	 S,	 Kusano	 K,	 Kubozono	 O,	 et	 al.	 Acute	 and	
chronic	effects	of	 smoking	on	arterial	 stiffness.	Circulation	 journal	 :	official	 journal	of	 the	 Japanese	
Circulation	Society.	2011;75(3):698‐702.	
18.	 Hill	 MA.	 HM	 Practical	 ‐	 Blood	 Vessel	 Histology:	 Retrieved	 July	 26,	 2013,	 from	
http://php.med.unsw.edu.au/embryology/index.php?title=HM_Practical_‐_Blood_Vessel_Histology;	
2013.	
19.	 Yu‐Jie	W,	Hui‐Liang	L,	Bing	L,	Lu	Z,	Zhi‐Geng	J.	Impact	of	smoking	and	smoking	cessation	on	
arterial	stiffness	in	healthy	participants.	Angiology.	2013;64(4):273‐80.	
20.	 Tomiyama	H,	Hashimoto	H,	Tanaka	H,	Matsumoto	C,	Odaira	M,	Yamada	J,	et	al.	Continuous	
smoking	and	progression	of	arterial	stiffening:	a	prospective	study.	Journal	of	the	American	College	
of	Cardiology.	2010;55(18):1979‐87.	
21.	 Roosli	 M,	 Rajkumar	 S.	 How	 long	 is	 the	 yardstick	 for	 smoking	 bans	 in	 Switzerland?	
International	journal	of	public	health.	2013;58(6):797‐8.	
22.	 Huynh	CK,	Moix	 J,	Dubuis	A.	Development	and	application	of	 the	passive	smoking	monitor	
MoNIC.	Revue	Médicale	Suisse.	2008;4(144):430‐3.	
23.	 Durham	AD,	Bergier	S,	Morisod	X,	Locatelli	I,	Zellweger	JP,	Huynh	CK,	et	al.	Improved	health	
of	hospitality	workers	after	a	Swiss	cantonal	smoking	ban.	Swiss	medical	weekly.	2011;141:w13317.	
24.	 Rajkumar	 S,	 Huynh	 CK,	 Bauer	 GF,	 Hoffmann	 S,	 Roosli	 M.	 Impact	 of	 a	 smoking	 ban	 in	
hospitality	venues	on	second	hand	smoke	exposure:	a	comparison	of	exposure	assessment	methods.	
BMC	public	health.	2013;13:536.	
25.	 Secondhand	 Smoke	 Exposure	 and	 Cardiovascular	 Effects:	 Making	 Sense	 of	 the	 Evidence.	
Practice	BoPHaPH,	editor:	The	National	Academies	Press;	2010.	
26.	 Zhang	 J,	 Fang	 SC,	 Mittleman	 MA,	 Christiani	 DC,	 Cavallari	 JM.	 Secondhand	 tobacco	 smoke	
exposure	and	heart	 rate	variability	and	 inflammation	among	non‐smoking	construction	workers:	a	
repeated	measures	study.	Environmental	health	:	a	global	access	science	source.	2013;12(1):83.	
5	Heart	Rate	Variability	and	Pulse	Wave	Velocity	
 
69	
 
27.	 Wilson	MD,	McGlothlin	JD,	Rosenthal	FS,	Black	DR,	Zimmerman	NJ,	Bridges	CD.	Ergonomics.	
The	effect	of	occupational	exposure	to	environmental	tobacco	smoke	on	the	heart	rate	variability	of	
bar	and	restaurant	workers.	Journal	of	occupational	and	environmental	hygiene.	2010;7(7):D44‐9.	
28.	 Barutcu	I,	Esen	AM,	Kaya	D,	Turkmen	M,	Karakaya	O,	Melek	M,	et	al.	Cigarette	smoking	and	
heart	rate	variability:	dynamic	influence	of	parasympathetic	and	sympathetic	maneuvers.	Annals	of	
noninvasive	 electrocardiology	 :	 the	 official	 journal	 of	 the	 International	 Society	 for	 Holter	 and	
Noninvasive	Electrocardiology,	Inc.	2005;10(3):324‐9.	
29.	 Levin	 FR,	 Levin	 HR,	 Nagoshi	 C.	 Autonomic	 functioning	 and	 cigarette	 smoking:	 heart	 rate	
spectral	analysis.	Biological	psychiatry.	1992;31(6):639‐43.	
30.	 Hayano	 J,	Yamada	M,	Sakakibara	Y,	Fujinami	T,	Yokoyama	K,	Watanabe	Y,	et	al.	Short‐	and	
long‐term	effects	of	cigarette	smoking	on	heart	rate	variability.	The	American	journal	of	cardiology.	
1990;65(1):84‐8.	
31.	 Kageyama	T,	Nishikido	N,	Honda	Y,	Kurokawa	Y,	Imai	H,	Kobayashi	T,	et	al.	Effects	of	obesity,	
current	 smoking	 status,	 and	 alcohol	 consumption	 on	 heart	 rate	 variability	 in	 male	 white‐collar	
workers.	International	archives	of	occupational	and	environmental	health.	1997;69(6):447‐54.	
32.	 Murata	 K,	 Landrigan	 PJ,	 Araki	 S.	 Effects	 of	 age,	 heart	 rate,	 gender,	 tobacco	 and	 alcohol	
ingestion	 on	 R‐R	 interval	 variability	 in	 human	 ECG.	 Journal	 of	 the	 autonomic	 nervous	 system.	
1992;37(3):199‐206.	
33.	 Yotsukura	M,	Koide	Y,	Fujii	K,	Tomono	Y,	Katayama	A,	Ando	H,	et	al.	Heart	 rate	variability	
during	the	first	month	of	smoking	cessation.	American	heart	journal.	1998;135(6	Pt	1):1004‐9.	
34.	 Minami	J,	Ishimitsu	T,	Matsuoka	H.	Effects	of	smoking	cessation	on	blood	pressure	and	heart	
rate	variability	in	habitual	smokers.	Hypertension.	1999;33(1	Pt	2):586‐90.	
35.	 Dinas	PC,	Koutedakis	Y,	Flouris	AD.	Effects	of	active	and	passive	tobacco	cigarette	smoking	
on	heart	rate	variability.	International	journal	of	cardiology.	2013;163(2):109‐15.	
36.	 Schulz	 PJ,	 Hartung	 U,	 Fiordelli	 M.	 Effect	 of	 smoke‐free	 legislation	 on	 Ticino	 gastronomy	
revenue.	International	journal	of	public	health.	2012;57(6):861‐6.	
5	Heart	Rate	Variability	and	Pulse	Wave	Velocity	
 
70	
 
	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
71	
 
6 ARTICLE	3:	The	Effect	of	a	Smoking	Ban	On	Respiratory	Health	
in	Non‐Smoking	Hospitality	Workers:	A	Prospective	Cohort	
Study	
	
Sarah	Rajkumar,	M.Sc.1,2		
Jürg	Hammer,	MD3	
Alexander	Moeller,	MD4		
Daiana	Stolz,	MD,	MPH5	
Georg	F.	Bauer	MD,	DrPH.6	
Cong	Khanh	Huynh,	Ph.D.7	
Martin	Röösli,	Ph.D.1,2	
1Swiss	Tropical	and	Public	Health	Institute,	Basel,	Switzerland	
2University	of	Basel,	Basel,	Switzerland	
3Department	of	Paediatric	Pulmonology	and	Intensive	Care	Medicine,	UKBB,	Basel,	
Switzerland	
4Department	of	Respiratory	Medicine,	University	Children's	Hospital,	Zurich,	
Switzerland	
5Clinic	of	Pulmonary	Medicine	and	Respiratory	Cell	Research,	University	Hospital	
Basel,	Basel,	Switzerland	
6Institute	of	Social	and	Preventive	Medicine,	University	of	Zürich	and	Center	for	
Organizational	and	Occupational	Sciences,	ETH	Zurich,	Switzerland	
7Institute	for	Work	and	Health,	Lausanne,	Switzerland	
	
	
	
	
	
	
Published	in	the	Journal	of	Occupational	and	Environmental	Medicine	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
72	
 
ABSTRACT		
Objective.	The	aim	of	this	study	was	to	examine	the	effect	of	a	smoking	ban	on	lung	
function,	 fractional	exhaled	nitric	oxide	 (FeNO)	and	respiratory	symptoms	 in	non‐
smoking	hospitality	workers.	
Methods.	 Secondhand	 smoke	 (SHS)	 exposure	 at	 the	 workplace,	 spirometry	 and	
FeNO	were	measured	in	92	non‐smoking	hospitality	workers	before	as	well	as	twice	
after	a	smoking	ban.		
Results.	 At	 baseline,	 SHS	 exposed	 hospitality	 workers	 had	 lung	 function	 values	
significantly	 below	 the	 population	 average.	 After	 the	 smoking	 ban,	 covariate	
adjusted	 odds	 ratio	 for	 cough	 was	 0.59	 (95%	 CI:	 0.36‐0.93)	 and	 for	 chronic	
bronchitis	0.75	(95%	CI:	0.55‐1.02)	compared	to	the	pre	ban	period.		
Conclusions.	The	below	average	 lung	 function	prior	 to	 the	smoking	ban	 indicates	
chronic	 damages	 from	 long‐term	 exposure.	 Respiratory	 symptoms	 such	 as	 cough	
significantly	decreased	within	12	months	after	the	ban.	
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BACKGROUND	
It	has	been	established	 that	both	active	and	passive	 smoking	are	 closely	 linked	 to	
progressive	 lung	 function	 decline	 (1,	 2).	 Cross‐sectional	 studies	 have	 observed	
significantly	 higher	 prevalences	 for	 respiratory	 symptoms	 such	 as	 cold,	 cough,	
phlegm	and	throat	problems	 in	persons	exposed	to	SHS	at	 the	workplace	(3‐6).	 In	
the	 last	decades,	smoking	bans	 for	public	places	 including	hospitality	venues	were	
implemented	 in	 many	 countries	 all	 over	 the	 world	 and	 potential	 benefits	 on	
respiratory	 health	 were	 evaluated.	 Several	 longitudinal	 studies	 examined	 self‐
reported	respiratory	symptoms	and	 lung	 function	before	and	after	a	smoking	ban.	
Some	 researchers	 found	 less	 respiratory	 symptoms	 in	 both	 non‐smokers	 and	
smokers	(7,	8)	and	could	show	that	this	reduction	did	not	occur	in	the	control	group	
(8,	9).	While	respiratory	symptoms	are	very	consistently	reported	as	declining	(7,	8,	
10,	11),	 findings	on	 lung	 function	outcomes	are	more	variable.	Two	studies	 in	bar	
workers	reported	significant	improvements	in	Forced	Vital	Capacity	(FVC),	but	not	
in	Forced	Expiratory	Volume	in	1	second	(FEV1)	or	Forced	Expiratory	Flow	25‐75%	
(FEF25‐75%)	after	two	months	(10)	or	one	year	(12)	of	smoking	ban	introduction.	A	
study	from	the	French	part	of	Switzerland	also	observed	significant	 improvements	
in	FVC,	most	pronounced	in	women,	non‐smokers	and	persons	above	35	years	(13).	
Conversely,	 another	 study	 found	 a	 significant	 increase	 in	 FEV1	 in	 healthy	 and	
asthmatic	 bar	 workers	 within	 one	 month	 after	 ban	 implementation	 but	 did	 not	
report	any	findings	on	FVC	or	FEF25‐75%	(11).	A	Swedish	study	did	not	observe	any	
noteworthy	improvements	in	lung	function	parameters	after	the	smoking	ban	(14).		
A	recent	Swiss	study	reported	a	significant	decrease	in	hospital	admission	for	acute	
exacerbation	of	COPD	after	a	smoking	ban	but	no	changes	for	asthma	or	pneumonia	
(15).		
Fractional	Exhaled	Nitric	Oxide	(FeNO)	is	a	marker	of	airway	inflammation,	that	has	
been	 increasingly	studied	 in	 the	past	20	years	(16).	Measurement	of	FeNO	 is	non‐
invasive	and	highly	reproducible	and	can	easily	be	performed	online	or	offline	(17).	
It	 has	 primarily	 been	 used	 to	 investigate	 and	monitor	 asthma.	 Allergen	 exposure	
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upregulates	 inducible	 NO	 synthase	 (iNOS)	 in	 the	 airway	 epithelial	 cells	 (16).	
Cigarette	smoke	is	believed	to	downregulate	iNOS	via	a	potential	negative	feedback	
mechanism	(18).	Decreased	FeNO	levels	have	been	observed	in	smoking	asthmatics	
(19)	 as	well	 as	 in	non‐atopic	 smokers	 (20)	 that	 rise	 after	 smoking	 cessation	 (21).	
The	 same	mechanisms	 might	 reduce	 FeNO	 levels	 when	 being	 exposed	 to	 second	
hand	smoke	(SHS).	However,	empirical	data	is	scarce	and	ambiguous.	Although	one	
study	 found	 decreased	 FeNO	 levels	 in	 non‐smokers	 exposed	 to	 SHS	 (22),	 several	
studies	 reported	 the	opposite	 in	young	children	exposed	 to	parental	 smoking	 (23,	
24).	This	 is	the	first	study	to	look	at	the	effects	of	SHS	exposure	elimination	at	the	
workplace	on	FeNO	levels	in	non‐smokers.		
The	implementation	of	a	national	smoking	ban	in	Switzerland	in	May	2010	was	used	
to	 set	 up	 a	 prospective,	 longitudinal	 study	 of	 non‐smoking	 hospitality	workers	 in	
three	cantons:	Zurich,	Basel	City	and	Basel	County.	The	two	aims	of	the	study	were	i)	
to	 compare	 baseline	 spirometry	 values	 of	 SHS	 exposed	 hospitality	 workers	 to	
reference	 values	 from	 the	 literature	 and	 ii)	 to	 directly	 relate	 work‐place	 SHS	
exposure	 in	 non‐smoking	 hospitality	 workers	 before	 and	 6‐12	 months	 after	 a	
smoking	ban	to	their	respiratory	health.		
METHODS	
Study	population	
The	 study	 population	 consisted	 of	 92	 participants	 in	 total:	 62	 non‐smoking	
hospitality	workers,	who	had	worked	for	at	 least	1	year	 in	venues	where	smoking	
was	either	partially	or	completely	allowed	prior	to	the	introduction	of	the	smoking	
ban,	14	non‐smoking	hospitality	workers	who	worked	in	a	smoke‐free	environment	
at	baseline,	and	16	non‐smokers	who	were	regularly	exposed	to	SHS	without	being	
employed	in	the	hospitality	sector.	These	additional	16	non‐smokers	were	recruited	
in	order	to	enlarge	the	sample	size.	All	hospitality	workers	worked	in	a	hospitality	
venue	 in	 one	 of	 the	 study	 cantons.	Data	were	 collected	 between	March	 2010	 and	
December	2011.	
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In	order	to	recruit	hospitality	workers,	a	list	of	hospitality	venues	in	the	cantons	of	
Zurich,	Basel	City	and	Basel	County	was	created	using	the	digital	Swiss	phonebook	
from	 2009.	 Each	 venue	 received	 a	 letter	 containing	 information	 about	 the	 study,	
with	a	request	to	distribute	screening	questionnaires	to	staff	serving	at	tables	or	at	
the	bar	(waiting	staff)	and	for	air	measurements	to	be	performed	by	the	study	team.	
These	letters	were	followed	by	phone	calls	and	visits	two	weeks	later.		
Screening	 questionnaires	 were	 distributed	 to	 the	 waiting	 staff,	 to	 provide	
information	on	the	eligibility	criteria	which	were	being	between	18	and	65	years	of	
age,	working	at	least	half‐time,	having	worked	for	at	least	one	year	in	the	hospitality	
sector	and	having	been	a	non‐smoker	for	at	least	5	years.	Eligible	study	participants	
were	invited	to	a	health	examination,	which	was	carried	out	in	one	of	the	two	study	
centres	in	Basel	City	and	Zurich.		
The	non‐hospitality	workers	were	 recruited	by	means	of	 an	 online	 advertisement	
looking	 for	 non‐smokers	 that	 were	 exposed	 to	 SHS	 on	 a	 regular	 basis,	 either	
privately	or	at	work.		
Health	examinations	
Ethical	approval	was	obtained	from	the	EKBB	(Ethics	committee	of	both	cantons	of	
Basel)	 and	 all	 participants	 signed	 an	 informed	 consent	 before	 every	 examination	
(Ref.	No.	EK	317/09).		
A	 baseline	 examination	 was	 conducted	 within	 the	 3	 months	 prior	 to	 the	
introduction	 of	 the	 smoking	 ban.	 Subsequently,	 all	 study	 participants	 who	 were	
exposed	 to	 SHS	 at	 baseline	 were	 invited	 for	 two	 follow‐up	 examinations	 at	 3‐6	
months	and	9‐12	months	after	the	smoking	ban	introduction.		
The	 health	 examinations	 comprised	 cardiovascular	 and	 respiratory	 tests.	
Spirometry	 tests	were	 performed	 using	 a	 portable	 EasyOne	 spirometer	 from	 ndd	
Medical	 Technologies	 and	 read	 out	with	 the	 EasyWare	 software.	 Each	 participant	
had	to	wear	a	nose	clip	and	was	required	to	perform	three	successful	measurements	
within	a	maximum	of	eight	trials	according	to	the	ATS	(American	Thoracic	Society)	
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guidelines	(25).	For	FVC	and	FEV1	the	single	highest	value	of	all	tests	was	used	for	
analysis,	 for	FEF25‐75%	 and	 the	FEV1/FVC	ratio	 the	value	 from	 the	best	 test	 (FVC	+	
FEV1=max.)	was	taken.	
FeNO	measurements	were	performed	with	a	pressure	controlled	SIEVERS	NOA	280	
offline	kit	using	a	Mylar	bag®	to	collect	the	exhaled	breath	following	the	ATS/ERS	
recommendations	 (26).	 Participants	 were	 asked	 to	 inhale	 through	 a	 mouthpiece	
attached	 to	 a	 NO‐scrubber	 and	 then	 exhale	 against	 a	 set	 expiratory	 resistance	
maintaining	a	constant	pressure	of	12‐16	mbar	without	wearing	a	mouthpiece.	The	
constant	pressure	was	achieved	by	visual	 feedback	 from	an	 inline	pressure	gauge.	
The	 pressure	 range	 allowed	maintaining	 a	 constant	 expiratory	 flow	 of	 50	ml/sec.	
After	five	seconds	the	expiratory	air	was	collected	into	a	Mylar	bag®	until	the	bag	
was	 full.	 Ambient	 air	 was	 pumped	 into	 an	 additional	 bag	 to	 check	 for	 exceeding	
levels	of	ambient	FeNO.	The	FeNO	content	was	measured	within	twelve	hours	with	
an	EcoMedics	CLD	88	analyser	using	Spiroware	3.0.	For	data	analysis	the	average	of	
the	two	personal	measurements	was	used.	
Participants	 were	 defined	 as	 asthmatics	 if	 they	 reported	 having	 suffered	 from	
asthma	at	an	adult	age.	Asthmatics	currently	on	inhaled	corticosteroids	(ICS)	were	
excluded	from	the	analysis	as	ICS	decrease	FeNO	levels	(4	baseline	and	6	follow‐up	
observations).	 A	 skin	 prick	 test	 at	 baseline	 comparing	 the	 six	 most	 common	
allergens:	birch,	mixed	grasses,	alternaria,	mugwort,	cat	hair	and	dermatophtgoides	
to	a	positive	and	a	negative	control	was	performed	in	each	participant	at	baseline.	
Test	solutions	were	obtained	from	Trimedal	 in	Dietlikon,	Switzerland.	Participants	
were	considered	sensitized	if	they	showed	a	minimal	wheal	size	of	3mm	to	at	least	
one	tested	allergen.	
Interviews	
Respiratory	and	allergy	symptoms	were	assessed	during	the	health	examinations	in	
a	computer‐based	interview	adapted	from	a	standardized	questionnaire	previously	
evaluated	 in	 the	 Swiss	 population	 (27).	 We	 asked	 about	 respiratory	 and	 allergy	
symptoms	 in	 the	 last	 three	 to	 twelve	 months	 respectively.	 Asthmatic	 symptoms	
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were	 defined	 as	 breathlessness,	 wheezing	 or	 chest	 tightness.	 A	 person	 was	
considered	 to	 have	 chronic	 bronchitis	 if	 he/she	 stated	 to	 suffer	 from	 cough	 or	
phlegm	(27).	Participants	were	counted	as	positive	for	hay	fever	if	they	had	suffered	
from	symptoms	in	the	present	or	the	previous	year.	Rhinitis	was	defined	as	sneezing	
and	 a	 running	 nose	 during	 the	 past	 twelve	 months	 without	 having	 a	 cold	 or	
influenza.	Eczema	was	considered	to	be	present	if	participants	had	ever	had	an	itchy	
skin	rash	in	areas	typical	for	eczema.		
Exposure	measurements	
SHS	 was	 objectively	 measured	 using	 newly	 developed	 MoNIC	 passive	 sampling	
badges	 as	previously	described	 (28).	MoNIC	badges	 are	 glass	 fibre	 filters	 that	 are	
washed	with	distilled	water,	methanol	 and	CH2Cl2,	 impregnated	with	5mg	 sodium	
bisulphate	 per	 filter	 and	 placed	 in	 an	 air‐tight	 plastic	 case.	 Badges	 were	 always	
transported	 between	 study	 centres,	 participants,	 and	 the	 laboratory	 in	 these	 air‐
tight	 cases.	 The	 amount	 of	 nicotine	 on	 the	 badge	 was	 determined	 by	 gas	
chromatography	 and	 used	 to	 calculate	 the	 number	 of	 passively	 smoked	
cigarettes/day	 (CE/d)	 assuming	 a	 nicotine	 content	 of	 0.2	 mg/cigarette	 and	 an	
average	ventilation	rate	of	10	L/min	(13,	29).	
In	 the	hospitality	venues	 that	agreed	to	participate,	at	 least	one	MoNIC	badge	was	
placed	 for	 one	 week,	 near	 the	 bar	 where	waiting	 personnel	 spend	much	 of	 their	
working	time	(hereafter	referred	to	as	“workplace	badge”).	We	calculated	for	each	
hospitality	 worker	 a	 time‐weighted	 average	 workplace	 exposure	 (28)	 by	
multiplying	their	average	workplace	concentration	by	their	workload	(in	percentage	
of	full	time	equivalent)	and	by	0.6,	which		represents	time	present	at	the	work	place,	
includes	holidays	and	considers	the	fact	that	nicotine	levels	decrease	when	a	venue	
is	unattended	(28).	For	non‐hospitality	workers	average	SHS	exposure	was	obtained	
from	a	personal	badge	that	participants	wore	on	themselves	on	a	typical	day.	
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Data	analysis	
In	 order	 to	 estimate	 the	 long‐term	 consequences	 of	 working	 in	 SHS	 exposed	
hospitality	venues	on	 lung	 function,	we	calculated	 for	each	 study	participant,	who	
was	 exposed	 to	 SHS	 at	 baseline,	 age,	 gender	 and	height	 adjusted	percentage	FEV1	
and	FVC	values	 from	reference	values	 for	a	non‐smoking	Swiss	population	sample	
(30).	
By	 considering	 the	 within	 subject	 correlation,	 mixed	 linear	 random	 intercept	
regression	models	were	 used	 to	 relate	 respiratory	 parameters	 to	work	 place	 SHS	
exposure	 at	 the	 time	 of	 each	 health	 examination	 (baseline	 and	 follow‐ups).	 Lung	
function	models	were	calculated	adjusting	for	age,	sex,	height,	BMI	(linear),	asthma	
(binary),	 season	 (cosine	 function),	 and	 device	 number	 (categorical).	 FeNO	 levels	
were	log‐transformed	and	back‐transformed	model	coefficients	are	reported.	FeNO	
models	 were	 adjusted	 for	 age,	 sex,	 allergy	 (binary),	 season	 (cosine	 function)	 and	
time	of	day	(cosine	function).	The	cosine	function	for	time	of	day	variations	assigned	
the	value	of	0	to	12pm	and	1	to	12am	and	for	seasonal	variations	the	value	of	0	to	1	
July	 and	 1	 to	 1	 January.	 Respiratory	 symptoms	were	 evaluated	 by	means	 of	 GEE	
(Generalized	Estimated	Equation)	 regression	models	 adjusted	 for	 age,	 sex,	 season	
and	systolic	blood	pressure.		
Data	were	analysed	using	Stata	10.1	and	Stata	12.0	(StataCorp	LP,	College	Station,	
TX).	
RESULTS	
Our	study	sample	comprised	92	participants	(Table	6‐1)	with	no	one	suffering	from	
COPD.	 Thereof	 23	 individuals	 were	 exposed	 throughout	 the	 study,	 55	 were	 only	
exposed	at	baseline,	but	not	anymore	at	 follow‐up	and	14	were	never	exposed.	At	
baseline	average	exposure	of	the	14	study	participants	who	were	never	exposed	to	
SHS	 was	 0.1	 (95%	 CI:	 0.0‐0.2)	 cigarette	 equivalents	 per	 day	 (CE/d)	 whereas	
exposure	 in	 the	 78	 SHS	 exposed	 study	 participants,	 was	 2.4	 (95%	 CI:	 1.7	 to	 3.1)	
CE/d.		Of	these	78	participants,	55	were	not	anymore	exposed	at	follow‐up	and	their	
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SHS	exposure	decreased	to	0.2	(95%	CI:	0.1	to	0.2)	CE/d	while	staying	at	1.6	(95%	
CI:	 0.7‐2.5)	 CE/d	 for	 the	 23	 participants	 who	were	 still	 exposed	 at	 the	 follow‐up	
examinations.		
From	the	lung	function	analyses,	20	observations	were	excluded	due	to	insufficient	
quality	 (n=16),	 technical	 problems	 (n=1)	 or	 insufficient	 cooperation	 (n=3).	 For	
FeNO,	 ten	 baseline	 and	 one	 follow‐up	 measurement	 had	 to	 be	 excluded	 from	
analysis	due	to	technical	problems.	
At	baseline,	age,	sex	and	height	specific	fitted	FVC	and	FEV1	curves	of	our	sample	of	
non‐smoking	SHS	exposed	hospitality	workers	was	below	the	population	reference	
curve	(30)	for	most	of	the	age	range	in	men	and	women	(Figure	6‐1).	The	difference	
was	 most	 pronounced	 for	 FEV1	 in	 women	 (Table	 6‐2).	 However,	 longitudinal	
exposure‐response	models	 did	 not	 indicate	 an	 association	 between	 lung	 function	
parameters	and	SHS	exposure	(Table	6‐3).	FVC	showed	a	decreasing	tendency	with	
increasing	exposure	but	 this	association	was	not	significant.	When	using	exposure	
measures	 from	 personal	 badges	 that	 took	 into	 account	 private	 exposure	 no	
association	could	be	observed	either	(data	not	shown).	
Average	FeNO	levels	of	non‐asthmatic	study	participants	was	11.3	(95%	CI:	10.3	to	
12.5)	ppb	and	of	asthmatic	study	participants	14.3	(95%	CI:	8.6	to	20.0)	ppb.	FeNO	
was	 not	 related	 to	 SHS	 exposure	 in	 the	 longitudinal	 exposure‐response	 model	
(Table	6‐3).	Other	co‐variables	that	were	included	into	the	model	such	as	smoking	
history,	former	smoking	status,	physical	activity	or	childhood	SHS	exposure	did	not	
show	 any	 association	 either	 and	 were	 therefore	 excluded	 from	 the	 final	 models.	
However,	 FeNO	 values	 are	 36.1%	 (95%‐CI:	 6.9	 to	 73.2)	 higher	 on	 1	 January	
compared	 to	 1	 July	 (p=0.01)	 according	 to	 the	 cosine	 seasonality	 function	 in	 the	
model.	
The	exposure‐response	model	yielded	an	odds	ratio	of	1.25	(95%	CI:	1.03‐1.53)	per	
CE/d	increase	 in	SHS	exposure	for	cough	and	1.13	(95%	CI:	0.99‐1.28)	for	chronic	
bronchitis	(Table	6‐4).	Since	the	average	SHS	exposure	reduction	from	the	smoking	
ban	was	2.4	CE/d,	these	odds	ratios	translate	in	a	smoking	ban	OR	of	0.59	(95%	CI:	
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0.36‐0.93)	for	cough	and	0.75	(95%	CI:	0.55‐1.02)	for	chronic	bronchitis.	We	found	
no	clear	associations	for	phlegm	and	asthma	symptoms.		
	
Figure	6‐1	Fitted	FVC	and	FEV1	at	baseline	for	men	(n=23)	and	women	(n=39)	adjusted	for	age	
and	height	in	comparison	to	reference	curves	
DISCUSSION	
In	 our	 study	 population,	 of	 SHS	 exposed	 non‐smoking	 hospitality	 workers,	 we	
observed	significantly	below‐average	values	of	FVC	and	FEV1	before	implementation	
of	 a	 smoking	 ban.	We	 found	 indications	 that	 introducing	 a	 smoke‐free	workplace	
reduced	cough	and	chronic	bronchitis	but	not	lung	function	parameters	or	FeNO.		
In	line	with	other	smoking	ban	studies	in	hospitality	workers	(10‐12)	below	average	
lung	 function	was	observed	 in	 the	study	participants	who	were	exposed	 to	SHS	at	
baseline	and	had	worked	under	such	circumstances	for	at	least	one	year	but	mostly	
substantially	 longer.	 On	 average	 our	 participants	 had	 worked	 in	 a	 SHS	 exposed	
environment	for	8.5	years	ranging	from	1	to	33	years.	In	women	the	reduction	of	the	
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lung	 function	 compared	 to	 the	 reference	 curve	 increases	 with	 age.	 For	 men,	 this	
pattern	was	 impeded	by	one	observation	with	exceptionally	good	 lung	 function	at	
high	age.	This	pattern,	although	based	on	 few	observations,	 suggests	a	continuous	
degradation	of	 the	 lung	 function	with	 increasing	exposure	 time.	 In	contrast	 to	our	
hypothesis	that	lung	function	would	increase	during	the	study,	we	did	not	observe	
any	 improvement	 in	 lung	 function	 6	 to	 12	 months	 after	 the	 introduction	 of	 the	
smoke‐free	workplaces.	This	corresponds	to	the	findings	of	a	Swedish	study	looking	
at	 71	 smokers	 and	 non‐smokers	 that	 did	 not	 find	 any	 significant	 changes	 in	
spirometry	 one	 year	 after	 implementation	 of	 a	 smoking	 ban	 (14)	 but	 contradicts	
three	other	studies	 that	observed	significant	 improvements	 in	FVC	of	bar	workers	
after	 eight	 weeks	 (10)	 to	 one	 year	 (12,	 13).	 According	 to	 our	 exposure‐response	
model	 FVC	 increased	 by	 0.16	 ppb	 per	 daily	 cigarette	 equivalent	 decrease	 in	 SHS	
exposure,	which	was	not	statistically	significant	(p=0.26)	(Table	6‐3).	
This	non‐significance	could	be	explained	by	the	relatively	small	exposure	reduction	
of	2.40	CE/d	on	average	from	before	to	after	the	ban.	Low	exposure	levels	may	be	
explained	 by	 the	 fact	 that	most	 of	 our	 study	 subjects	 worked	 in	 restaurants	 that	
served	food.	Our	measurements	performed	in	bars	yielded	much	higher	SHS	levels	
but	waiters	there	were	mostly	active	smokers	and/or	unwilling	to	participate	in	the	
study.	 All	 previous	 studies	 reporting	 significant	 improvements	 in	 FVC	 or	 FEV1	
looked	at	bar	workers	 that	presumably	experienced	a	sharper	decline	 in	exposure	
(10‐12).	
To	 the	 best	 of	 our	 knowledge	 this	 is	 the	 first	 study	 to	 prospectively	measure	 the	
effect	of	a	smoking	ban	on	FeNO.	We	hypothesized	that	the	introduction	of	smoke‐
free	 work	 places	 would	 lead	 to	 an	 increase	 in	 FeNO	 as	 has	 been	 observed	 in	 a	
smoking	cessation	study	 (21)	but	we	did	not	observe	an	association	between	SHS	
exposure	 and	 FeNO	 levels	 in	 the	 exposure	 response	 analysis.	 Different	
developments	 in	 heavily	 and	 lightly	 SHS	 exposed	 persons	 regarding	 FeNO,	 as	
proposed	by	Malinovschi	et	al.	(31)	for	heavy	and	light	smokers	could	explain	this.	
The	interacting	effects	of	SHS	(32)	and	asthma	(33,	34)	on	FeNO	levels	 is	complex	
and	 not	 yet	 fully	 understood.	 In	 addition	 to	 allergic	 inflammation	 further	
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mechanisms	 may	 be	 involved	 in	 FeNO	 synthesis	 as	 indicated	 by	 the	 higher	
fluctuation	observed	in	asthmatics	in	our	study.	So	far	only	11‐30%	of	the	variance	
of	 FeNO	 levels	 is	 explained	 by	 anthropometric	 characteristics	 compared	 to	
spirometry	where	60‐75%	of	the	variation	is	explained	(16).	This	is	mainly	because	
measurement	 techniques	 and	 the	 selected	 influencing	 factors	 differ	 between	
studies.		
Research	on	the	effect	of	active	smoking	on	FeNO	is	fairly	consistent	with	smokers	
showing	reduced	 levels	 (17,	21,	22).	 Interestingly	our	observed	FeNO	values	were	
also	at	the	lower	end	or	even	below	the	range	of	population	based	reference	FeNO	
values	that	have	been	published	(35,	36)	although	these	cover	a	 fairly	wide	range.	
Dressel	et	al.	(35)	measured	values	with	a	geometric	mean	of	19.6	÷	1.92	ppb	in	a	
sample	of	897	women	with	an	average	age	of	34.5	÷	13	years	and	a	24.3%	smoking	
prevalence.	Matsunaga	et	al.	(36)	reports	mean	values	of	16.9	(95%‐CI:	6.5	to	35.0)	
ppb	 for	a	non‐smoking	 Japanese	adult	population	of	240.	Our	observed	 low	 levels	
may	 be	 the	 consequence	 of	 long	 term	 SHS	 exposure	 similar	 to	 the	 reduced	 FeNO	
levels	of	smokers.	
We	also	measured	heart	rate	variability	and	pulse	wave	velocity	in	the	same	study	
and	reported	these	findings	elsewhere	(37).	We	found	significant	improvements	in	
these	cardiovascular	parameters	after	the	smoking	ban	introduction.	This	suggests	
that	 cardiovascular	 indicators	 react	 more	 sensitively	 within	 the	 first	 12	 months	
after	a	substantial	SHS	exposure	reduction	than	respiratory	markers.		
A	 major	 asset	 of	 this	 study	 is	 the	 prospective	 design	 with	 repeated	 health	
examinations.	 The	 prospective	 design	 avoids	 recall	 bias	 in	 directly	 measured	
parameters	 –	 limiting	 this	potential	 bias	 to	 self‐reported	 respiratory	 symptoms.	A	
further	strength	is	that	exposure	data	was	collected	at	the	same	time	as	the	health	
outcomes.	 By	 using	 the	 MoNIC	 badge,	 nicotine	 exposure	 was	 directly	 quantified	
without	using	a	surrogate	measure	such	as	airborne	particulate	matter.	A	limitation	
of	the	study	is	the	small	sample	size.	It	was	particularly	difficult	to	find	SHS	exposed	
non‐smoking	 hospitality	 workers	 and	 we	 were	 therefore	 forced	 to	 include	 some	
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non‐hospitality	 workers.	 Potential	 bias	 from	 this	 recruitment	 strategy	 was	
minimized	 by	 carefully	 checking	 all	 relevant	 confounding	 factors	 in	 the	 data	
analysis.	
CONCLUSIONS	
In	our	study	sample,	of	non‐smoking	hospitality	workers,	 lung	function	was	below	
the	 average	 population	 before	 implementation	 of	 the	 smoking	 ban	 and	 did	 not	
change	within	one	year	in	relation	to	a	smoking	ban	implementation.	However,	we	
found	 indications	 that	 cough	and	chronic	bronchitis	occurred	 less	 frequently	after	
the	smoking	ban.	These	results	 indicate	 that	damages	 from	SHS	 to	 the	respiratory	
system	 recover	 very	 slowly	 if	 at	 all	 and	 emphasize	 the	 need	 for	 a	 comprehensive	
smoking	ban	to	avoid	reduced	lung	function	in	non‐smokers	due	to	SHS	at	the	work	
place.	
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Table	6‐1	Characteristics	of	the	study	population	(n=92)	
	
Female	sex	 57	(62%)	
Age	(years)	 40.3	(95%	CI:	37.6	to	43.0)	
BMI	(kg/m2)	 25.6	(95%	CI:	24.7	to	26.5)	
Smoking	status	
Never‐smokers	 67	(72.8	%)	
Ex‐smokers	 25	(27.2	%)	
Self‐reported	physical	activity†	 45	(48.9	%)	
Respiratory	Symptoms	 	
Bronchitis	symptoms	
cough	 27	(29.4	%)	
phlegm	 11	(12.0	%)	
Chronic	bronchitis	 2	(2.2	%)	
Asthma	symptoms	 24	(26.1	%)	
Allergy	Symptoms	
Hay	fever	 21	(22.8	%)	
Rhinitis	 30	(32.6	%)	
Eczema	 6	(6.5	%)	
Comorbidities	 	
Self‐reported	bronchial	asthma	 13	(14.1	%)	
Allergic*	 60	(65.2	%)	
Workplace	and	exposure	(n=76)	 	
Average	workload	(%)	 92.6	(95%	CI:	88.8	to	96.4)	
Type	of	workplace	 bar	 7	(9.2	%)	
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café	 18	(23.7	%)	
restaurant	 51	(67.1	%)	
Exposed	throughout	the	study	 23	(25.0	%)	
Exposed	at	baseline,	not	exposed	anymore	at	
follow‐up	 55	(59.8	%)	
Never	exposed	 14	(15.2	%)	
Values	shown	are	arithmetic	means	at	baseline	except	where	indicated	
†deϐined	as:		answered	yes	to:	do	you	sweat	at	least	once/week	due	to	physical	activity?	
*reacted	positively	to	at	least	one	skin	prick	test	
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Table	6‐2	FVC	and	FEV1	baseline	measurements	of	exposed	participants	in	
comparison	to	reference	values	[29]	
	 All	(n=62)	 Women	(n=39)	 Men	(n=23)	
FVC	(in	%	of	
reference	value)	 93.1	(90.2	to	95.9)	 93.3	(89.7	to	97.0)	 92.6	(87.8	to	97.5)	
FEV1	(in	%	of	
reference	value)	 92.4	(89.4	to	95.4)	 91.9	(88.2	to	95.6)	 93.2	(87.7	to	98.6)	
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Table	6‐3	Multivariable	exposure‐response	models	relating	SHS	exposure	at	the	
workplace	to	respiratory	outcomes	
	
	 Coefficient	(change	/	unit	increase	
in	cigarette	equivalents)	(95%	CI)	 p‐Value	
FEV1	(l/s)*	 0.04	(‐0.28	to	0.37)	 0.79	
FVC	(l)*	 ‐0.16	(‐0.64	to	0.11)	 0.26	
FEF25‐75%	(l/s)*	 0.31	(‐0.62	to	1.25)	 0.51	
FEV1/FVC	ratio	*	 0.16	(‐0.09	to	0.41)	 0.20	
FeNO	(ppb)§	 0.8	(‐2.2	to	3.9)	 0.62	
*Adjusted	for	age,	sex,	height,	BMI,	asthma,	season,	device	
§Adjusted	for	age,	sex,	allergy,	seasonality,	time	of	day	
1From	the	lung	function	analyses,	20	observations	were	excluded	due	to	insufficient	quality	(n=16),	
technical	problems	(n=1)	or	insufficient	cooperation	(n=3).	For	FeNO,	eleven	measurements	had	to	
be	excluded	from	analysis	due	to	technical	problems.	
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Table	6‐4	Multivariable	logistic	regression	models	relating	SHS	exposure	at	the	
workplace	to	self‐reported	respiratory	symptoms	
	
 
OR	per	unit	increase	in	
cigarette	equivalents	
(95%	CI)	
p‐value	
Cough	 1.25	(1.03	to	1.53)	 0.03	
Phlegm	 0.98	(0.89	to	1.09)	 0.76	
Chronic	bronchitis	 1.13	(0.99	to	1.28)	 0.07	
Asthma	symptoms	 1.11	(0.96	to	1.29)	 0.16	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
90	
 
References	
1.	 Downs	 SH,	 Brandli	 O,	 Zellweger	 JP,	 Schindler	 C,	 Kunzli	 N,	 Gerbase	MW,	 et	 al.	 Accelerated	
decline	 in	 lung	 function	 in	 smoking	 women	 with	 airway	 obstruction:	 SAPALDIA	 2	 cohort	 study.	
Respiratory	research.	2005;6:45.	
	
2.	 Xu	X,	Dockery	DW,	Ware	JH,	Speizer	FE,	Ferris	BG,	Jr.	Effects	of	cigarette	smoking	on	rate	of	
loss	of	pulmonary	function	in	adults:	a	longitudinal	assessment.	The	American	review	of	respiratory	
disease.	1992;146(5	Pt	1):1345‐8.	
3.	 Ho	 SY,	 Lam	 TH,	 Chung	 SF,	 Lam	 TP.	 Cross‐sectional	 and	 prospective	 associations	 between	
passive	 smoking	 and	 respiratory	 symptoms	 at	 the	 workplace.	 Annals	 of	 epidemiology.	
2007;17(2):126‐31.	
4.	 Lam	 TH,	 Ho	 LM,	 Hedley	 AJ,	 Adab	 P,	 Fielding	 R,	McGhee	 SM,	 et	 al.	 Environmental	 tobacco	
smoke	 exposure	 among	 police	 officers	 in	Hong	 Kong.	 JAMA	 :	 the	 journal	 of	 the	 American	Medical	
Association.	2000;284(6):756‐63.	
5.	 Minov	 J,	 Karadzinska‐Bislimovska	 J,	 Vasilevska	 K,	 Risteska‐Kuc	 S,	 Stoleski	 S.	 Effects	 of	
passive	smoking	at	work	on	respiratory	symptoms,	 lung	 function,	and	bronchial	 responsiveness	 in	
never‐smoking	office	cleaning	women.	Arhiv	za	higijenu	rada	i	toksikologiju.	2009;60(3):327‐34.	
6.	 White	 JR,	 Froeb	 HF,	 Kulik	 JA.	 Respiratory	 illness	 in	 nonsmokers	 chronically	 exposed	 to	
tobacco	smoke	in	the	work	place.	Chest.	1991;100(1):39‐43.	
7.	 Ayres	JG,	Semple	S,	MacCalman	L,	Dempsey	S,	Hilton	S,	Hurley	JF,	et	al.	Bar	workers'	health	
and	 environmental	 tobacco	 smoke	 exposure	 (BHETSE):	 symptomatic	 improvement	 in	 bar	 staff	
following	 smoke‐free	 legislation	 in	 Scotland.	 Occupational	 and	 environmental	 medicine.	
2009;66(5):339‐46.	
8.	 Fernandez	 E,	 Fu	M,	 Pascual	 JA,	 Lopez	MJ,	 Perez‐Rios	M,	 Schiaffino	 A,	 et	 al.	 Impact	 of	 the	
Spanish	 smoking	 law	 on	 exposure	 to	 second‐hand	 smoke	 and	 respiratory	 health	 in	 hospitality	
workers:	a	cohort	study.	PloS	one.	2009;4(1):e4244.	
9.	 Fahim	 AE,	 El‐Prince	 M.	 Passive	 Smoking,	 Pulmonary	 Function	 and	 Bronchial	 Hyper‐
responsiveness	among	Indoor	Sanitary	Workers.	Industrial	health.	2012.	
10.	 Eisner	MD,	Smith	AK,	Blanc	PD.	Bartenders'	respiratory	health	after	establishment	of	smoke‐
free	bars	and	taverns.	JAMA	:	the	journal	of	the	American	Medical	Association.	1998;280(22):1909‐
14.	
11.	 Menzies	D,	Nair	A,	Williamson	PA,	Schembri	S,	Al‐Khairalla	MZ,	Barnes	M,	et	al.	Respiratory	
symptoms,	pulmonary	function,	and	markers	of	inflammation	among	bar	workers	before	and	after	a	
legislative	ban	on	smoking	in	public	places.	JAMA	:	the	journal	of	the	American	Medical	Association.	
2006;296(14):1742‐8.	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
91	
 
12.	 Goodman	P,	Agnew	M,	McCaffrey	M,	 Paul	 G,	 Clancy	 L.	 Effects	 of	 the	 Irish	 smoking	 ban	 on	
respiratory	health	of	bar	workers	and	air	quality	in	Dublin	pubs.	American	journal	of	respiratory	and	
critical	care	medicine.	2007;175(8):840‐5.	
13.	 Durham	AD,	Bergier	S,	Morisod	X,	Locatelli	I,	Zellweger	JP,	Huynh	CK,	et	al.	Improved	health	
of	hospitality	workers	after	a	Swiss	cantonal	smoking	ban.	Swiss	medical	weekly.	2011;141:w13317.	
14.	 Larsson	 M,	 Boethius	 G,	 Axelsson	 S,	 Montgomery	 SM.	 Exposure	 to	 environmental	 tobacco	
smoke	and	health	effects	among	hospitality	workers	in	Sweden‐‐before	and	after	the	implementation	
of	a	smoke‐free	law.	Scandinavian	journal	of	work,	environment	&	health.	2008;34(4):267‐77.	
15.	 Humair	JP,	Garin	N,	Gerstel	E,	Carballo	S,	Carballo	D,	Keller	PF,	et	al.	Acute	respiratory	and	
cardiovascular	 admissions	 after	 a	 public	 smoking	 ban	 in	 geneva,	 Switzerland.	 PloS	 one.	
2014;9(3):e90417.	
16.	 Alving	K,	Malinovschi	A.	Chapter	1.	Basic	aspects	of	exhaled	nitric	oxide.	2010.	
17.	 Kharitonov	SA,	Gonio	F,	Kelly	C,	Meah	S,	Barnes	PJ.	Reproducibility	of	exhaled	nitric	oxide	
measurements	 in	 healthy	 and	 asthmatic	 adults	 and	 children.	 The	 European	 respiratory	 journal	 :	
official	journal	of	the	European	Society	for	Clinical	Respiratory	Physiology.	2003;21(3):433‐8.	
18.	 Hoyt	 JC,	 Robbins	 RA,	 Habib	M,	 Springall	 DR,	 Buttery	 LD,	 Polak	 JM,	 et	 al.	 Cigarette	 smoke	
decreases	 inducible	 nitric	 oxide	 synthase	 in	 lung	 epithelial	 cells.	 Experimental	 lung	 research.	
2003;29(1):17‐28.	
19.	 Horvath	I,	Donnelly	LE,	Kiss	A,	Balint	B,	Kharitonov	SA,	Barnes	PJ.	Exhaled	nitric	oxide	and	
hydrogen	 peroxide	 concentrations	 in	 asthmatic	 smokers.	 Respiration;	 international	 review	 of	
thoracic	diseases.	2004;71(5):463‐8.	
20.	 Kharitonov	 SA,	 Robbins	 RA,	 Yates	 D,	 Keatings	 V,	 Barnes	 PJ.	 Acute	 and	 chronic	 effects	 of	
cigarette	smoking	on	exhaled	nitric	oxide.	American	journal	of	respiratory	and	critical	care	medicine.	
1995;152(2):609‐12.	
21.	 Robbins	RA,	Millatmal	T,	Lassi	K,	Rennard	S,	Daughton	D.	 Smoking	 cessation	 is	 associated	
with	an	increase	in	exhaled	nitric	oxide.	Chest.	1997;112(2):313‐8.	
22.	 Nadif	R,	Matran	R,	Maccario	J,	Bechet	M,	Le	Moual	N,	Scheinmann	P,	et	al.	Passive	and	active	
smoking	and	exhaled	nitric	oxide	 levels	according	to	asthma	and	atopy	 in	adults.	Annals	of	allergy,	
asthma	 &	 immunology	 :	 official	 publication	 of	 the	 American	 College	 of	 Allergy,	 Asthma,	 &	
Immunology.	2010;104(5):385‐93.	
23.	 Franklin	PJ,	Turner	S,	Mutch	R,	Stick	SM.	Parental	smoking	increases	exhaled	nitric	oxide	in	
young	 children.	 The	 European	 respiratory	 journal	 :	 official	 journal	 of	 the	 European	 Society	 for	
Clinical	Respiratory	Physiology.	2006;28(4):730‐3.	
24.	 Frey	 U,	 Kuehni	 C,	 Roiha	 H,	 Cernelc	 M,	 Reinmann	 B,	 Wildhaber	 JH,	 et	 al.	 Maternal	 atopic	
disease	modifies	effects	of	prenatal	risk	factors	on	exhaled	nitric	oxide	in	infants.	American	journal	of	
respiratory	and	critical	care	medicine.	2004;170(3):260‐5.	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
92	
 
25.	 Miller	MR,	Hankinson	J,	Brusasco	V,	Burgos	F,	Casaburi	R,	Coates	A,	et	al.	Standardisation	of	
spirometry.	The	European	respiratory	 journal	 :	 official	 journal	of	 the	European	Society	 for	Clinical	
Respiratory	Physiology.	2005;26(2):319‐38.	
26.	 ATS/ERS	 recommendations	 for	 standardized	 procedures	 for	 the	 online	 and	 offline	
measurement	of	 exhaled	 lower	 respiratory	nitric	oxide	and	nasal	nitric	oxide.	American	 journal	of	
respiratory	and	critical	care	medicine.	2005;171(8):912‐30.	
27.	 Sistek	D,	Tschopp	JM,	Schindler	C,	Brutsche	M,	Ackermann‐Liebrich	U,	Perruchoud	AP,	et	al.	
Clinical	 diagnosis	 of	 current	 asthma:	 predictive	 value	 of	 respiratory	 symptoms	 in	 the	 SAPALDIA	
study.	Swiss	Study	on	Air	Pollution	and	Lung	Diseases	in	Adults.	The	European	respiratory	journal	:	
official	journal	of	the	European	Society	for	Clinical	Respiratory	Physiology.	2001;17(2):214‐9.	
28.	 Rajkumar	 S,	 Huynh	 CK,	 Bauer	 GF,	 Hoffmann	 S,	 Roosli	 M.	 Impact	 of	 a	 smoking	 ban	 in	
hospitality	venues	on	second	hand	smoke	exposure:	a	comparison	of	exposure	assessment	methods.	
BMC	public	health.	2013;13:536.	
29.	 Huynh	CK,	Moix	J,	Dubuis	A.	[Development	and	application	of	the	passive	smoking	monitor	
MoNIC].	Revue	Médicale	Suisse.	2008;4(144):430‐3.	
30.	 Brandli	 O,	 Schindler	 C,	 Kunzli	 N,	 Keller	 R,	 Perruchoud	AP.	 Lung	 function	 in	 healthy	 never	
smoking	 adults:	 reference	 values	 and	 lower	 limits	 of	 normal	 of	 a	 Swiss	 population.	 Thorax.	
1996;51(3):277‐83.	
31.	 Malinovschi	 A,	 Janson	 C,	 Hogman	 M,	 Rolla	 G,	 Toren	 K,	 Norback	 D,	 et	 al.	 Bronchial	
responsiveness	is	related	to	increased	exhaled	NO	(FE(NO))	in	non‐smokers	and	decreased	FE(NO)	
in	smokers.	PloS	one.	2012;7(4):e35725.	
32.	 Yates	DH,	Breen	H,	Thomas	PS.	Passive	smoke	 inhalation	decreases	exhaled	nitric	oxide	 in	
normal	subjects.	American	journal	of	respiratory	and	critical	care	medicine.	2001;164(6):1043‐6.	
33.	 de	 la	Riva‐Velasco	E,	Krishnan	 S,	Dozor	AJ.	 Relationship	between	 exhaled	nitric	 oxide	 and	
exposure	 to	 low‐level	 environmental	 tobacco	 smoke	 in	 children	 with	 asthma	 on	 inhaled	
corticosteroids.	 The	 Journal	 of	 asthma	 :	 official	 journal	 of	 the	 Association	 for	 the	 Care	 of	 Asthma.	
2012;49(7):673‐8.	
34.	 Laoudi	Y,	Nikasinovic	L,	Sahraoui	F,	Grimfeld	A,	Momas	I,	Just	J.	Passive	smoking	is	a	major	
determinant	of	exhaled	nitric	oxide	levels	in	allergic	asthmatic	children.	Allergy.	2010;65(4):491‐7.	
35.	 Dressel	 H,	 de	 la	Motte	 D,	 Reichert	 J,	 Ochmann	U,	 Petru	 R,	 Angerer	 P,	 et	 al.	 Exhaled	 nitric	
oxide:	 independent	 effects	 of	 atopy,	 smoking,	 respiratory	 tract	 infection,	 gender	 and	 height.	
Respiratory	medicine.	2008;102(7):962‐9.	
36.	 Matsunaga	K,	Hirano	T,	Kawayama	T,	Tsuburai	T,	Nagase	H,	Aizawa	H,	et	al.	Reference	ranges	
for	 exhaled	 nitric	 oxide	 fraction	 in	 healthy	 Japanese	 adult	 population.	 Allergology	 international	 :	
official	journal	of	the	Japanese	Society	of	Allergology.	2010;59(4):363‐7.	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
93	
 
37.	 Rajkumar	S,	Schmidt‐Trucksaess	A,	Wellenius	GA,	Bauer	GF,	Huynh	CK,	Moeller	A,	et	al.	The	
effect	of	workplace	smoking	bans	on	heart	rate	variability	and	pulse	wave	velocity	of	non‐smoking	
hospitality	workers	International	Journal	of	Public	Health.	2014.	
30.	 Dressel	 H,	 de	 la	Motte	 D,	 Reichert	 J,	 Ochmann	U,	 Petru	 R,	 Angerer	 P,	 et	 al.	 Exhaled	 nitric	
oxide:	 independent	 effects	 of	 atopy,	 smoking,	 respiratory	 tract	 infection,	 gender	 and	 height.	
Respiratory	medicine.	2008	Jul;102(7):962‐9.	PubMed	PMID:	18396030.	Epub	2008/04/09.	eng.	
31.	 Karrasch	S,	Ernst	K,	Behr	 J,	Heinrich	 J,	Huber	RM,	Nowak	D,	et	al.	Exhaled	nitric	oxide	and	
influencing	 factors	 in	a	 random	population	 sample.	Respiratory	medicine.	2011	May;105(5):713‐8.	
PubMed	PMID:	21146387.	Epub	2010/12/15.	eng.	
6	Lung	Function,	Respiratory	Symptoms	and	Fractional	Exhaled	Nitric	Oxide	
 
94	
 
	
7	Behaviour	and	Acceptance	
 
95	
 
7 ARTICLE	4:	Evaluation	of	implementation,	compliance	and	
acceptance	of	partial	smoking	bans	among	Swiss	hospitality	
workers	before	and	after	the	Swiss	Tobacco	Control	Act		
	
Sarah	Rajkumar	M.Sc.1,2		
Susanne	Hoffmann	Ph.D.3	
Martin	Röösli	Ph.D.1,2	
Georg	F.	Bauer	MD,	DrPH.3	
1Swiss	Tropical	and	Public	Health	Institute,	Basel,	Switzerland	
2University	of	Basel,	Basel,	Switzerland	
3Institute	 of	 Social	 and	 Preventive	 Medicine,	 University	 of	 Zürich	 and	 Centre	 for	
Organizational	and	Occupational	Sciences,	ETH	Zurich,	Switzerland	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Published	in	the	Journal	of	Public	Health	
7	Behaviour	and	Acceptance	
 
96	
 
ABSTRACT		
Background.	 The	 WHO	 recommends	 uniform	 comprehensive	 smoking	 bans	 in	
public	 places.	 In	 Switzerland,	 regulations	 differ	 between	 various	 areas	 and	 are	
mostly	 incomplete	 for	 hospitality	 venues.	 As	 ambiguous	 regulations	 offer	 more	
leeway	for	implementation,	we	evaluated	the	Swiss	regulations	with	respect	to	their	
effects	on	implementation,	acceptance	and	compliance	among	hospitality	workers.		
Methods.	In	our	longitudinal	study,	a	standardized,	self‐administered	questionnaire	
was	mailed	to	a	sample	of	185	hospitality	workers	before	and	4‐6	month	after	the	
smoking	 ban	 came	 into	 effect.	 The	 matched	 longitudinal	 sample	 comprised	 71	
participants	 (repeated	 response	 rate	 38.4%).	 We	 developed	 a	 seven‐item	
acceptance	 scale.	 Logistic	 regressions	 were	 performed	 to	 explore	 the	 factors	
associated	with	acceptance.		
Results.	 Acceptance	 of	 smoking	 bans	 was	 influenced	 by	 smoking	 status	 and	
perceived	annoyance	with	second‐hand	smoke	in	private.	Although	not	statistically	
significant	(p=0.09),	we	found	some	indications	that	post	ban	acceptance	increased	
in	 an	 area	 with	 strict	 regulations	 whereas	 it	 decreased	 in	 two	 areas	 with	 less	
stringent	regulations.		
Conclusions.	 Tobacco	 bans	 in	 Swiss	 hospitality	 venues	 are	 still	 in	 a	 period	 of	
consolidation.	 The	 incomplete	 nature	 of	 the	 law	 may	 also	 have	 had	 a	 negative	
impact	on	the	development	of	greater	acceptance.	
Keywords:	 Environmental	 Tobacco	 Smoke,	 Implementation	 Research,	 Workplace	
Health	Promotion,	Second	Hand	Smoke,	Acceptance	
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INTRODUCTION	
Smoking	 policies,	 such	 as	 smoking	 restrictions	 in	 public	 areas,	 aim	 1)	 to	 reduce	
second	hand	smoke	(SHS)	for	the	purpose	of	protecting	non‐smokers,	2)	to	reduce	
tobacco	consumption	among	smokers,	and	3)	 to	encourage	smoking	cessation	(1).	
Thus,	 most	 effectiveness	 studies	 dealing	 with	 the	 impact	 of	 smoking	 bans	 focus	
either	 on	 medical	 issues,	 SHS	 exposure	 or	 changes	 in	 smoking	 behaviour	 (2‐5).	
However,	implementing	a	new	regulation	such	as	a	smoking	ban	can	only	succeed	if	
the	 target	 group	 accepts	 and	 complies	 with	 the	 new	 rule	 (5‐8).	 This	 particularly	
applies	 to	 situations	 where	 partial	 bans	 allow	 for	 a	 variation	 in	 the	 degree	 of	
implementation,	 as	 is	 the	 case	 in	 Switzerland.	 After	 intense	 public	 debate,	 and	
disregarding	 the	WHO	recommendation	 for	 total	 smoking	bans,	 the	Swiss	Federal	
Law	 on	 protection	 from	 SHS	 partially	 banned	 smoking	 in	 closed	 public	 spaces,	
including	hospitality	venues,	in	May	2010.	Small	bars	and	restaurants	up	to	80	m2	
remain	 open	 to	 smokers	 if	 they	 are	 marked	 on	 the	 outside	 as	 smoking	
establishments	and	 if	 the	staff	have	agreed	to	work	 there.	Larger	venues	have	 the	
option	 of	 providing	 designated	 smoking	 rooms	 with	 ventilation.	 The	 cantons	 –	
administrative	zones	in	Switzerland	‐	are	allowed	to	tighten	these	regulations.	As	a	
consequence,	numerous	regulations	with	different	exceptions	have	been	introduced	
in	various	cantons	in	Switzerland.	
This	 situation	 raises	 the	 question	 as	 to	 the	 role	 of	 psychosocial	 factors	 such	 as	
acceptance	and	compliance	in	the	implementation	of	smoking	regulations.	The	few	
available	 research	 results	 on	 these	 issues	 are	 inconsistent	 due	 to	 heterogeneous	
concepts	and	operationalizations.	Borland	et	al.	(2006)	report	high	compliance	with	
smoking	bans	and	greater	support	for	total	smoking	bans	by	a	smoking	sample	from	
the	 general	 population	 (9).	 They	 assessed	 attitudes	 to	 smoking	 restriction,	 asking	
whether	 smoking	 should	 be	 allowed	 in	 some	 areas.	 Thomson	 and	Wilson	 (2006)	
report	 increasing	 public	 support	 six	 months	 after	 implementation	 of	 the	 New	
Zealand	act,	measuring	attitudes	 to	workers’	 rights	 to	 smoke‐free	workplaces	and	
support	 for	 smoke‐free	 hospitality	 venues	 (10).	 Other	 studies	 examined	 attitudes	
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towards	smoking	regulations	via	an	assessment	of	agreement	vs.	disagreement	in	a	
sample	of	workers	 in	the	metal	 industry	(11)	or	approval	vs.	non‐approval	among	
the	general	population	(12).		
For	our	study,	we	define	acceptance	as	the	expression	of	consent	to	and	support	of	
the	current	smoking	bans.	Compliance	covers	how	smoking	bans	are	respected	and	
evaluated	 by	 both	 employees	 and	 guests.	 Hospitality	 workers	 are	 of	 particular	
interest	in	this	context:	First,	they	are	significantly	more	exposed	to	SHS	compared	
to	other	occupational	groups	(13).	Thus,	they	benefit	the	most	from	complete	bans.	
Several	 studies	 addressed	 the	 impact	 of	 a	 complete	 smoking	 ban	 in	 hospitality	
venues	 on	 the	 health	 of	 the	 employees	 and	 found	 a	 consistent	 decrease	 of	 self‐
reported	 respiratory	 symptoms	 after	 reduction	 of	 the	 exposure	 (14‐19).	 Second,	
they	 are	 confronted	 with	 the	 implementation	 of	 bans	 directly;	 as	 they	 have	 to	
enforce	the	bans	among	their	guests.	Thus,	we	assume	acceptance	of	smoking	bans	
among	 them	 as	 an	 important	 factor	 for	 a	 successful	 implementation	 of	 smoking	
restrictions.		
Study	aim	and	research	questions	
Our	 study	aimed	 to	evaluate	 the	partial	 smoking	 regulations	 in	hospitality	venues	
introduced	 by	 the	 Swiss	 Tobacco	 Control	 Act	 with	 respect	 to	 the	 degree	 of	 their	
implementation,	acceptance	and	compliance.	The	specific	research	questions	were:		
1)	 Did	the	smoking	regulations	in	hospitality	venues	change	after	the	ban	came	
into	effect?	
2)	 Did	compliance	and	acceptance	of	smoking	regulations	change	after	the	ban?	
3)	 Which	 factors	 are	 associated	with	 acceptance	 of	 smoking	 regulations	 after	
the	 ban	 and	 are	 changes	 in	 acceptance	 related	 to	 the	 smoking	 regulation	 of	 the	
respective	canton?	
METHODS	
In	 our	 longitudinal	 study,	 a	 standardized,	 self‐administered	 questionnaire	 was	
mailed	to	a	convenience	sample	of	hospitality	workers	in	the	Swiss	cantons	of	Basel	
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City	 (BS),	 Basel	 County	 (BL)	 and	 Zurich	 (ZH)	 before	 and	 after	 the	 law	 came	 into	
effect	in	May	2010.		
Sample	and	response	
From	 March	 to	 May	 2010,	 study	 participants	 were	 recruited	 in	 their	 workplace	
either	 by	 site	 visits	 or	 letters	 sent	 to	 venues	 and	 by	 newspaper	 ads.	 These	
participants	received	the	questionnaire	by	mail.	Some	participants	also	took	part	in	
a	related	medical	study	and	completed	the	questionnaire	by	themselves	during	their	
medical	 examination	 or	 mailed	 it	 in	 afterwards.	 The	 follow‐up	 survey	 was	
conducted	four	to	six	months	after	the	law	came	into	effect.	Both	surveys	included	
reminder	mailings	to	non‐responders.	The	overall	sample	size	was	185.	In	the	first	
survey,	109	hospitality	workers	participated	(response	rate:	58,9%)	and	83	 in	the	
second	survey	(response	rate:	44,9%).	The	matched	longitudinal	sample	consists	of	
71	participants	(repeated	response	rate:	38,4%),	working	in	45	different	venues.		
Table	 7‐1	 shows	 the	 response	 rates	 split	 up	 for	 the	 four	 participating	 cantons	 as	
well	 as	 the	 proportion	 of	 participants	 recruited	 during	 the	 medical	 exam.	
Accordingly,	 in	 the	 canton	 BL,	 the	 response	 rate	 was	 higher	 than	 in	 the	 other	
cantons	 as	 a	 larger	 proportion	 of	 the	 participants	 had	 been	 recruited	 during	 the	
medical	exam	where	people	could	be	better	motivated	to	participate	in	the	survey	
then	through	mailing	the	questionnaires.		
Questionnaire	
A	 self‐administered	 questionnaire	 was	 developed	 on	 the	 basis	 of	 an	 extensive	
literature	review.	The	content	of	 the	questionnaire	was	guided	by	the	above	 listed	
research	 questions	 and	 by	 the	 availability	 of	 previously	 validated	 instruments.		
Items	previously	applied	for	oral	interviews	were	adapted	to	a	written	survey.	The	
questionnaire	was	conducted	in	German	and	contained	83	questions	about	current	
smoking	 regulations	 at	 the	 workplace	 and	 their	 compliance	 (5,	 6,	 20,	 21).	
Acceptance	 of	 smoking	 bans	was	 assessed	 in	 the	 form	 of	 progressive	 support	 for	
bans	 in	 restaurants	 and	 bars.	 Based	 on	 previous	 operationalizations,	 acceptance	
was	 determined	 by	 ten	 items	 on	 a	 six‐point	 Likert‐scale	 covering	 the	 range	 from	
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complete	agreement	to	no	agreement	at	all	plus	a	response	option	“I	do	not	know”	
(22).	These	 items	covered	 the	 three	aspects	of	 acceptance	previously	 identified	 in	
the	 literature:	 cognitive	 acceptance	 issues	 (personal	 relevance,	 knowledge),	 social	
factors	 (perception	 of	 non‐smoking	 as	 a	 social	 norm	 and	 perception	 of	 relevant	
peers)	 and	 proactive	 acceptance	 (6,	 23‐26).	 Factors	 possibly	 associated	 with	
acceptance	 were	 self‐reported	 exposure	 to	 SHS	 at	 work	 and	 in	 private	 (27)	 and	
perceived	annoyance	at	the	workplace	and	as	a	guest.	Smoking	status	and	behaviour	
(smokers	 only)	 were	 assessed	 according	 to	 the	 WHO	 definition	 (28).	 Cardio‐
respiratory	health	and	allergies	were	surveyed	with	a	selection	of	questions	adapted	
from	the	Sapaldia	II	questionnaire	(29).		
Refinement	of	the	acceptance	scale	
The	newly	developed	acceptance	scale	was	initially	tested	with	all	baseline	data.	For	
the	ten‐item	acceptance	scale,	we	found	a	Cronbach’s	α	=	.80	(N=100).	The	normally	
distributed	 ten‐item	 scale	 correlates	 significantly	 with	 the	 independent	 item	
“attitude	to	the	law”	(r	=	 .647).	Nevertheless,	three	items	reduced	the	reliability	of	
the	scale:	perception	of	non‐smoking	as	a	social	norm	(Cronbach’s	α	if	item	deleted	
=	 .83,	 N=103),	 information	 about	 cantonal	 smoking	 bans	 (Cronbach’s	 α	 if	 item	
deleted	=	.85,	N=105)	and	proactive	acceptance	(Cronbach’s	α	if	item	deleted	=	.87,	
N=112).	Since	all	 three	 items	have	many	missing	values,	 they	were	excluded	 from	
further	analyses.	As	exploratory	factor	analysis	found	no	consistent	factor	structure,	
we	 used	 the	 one‐factorial,	 normally	 distributed	 seven‐item	 acceptance	 scale	
(Cronbach’s	 α	 =	 .87,	 Table	 7‐2)	 for	 further	 analysis.	 To	 include	 as	many	 cases	 as	
possible,	we	 used	 a	mean	 scale	with	 at	 least	 six	 of	 seven	 valid	 items.	Within	 our	
longitudinal	sample	(N=71),	the	seven‐item	acceptance	scale	yields	a	Cronbach’s	α	=	
.85	at	baseline	and	a	Cronbach’s	α	=	.82	at	follow‐up.		
Data	analysis	
Statistical	analysis	was	performed	using	SPSS	(Version	19.0.0,	IBM).	We	applied	the	
Chi2	 hypothesis	 test	 to	 compare	 baseline	 to	 follow‐up.	 To	 explore	 which	 factors	
were	associated	with	acceptance	we	applied	logistic	regression	with	follow‐up	data	
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in	a	forward	selection	procedure.	The	final	model	contains	apart	from	sex,	age	and	
smoking	 status	 perceived	 annoyance	 at	 the	 workplace	 and	 feeling	 annoyed	 as	 a	
guest	in	a	hospitality	venue	as	independent	variables.	
	
	
Figure	7‐1	Implementation	of	smoking	regulations	in	hospitality	venues	before	and	after	the	
Swiss	Tobacco	Control	Act	(n	=	71)	
RESULTS	
In	the	matched	longitudinal	sample	(n=71)	49.3%	were	non‐smokers	(including	ex‐
smokers)	and	64.8%	were	women.	The	average	age	was	40.0	(95%‐CI:	36.9	to	43.2).	
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For	85.5%	working	in	the	hospitality	sector	was	the	main	employment	and	85.5%	
were	permanently	employed.	
Implementation	of	smoking	regulations	in	hospitality	venues	
The	smoking	regulations	for	guests	and	employees	before	and	after	implementation	
of	the	law	are	shown	in	Figure	7‐1.	Compared	to	14.1%	before	the	law,	76.1%	of	the	
hospitality	 workers	 reported	 a	 complete	 smoking	 ban	 after	 implementation	
(p<0.001).	More	 than	half	 of	 the	 employees	 exclusively	worked	 in	 strictly	 smoke‐
free	 areas	 (60.6%)	 after	 the	 ban	 came	 into	 effect,	 while	 only	 1.4%	 reported	 still	
working	in	smoking	sections	only	(p<0.001).		
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Figure	7‐2	Compliance	with	 smoking	 regulations	 in	hospitality	venues	before	and	after	 the	
Swiss	Tobacco	Control	Act.	
Pre	Ban	all:	All	baseline	respondents.	Pre	Ban	med	only:	All	baseline	respondents	that	participated	in	
the	medical	examination	(not	covered	in	this	article).	Pre	Ban	matched	sample:	All	respondents	that	
also	participated	twice,	at	baseline.	Post	Ban	matched	sample:	All	respondents	that	also	participated	
twice,	at	follow‐up	
Changes	in	compliance	and	acceptance	
Figure	 7‐2	 shows	 changes	 in	 compliance	with	 smoking	 regulations	 in	 the	 venues.	
The	majority	of	hospitality	workers	considered	the	prevailing	smoking	regulations	
for	both	guests	and	employees	to	be	adequate	–	both	before	and	after	the	new	law.	
After	 it	 came	 into	 force,	more	persons	considered	 the	current	 smoking	ban	as	 too	
strict	 both	 for	 guests	 (plus	 12.6%;	 p=0.013)	 and	 employees	 (plus	 8.5%;	 p=0.25).	
Nevertheless,	 regulations	 were	 more	 often	 reported	 to	 be	 respected	 by	 guests	
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(p=0.001)	 and	 employees	 (p=0.16).	 From	baseline	 to	 follow	up,	 the	 percentage	 of	
study	participants	who	felt	annoyed	by	SHS	at	work	dropped	from	52.9%	to	13.4%	
(p	<	0.001).	From	baseline	 to	 follow	up,	 the	percentage	of	 study	participants	who	
felt	annoyed	by	second	hand	smoke	as	a	guest	dropped	from	50.0%	to	42.4%	(p	=	
0.628).	In	addition,	Figure	7‐2	shows	that	there	was	no	bias	when	comparing	way	of	
recruitment	 for	 the	study	(during	medical	exam	or	via	mail)	and	when	comparing	
base‐line	results	for	baseline	only	vs.	longitudinal	participants.	
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Figure	7‐3	Changes	 in	acceptance	of	 smoking	ban	 in	Basel	City	 (BS),	Basel	County	 (BL)	and	
Zurich	(ZH)	
Figure	7‐3	shows	similar	changes	of	the	acceptance	in	relation	to	the	stringency	of	
the	cantonal	law	for	both	smokers	and	non‐smokers:	In	ZH	and	BS,	two	cantons	that	
allowed	exceptions,	acceptance	had	decreased	six	months	after	the	law.	In	BL	where	
a	 complete	 smoking	 ban	 was	 implemented,	 acceptance	 increased	 for	 both	 non‐
smokers	 and	 smokers	 (p=0.09	 for	 interaction	 between	 canton	 and	 pre/post	
acceptance).	
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Factors	associated	with	acceptance		
In	 our	 longitudinal	 sample,	 follow‐up‐acceptance	 correlates	 significantly	 with	
perceived	 annoyance	 at	 the	workplace	 (r=	 .71)	 and	 as	 a	 guest	 in	 private	 (r=	 .74).		
Figure	7‐3	shows	that	non‐smokers	had	a	higher	acceptance	score	than	smokers	at	
all	 times	 (p<0.001).	Among	non‐smokers	 the	 acceptance	 score	 changed	 from	3.55	
(95%‐CI:	 3.24	 to	 3.87)	 at	 baseline	 to	 3.43	 (95%‐CI:	 3.12	 to	 3.73)	 at	 follow‐up,	 in	
smokers	the	score	dropped	from	2.11	(95%‐CI:	1.71	to	2.52)	to	1.87	(95%‐CI:	1.47	
to	2.72).	A	multiple	regression	analysis	showed	that	perceived	annoyance	as	a	guest	
in	 private	 and	 smoking	 status	 affects	 acceptance	whereas	 age,	 sex,	 and	 perceived	
annoyance	 in	 the	 workplace	 were	 not	 significantly	 correlated	 with	 acceptance	
(Table	7‐3).	
DISCUSSION	
Main	findings	of	this	study	
This	longitudinal	study	evaluated	heterogeneous	smoking	regulations	in	hospitality	
venues	in	Switzerland	implemented	via	a	national	Tobacco	Control	Act	in	May	2010.	
Our	 results	 show	 that	 smoking	 regulations	were	 considerably	 tightened	 after	 the	
law	came	 into	effect,	 leading	 to	a	complete	smoking	ban	 in	most	of	 the	hospitality	
venues	investigated	(82.5%).	The	implementation	also	improved	self‐reported	SHS	
exposure,	as	more	hospitality	workers	worked	in	less	exposed	areas	after	the	law.		
Hospitality	workers	reported	better	compliance	of	the	guest	and	the	employees	with	
the	 smoking	 regulation	 after	 the	 regulations	 have	 been	 tightened,	 although	 the	
proportion	 of	 hospitality	 workers	 who	 evaluated	 the	 newly	 introduced	 smoking	
bans	as	too	strict	for	the	guests	and	themselves	has	increased.	Regarding	the	factors	
influencing	acceptance	after	implementation	of	the	law,	the	current	smoking	status	
(non‐smokers	vs.	smokers)	and	perceived	annoyance	with	SHS	as	a	guest	in	private	
proved	to	be	significant,	explaining	a	large	part	of	the	variance.	
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What	is	already	known	
A	 large	 population	 survey	 found	 a	 marked	 reduction	 of	 SHS	 exposure	 in	 Swiss	
restaurants	at	the	end	of	2010	(30)	that	was	also	confirmed	with	measurements	in	
our	study	(31).	Earlier	international	studies	observed	an	increase	of	the	overall	level	
of	acceptance	after	 implementation	of	 statutory	smoking	regulations,	 a	 finding	we	
consistently	 only	 could	 confirm	 for	 the	 canton	 that	 introduced	 a	 strict	 smoking	
regulation	(5,	32).	Previous	studies	also	showed	that	such	smoking	restrictions	are	
accepted	by	both	non‐smokers	 and	 smokers	 (9,	 11)	 although	acceptance	 is	highly	
influenced	 by	 personal	 relevance	 (23,	 25)	 –	 as	 exemplified	 by	 our	 finding	 that	
feeling	 annoyed	 by	 second	 hand	 smoke	 in	 private	 as	 a	 guest	 predicts	 follow‐up	
acceptance	 of	 smoking	 regulations.	 The	 finding	 that	 none	 of	 the	 other	 examined	
factors	(sex,	age,	perceived	annoyance	with	SHS	in	the	workplace)	were	related	to	
acceptance	is	in	line	with	the	results	of	general	acceptance	research.		
What	this	study	adds	
This	 study	provided	 the	 rare	opportunity	 for	 a	 comparative,	 longitudinal	 study	of	
the	differential	impact	of	different	smoking	regulations	between	cantons	within	the	
comparable	 cultural	 context	 of	 a	 single	 country.	 Our	 observation	 that	 tightened	
regulations	 are	 better	 complied	 with	 may	 indicate	 that	 stricter	 rules	 are	 more	
current	 and	 thus	 better	 followed.	 An	 alternative	 explanation	 may	 be	 social	
desirability	 ‐	 that	 employees	did	not	want	 to	 risk	 any	problems	by	admitting	 that	
rules	are	not	respected	at	the	time	of	the	interview.	
Contextual	 factors	may	explain	 the	 relatively	 small	 change	of	 acceptance	after	 the	
introduction	 of	 the	 ban	 compared	 to	 other	 countries	 (5,	 32).	 	 Due	 to	 the	 political	
system	of	basic	democracy	 in	Switzerland,	 the	pros	and	cons	of	 the	new	law	were	
heavily	discussed	 in	 the	media	and	 in	public	 long	before	 the	 law	came	 into	effect.	
Such	 a	 public	 discourse	 can	 stabilize	 the	 formation	 of	 opinions	 and	 consequently	
individual	acceptance	of	the	law	before	its	implementation	(6).		
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We	found	a	striking	pattern	with	respect	to	the	type	of	smoking	regulation.	 	In	the	
canton	 that	 implemented	 a	 comprehensive	 ban,	 acceptance	 in	 both	 smokers	 and	
non‐smokers	 was	 lowest	 prior	 to	 the	 introduction	 of	 the	 ban	 and	 increased	
afterwards,	 whereas	 in	 the	 two	 other	 cantons	 with	 incomplete	 smoking	 bans	
acceptance	score	decreased	between	baseline	and	follow‐up.	
Although	 not	 statistically	 significant	 in	 our	 small	 sample,	 this	 suggests	 that	 a	
complete	ban	without	exceptions	is	the	least	contended.	In	contrast,	implementation	
of	 an	 incomplete	 law	 does	 not	 have	 the	 same	 positive	 effect	 on	 increasing	
acceptance	as	a	clear,	unambiguous	regulation.	This	provides	additional	support	for	
the	WHO	recommendation	of	complete	smoking	bans.		
Limitations	of	this	study	
Due	to	the	intense	and	emotional	public	debate	on	the	smoking	ban,	it	was	difficult	
to	 recruit	 hospitality	 workers	 for	 the	 study,	 leading	 to	 a	 small	 sample	 size	 and	
potentially	to	a	selection	bias	towards	workers	who	already	had	a	higher	acceptance	
of	 the	 law	 compared	 to	non‐participants.	 Further,	 our	 sample	mainly	 consisted	of	
German‐speaking	hospitality	workers.	This	indicates	that	non‐participants	may	not	
have	 completed	 our	 survey	 due	 to	 language	 problems	 and	 that	 one	 should	 not	
generalize	 the	 results	 to	 non‐German‐speaking	 hospitality	 workers.	 Thus,	 we	
assume	there	to	be	more	smokers	and	lower	acceptance	among	non‐participants.	At	
study‐follow‐up,	 we	 did	 not	 observe	 a	 selection	 bias	 as	 the	 respondents	 that	
participated	 twice	 did	 not	 significantly	 differ	 in	 acceptance	 at	 baseline	 from	 the	
sample	that	only	responded	once.	Also,	as	the	follow‐up	observations	were	carried	
out	within	four	to	six	months	after	implementation	of	the	law,	 long‐term	effects	of	
the	smoking	ban	cannot	be	assessed.		
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Table	7‐1	Overall	sample	size	and	response	rates	stratified	for	the	different	cantons	
	 Total	(n=185)	 AG	(n=5)	 BL	(n=18)	 BS	(n=101)	 ZH	(n=61)	
	
	
All	 Med	only	
(n=57)	
All	 Med	only	
(n=1)	
All	 Med	only	
(n=14)	
All	 Med	only	
(n=25)	
All	 Med	only	
(n=17)	
Response	rate	
baseline	(%)	
109	
(58.9%)	
41	
(71.9%)	
0	
(0%)	
0	(0%)	 15	
(83.3%)	
11	
(78.6%)	
61	
(60.4%)	
18	(72%)	 33	
(54.1%)	
12	
(70.6%)	
Response	rate	
follow‐up	(%)	
83	
(44.9%)	
43	
(75.4%)	
	
0	
(0%)	
0	(0%)	 14	
(77.8%)	
12	
(85.7%)	
43	
(42.6%)	
18	(72%)	 26	
(42.6%)	
13	
(76.5%)	
Response	rate	
matched	
sample	(%)	
71	
(38.4%)	
35	
(61.4%)	
0	
(0%)	
0	(0%)	 13	
(72.2%)	
11	
(78.6%)	
36	
(35.6%)	
14	(56%)	 22	
(36.1%)	
10	
(58.9%)	
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Table	7‐2	Items	chosen	for	7‐item	acceptance	scale	rated	on	a	six‐point	Likert‐scale.	
1	 It	is	important	to	protect	staff	and	guests	from	second	hand	smoke.		
2	 Public	smoking	bans	infringe	personal	freedom.		
3	 Non‐smokers	are	harmed	by	second	hand	smoke.			
4	 Non‐smokers	are	bothered	by	second	hand	smoke.		
5	 Most	of	our	guests	agree	to	smoking	bans	in	bars	and	restaurants.	
6	 Most	of	my	colleagues	agree	to	smoking	bans	in	bars	and	restaurants.	
7	 The	head	of	our	venue	agrees	to	smoking	bans	in	bars	and	restaurants.	
Note.	Original	German	items	are	translated	into	English.	Item	2	was	inversely	coded.	Each	six‐point	item	
ranged	from	“I	completely	agree”	to	“I	do	not	agree	at	all”	plus	a	response	option	“I	do	not	know”.	
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Table	7‐3	Linear	regression	analysis	predicting	follow‐up	acceptance	of	smoking	
regulations	(N=63)	
Variables	 Coefficient	(95%‐CI)	 p‐Value	
Constant	 2.07	(0.72	to	3.43)	 0.003	
Age		 ‐0.01	(‐0.29	to	0.01)	 0.385	
Sex	[female]	 0.18	(‐0.34	to	0.71)	 0.491	
Being	a	smoker	 ‐0.83	(‐1.45	to	‐0.21)	 0.009	
Feeling	annoyed	by	second	hand	smoke	in	private	
(as	a	guest)	 0.36	(0.19	to	0.54)	 <0.001	
Feeling	annoyed	by	second	hand	smoke	at	work	 0.08	(‐0.13	to	0.29)	 0.431	
Note.	Total	R2	=	0.51	
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8 SUMMARY	OF	THE	MAIN	FINDINGS	
The	overall	aim	of	this	study	was	to	examine	changes	in	SHS		
exposure	and	cardio‐respiratory	health	in	non‐smoking		
hospitality	workers	as	well	as	behaviour	and	acceptance		
in	smoking	and	non‐smoking	hospitality	workers.	We		
compared	an	intervention	group	that	experienced	a	smoking	ban	at	the	workplace	
to	a	control	group	that	did	not	undergo	any	changes	in	exposure.		
Did	SHS	levels	in	a	hospitality	venue	reflect	the	current	regulation?	
We	performed	225	badge	measurements	in	193	hospitality	venues	during	baseline	
visits.	First	follow‐up	visits	were	conducted	199	days	later,	on	average,	in	51	venues	
with	58	badges.		At	the	second	follow‐up,	42	badges	were	placed	in	36	venues.	The	
results	 of	 our	 SHS	 exposure	measurements	 clearly	 reflected	 the	 present	 smoking	
regulation	 in	 the	 venue.	 Completely	 smoke‐free	 venues	 had	 the	 lowest	 numbers	
with	0.1	cigarette	equivalents	per	day	(CE/d)	(95%	CI:	0.01	to	0.2;	n=11)	before	the	
smoking	ban	while	places	without	any	restriction	yielded	the	highest	average	value	
with	6.1	CE/d	(95%	CI:	4.7	to	7.5;	n=93).	Venues	with	partial	smoking	bans	had	as	
expected	higher	results	in	the	smoking	section	(4.4	CE/d	(95%	CI:	3.2	to	5.5;	n=93))	
and	lower	in	the	non‐smoking	section	(0.9	CE/d	(95%	CI:	0.5	to	1.6;	n=28)).	As	there	
was	only	one	venue	with	a	non‐smoking	section	that	was	separated	by	a	door,	it	was	
not	possible	 to	 stratify	 for	another	 increment.	There	were	11	restaurants	or	cafés	
that	 applied	 a	 special	 time	 regulation	 before	 the	 ban,	 prohibiting	 smoking	 during	
mealtimes.	In	these	venues	exposure	was	lower	than	in	an	average	restaurants	(2.0	
CE/d	(95%	CI:	0.5	to	3.5)),	but	exposure	levels	were	in	general	lower	in	restaurants.	
We	 found	 the	 highest	 levels	 in	 bars	 (10.0	 CE/d	 (95%	 CI:	 7.1	 to	 12.9;	 n=36)),	
followed	by	cafés	(4.5	CE/d	(95%	CI:	3.1	 to	6.0;	n=31))	and	restaurants	(3.3	CE/d	
(95%	CI:	2.5	to	4.0;	n=126)).		
How	did	SHS	exposure	change	after	implementation	of	a	smoking	ban?	
The	intervention	group	comprised	56	persons	at	baseline,	44	persons	at	follow‐up	1	
(79	%)	and	42	at	follow‐up	2	(75	%).	These	were	compared	to	the	control	groups:	6	
“It is apparent that 
the effects of SHS on 
others is now the 
most powerful 
antismoking weapon 
being employed 
against the 
industry.” 
 
Philip Morris 1987 
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persons	working	in	smoking	venues	that	did	not	change	their	rule	(Control	Group	I),	
14	 hospitality	 workers	 who	 had	 always	 worked	 in	 smoke‐free	 environments	
(Control	Group	II)	and	16	persons	who	were	regularly	exposed	to	SHS	privately	or	
at	work	without	being	employed	 in	the	hospitality	sector	(Control	Group	III).	Two	
members	 of	 Control	 Group	 I	 returned	 for	 a	 second	 examination	 (33%),	 while	 10	
(62.5%)	 and	 5	 (31.3%)	 participants	 in	 Control	 Group	 III	 underwent	 second	 and	
third	examinations,	respectively.	For	analysis,	Control	Groups	I	and	III	were	merged	
into	 one	 “exposed	 Control	 Group”.	 (More	 detailed	 information	 on	 the	 different	
control	groups	can	be	found	in	Section	3	of	this	thesis.)	
We	 used	 a	 time‐weighted	 average	 of	 the	 workplace	 MoNIC	 badge	 as	 exposure	
measure	 in	 all	 analyses.	 	The	 two	 follow‐up	measurements	were	merged	 into	one	
post‐ban	measure.	Average	exposure	in	the	intervention	group	at	baseline	was	2.6	
(95%	CI:	1.7	 to	3.4)	cigarette	equivalents/day	(CE/d)	and	0.2	(95%	CI:	0.1	 to	0.2)	
CE/d	 at	 follow‐up	 resulting	 in	 an	 exposure	 reduction	 of	 2.4	 CE/d.	 In	 the	 exposed	
control	group	exposure	at	baseline	was	2.1	(95%	CI:	1.0‐3.2)	CE/d	and	1.6	(95%	CI:	
0.7‐2.5)	CE/d	at	follow‐up.	
Which	cardio‐respiratory	health	factors	in	non‐smokers	were	affected	by	long‐term	
SHS	exposure?	
We	examined	two	cardiovascular	outcomes:	heart	rate	variability	(HRV)	and	pulse	
wave	 velocity	 (PWV).	 Respiratory	 outcomes	 were	 fractional	 exhaled	 nitric	 oxide	
(FeNO),	lung	function	and	self‐reported	symptoms.	
In	 order	 to	 answer	 this	 research	 question	we	 did	 a	 cross‐sectional	 analysis	 of	 all	
baseline	 data	 and	 compared	 it	 if	 possible	 to	 reference	 values	 from	 large	 scale	
studies	and	to	corresponding	personal	exposure.	
We	found	spirometric	outcomes	FVC	and	FEV1	to	be	lower	in	both	men	and	women	
that	had	been	before	the	ban	compared	to	the	average	Swiss	population.		
When	 directly	 relating	 outcomes	 to	 exposure	 at	 baseline	we	 assumed	 this	 would	
correspond	 to	 long‐term	 exposure.	We	 found	 an	 association	 with	 FeNO.	 Per	 unit	
increase	in	CE/d	average	FeNO	values	in	our	whole	population	decreased	by	4.20	(‐
7.69	to	‐0.57)	ppb	(p=0.024).		
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Cardiovascular	 parameters	 and	 lung	 function	 parameters	 did	 not	 show	 any	
association	with	exposure	at	baseline.	
From	the	respiratory	symptoms	we	found	cough	to	have	a	significantly	elevated	OR	
of	1.28	(95%‐CI:	1.07	to	1.53;	p‐value:	0.007).	Other	symptoms	were	not	associated	
to	exposure	in	our	sample.	
Was	there	a	dose‐response	relationship	between	current	SHS	exposure	and	cardio‐
respiratory	health	markers?	
For	this	longitudinal	analysis	comparing	exposure	to	outcomes	under	consideration	
of	a	within‐subject	correlation	we	created	a	random	intercept	model	and	calculated	
covariate‐adjusted	exposure	response	associations.		
Both	 cardiovascular	 markers	 showed	 a	 strong	 correlation	 with	 exposure	 in	 this	
model.	 All	 parameters	 behaved	 according	 to	 hypothesis.	 SDNN	 increased	by	1.8%	
(95%‐CI:‐0.1	to	3.8;	p=0.069)	per	unit	decrease	in	CE/d.	RMSSD	increased	by	2.3%	
(95%‐CI:	 0.2	 to	 4.4;	 p=0.031),	 HF	 by	 5.7%	 (95%‐CI:	 0.9	 to	 10.2;	 p=0.020),	 LF	 by	
0.6%	 (95%‐CI:‐4.1	 to	 5.1;	 p=0.802)	 and	 Total	 Power	 by	 4.1%	 (95%‐CI:0.0	 to	 8.0;	
p=0.051)	while	 the	LF/HF	 ratio	as	 expected	decreased	by	 ‐5.7%	 (95%‐CI:‐9.1	 to	 ‐
2.4;	p=0.001).	
Pulse	Wave	Velocity	decreased	by	‐0.72%	(95%‐CI:‐0.40	to	‐1.05;	p<0.001)	per	unit	
decrease	 in	 CE/d,	 also	 corresponding	 to	 higher	 arterial	 stiffness	 with	 higher	
exposure.	Systolic	blood	pressure	decreased	very	slightly.		
This	model	did	not	show	any	association	when	done	with	spirometry	or	FeNO.		
Did	cardio‐respiratory	health	improve	after	SHS	exposure	cessation	irrespective	of	
exact	exposure?	
This	model	explored	changes	in	health	from	before	to	after	the	ban	comparing	the	
intervention	 group	 and	 the	 control	 group	 that	 remained	 exposed	 irrespective	 of	
exposure.	 For	 each	 outcome	 a	 linear	 mixed	 effects	 model	 with	 a	 random	 subject	
intercept	 was	 fit	 including	 a	 (study	 group*pre/post	 ban)‐interaction	 term	 and	
adjusting	for	appropriate	co‐variables.	
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	All	HRV	parameters	were	fairly	close	together	at	baseline	and	significantly	diverged	
at	follow‐up.	The	strongest	effect	could	be	observed	in	HF	(p=0.007)	and	the	HF/LF	
ratio	(p=0.009).		
At	baseline	PWV	was	lower	in	the	control	group	than	in	the	intervention	group	and	
remained	on	a	steady	level	at	follow‐up	while	the	intervention	group	improved	but	
without	 reaching	 numbers	 as	 low	 as	 the	 control	 group	 (p=0.12).	 Systolic	 blood	
pressure	 diverged	 with	 the	 intervention	 group	 decreasing	 and	 the	 control	 group	
increasing	(p=0.129)	but	values	had	been	different	at	baseline	already.	
Contrary	 to	 our	 expectations	we	observed	 a	decrease	 in	 FeNO	 in	 the	 intervention	
group	from	10.8	ppb	(95%‐CI:	9.3	to	12.6)	to	8.0	ppb	(95%‐CI:	7.0	to	9.2)	after	the	
smoking	ban	that	was	significantly	different	from	the	control	group	which	showed	
an	increasing	tendency	from	11.0	ppb	(95%‐CI:	8.6	to	14.0)	to	12.6	ppb	(95%‐CI:	9.6	
to	16.5)	(p=0.006).		
We	did	not	observe	any	development	in	 lung	function	or	a	decrease	in	respiratory	
symptoms	one	year	after	the	ban.		
Were	different	regulations	accepted	and	were	they	complied	with?	Which	factors	did	
acceptance	depend	on?	
For	 the	 behaviour	 and	 acceptance	 survey	 evaluation	 we	 analysed	 the	 matched	
sample	that	comprised	26	smoking	and	45	non‐smoking	participants.	Compared	to	
14.1%	before	 the	 law,	76.1%	of	hospitality	workers	 reported	a	 complete	 smoking	
ban	after	implementation	(p<0.001).	From	baseline	to	follow	up,	the	percentage	of	
study	participants	who	felt	annoyed	by	SHS	at	work	dropped	from	52.9%	to	13.4%	
(p	<	0.001).		
We	found	that	non‐smokers	were	more	in	favour	of	the	smoking	ban	right	from	the	
start	 and	 remained	 so.	 In	 ZH	 and	 BS,	 two	 cantons	 that	 allowed	 exceptions,	
acceptance	had	decreased	six	months	after	the	law.	In	BL	where	a	complete	smoking	
ban	was	implemented,	acceptance	increased	(p=0.09	for	interaction	between	canton	
and	pre/post	acceptance).		
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In	general,	Swiss	hospitality	workers	continued	to	 feel	 that	 the	ban	was	 too	strict.	
We	did	not	find	any	changes	in	smoking	status	or	intention	to	quit.	A	large	part	of	
the	questions	that	we	asked	did	not	give	any	significant	results	or	even	tendencies.	
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9 OVERALL	DISCUSSION	AND	CONCLUSION	
The	thesis	abides	by	the	strategic	nexus	of	the	Swiss	TPH	
by	contributing	to	innovation,	validation	and	application	of	
tools	and	research	(Table	9‐1)	
	
Table	9‐1	Contributions	of	this	thesis	to	the	strategic	nexus	of	Swiss	TPH	
INNOVATION	 VALIDATION	 APPLICATION	
The	long‐term	effects	of	SHS	
exposure	on	heart	rate	
variability	and	pulse	wave	
velocity	were	assessed.	
	 	
The	effects	of	SHS	exposure	
cessation	on	HRV,	PWV	and	
FeNO	were	explored.	
	 	
	 Several	exposure	measurement	
techniques	were	compared	and	
evaluated.	
	 A	smoking	ban	was	shown	to	
be	an	effective	intervention	to	
protect	cardiovascular	health	
in	non‐smoking	hospitality	
workers.	
	
	 	 Published	results	were	taken	up	
in	a	political	campaign	
exemplifying	an	attempt	to	
translate	research	results	into	
policy.	
9.1	 Our	findings	in	context:	How	do	they	fit	in	with	other	studies?	
Most	 prior	 smoking	 ban	 studies	 limited	 their	 health	 examinations	 to	 respiratory	
symptoms	and	lung	function	measurements	(90‐94).	This	study	was	the	first	to	look	
at	cardiovascular	markers	in	relation	to	long	term	SHS	exposure	cessation.	
In	 this	section	the	main	 findings	mentioned	in	the	previous	sections	are	discussed	
cross‐sectionally.		
“Portray the debate 
as one between the 
anti-smoking lobby 
and the smoker, 
instead of ‘pro-
health and public 
citizens’ versus the 
tobacco industry.” 
 
Philip Morris 
USA,1992
9	Discussion	
 
122	
 
Did	SHS	levels	in	a	hospitality	venue	reflect	the	current	regulation?	
We	were	 able	 to	 reproduce	 results	 from	 previous	 studies	with	 our	 SHS	 exposure	
measurements	that	reflected	the	present	smoking	regulation	in	the	venue	(20).	The	
high	levels	of	SHS	we	found	in	bars	underline	the	common	ground	of	drinking	and	
smoking	 that	 has	 been	 documented	 in	 other	 studies	 (95).	 A	 German	 study	 also	
included	 clubs	 and	 discotheques	 and	 found	 PM	 levels	 there	 to	 exceed	 bars	
considerably	(96),	but	we	did	not	include	any	such	venues.	
What	is	the	most	suitable	way	of	assessing	personal	SHS	exposure?	
The	 three	exposure	measurement	methods	we	applied	gave	us	 five	parameters	 to	
evaluate	and	compare.		
The	 most	 conventional	 way	 to	 assess	 exposure	 is	 by	 questionnaire.	 In	 large	
monitoring	 studies	 this	 method	 can	 give	 a	 good	 overall	 impression	 of	 regular	
exposure	 patterns	 (97).	 For	 direct	 comparison	with	 health	 outcomes,	 however,	 it	
may	 not	 be	 sensitive	 enough.	 Self‐reported	 data	 is	 subject	 to	 recall	 bias	 and	
categorical	answers	that	cover	wide	ranges	such	as	number	of	years	and	hours	per	
day	that	people	were	exposed	make	them	fairly	inaccurate.	In	comparison	to	active	
smoking,	 remembering	 details	 of	 passive	 smoking	 can	 be	 even	 more	 difficult,	
especially	 in	 times	when	 indoor	 smoking	was	 still	 commonplace.	 To	 address	 this	
issue	we	 included	 some	 specific	 questions	 in	 our	 study	 to	 complement	 the	 badge	
and	saliva	results.	We	found	no	correlation.	
Using	 biological	 samples	 such	 as	 blood,	 saliva	 or	 urine	 to	 detect	 nicotine	 and	
cotinine	is	one	method	to	measure	SHS	exposure	which	has	been	applied	in	studies	
measuring	 only	 exposure	 (98)	 or	 exposure	 in	 relation	 to	 health	 factors	 (92,	 99).	
Usually	cotinine	is	used	as	it	has	a	longer	half‐life	than	nicotine	and	can	therefore	be	
detected	 for	 longer	 periods	 after	 exposure.	 Cotinine	 has	 been	 widely	 used	 as	 an	
objective	 and	 tobacco‐specific	 exposure	measure	which	 has	 a	 high	 specificity	 and	
sensitivity	 (100).	 It	 may	 also	 be	 extracted	 from	 a	 hair	 sample	 allowing	
determination	 of	 long	 term	SHS	 exposure	 from	up	 to	 several	months	 prior	 (101).	
This	method	has	not	been	used	very	often,	possibly	due	to	lack	of	willingness	from	
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participants	 or	 interference	 by	 personal	metabolism.	 In	 general,	 salivary	 cotinine	
can	 be	 recommended	 for	 the	 measurement	 of	 SHS	 exposure	 if	 sampling	 time	 is	
standardized	and	a	detailed	study	protocol	records	the	hours	of	and	since	exposure.	
The	MoNIC	badge	is	easy	to	handle	and	delivers	objective,	nicotine‐specific	data.	The	
badge	was	adapted	 from	a	method	developed	by	Hammond	and	Ogden	more	 than	
20	years	 ago	 (102,	 103).	Two	SHS	 exposure	 studies	 in	 South	America	 applied	 the	
method	 reporting	 clear	 results	 (104,	 105).	 However,	 the	 badge	 did	 not	 establish	
itself	as	a	standard	method.	SHS	studies	preferably	measured	a	proxy	such	as	PM2.5	
(106‐108),	derived	nicotine	from	VOC	(volatile	organic	compounds)	measurements	
(96),	 used	 a	 questionnaire	 (109)	 or	 sampled	 biomarkers	 for	 personal	 exposure	
(110).	Variable	methods	make	a	direct	comparison	of	studies	more	challenging.	
As	we	were	 primarily	 interested	 in	 changes	 in	workplace	 exposure	we	 chose	 the	
workplace	badge	as	a	basis	to	calculate	a	time‐weighted	average	for	each	person	to	
control	for	workload	and	decreasing	levels	when	the	venue	is	closed	(see	Article	1,	
Section	 4).	 The	 personal	 badge	was	 too	 day‐specific	 and	 included	 time	 periods	 at	
home	or	 at	 leisure	 that	were	not	of	 interest	 to	us	 and	distorted	 results.	The	 clear	
results	of	the	baseline	venue	measurements	underline	the	usefulness	of	the	MoNIC	
badge	as	a	passive	sampler	for	on‐site	measurements.	In	future	studies	it	could	also	
be	 suitable	 for	 outdoor	 measurements	 at	 building	 entrances	 or	 bus	 stops.	 To	
measure	personal	SHS	exposure	by	wearing	a	badge,	specific	localities	and	activities	
during	measurement	 need	 to	 be	 taken	 into	 account.	 A	 combination	with	 a	 timely	
biological	marker	may	be	recommended.	
When	 correlating	 the	 workplace	 and	 the	 personal	 badge	 the	 coefficient	 of	
determination	 was	 fair	 (R2=51%;	 p<0.001),	 but	 with	 salivary	 data	 it	 was	 poor	
(R2=0.9%	for	personal	badge	vs.	cotinine)	as	in	the	validation	study	(R2=4.5%)	(88).	
Practical	issues	regarding	the	three	methods	are	discussed	in	section	9.2.	
How	did	SHS	exposure	change	after	implementation	of	a	smoking	ban?	
We	 oversampled	 restaurants	 compared	 to	 bars,	 especially	 at	 follow‐up	 as	 there	
were	 hardly	 any	 participants	 that	 worked	 in	 bars.	 This	 presumably	 led	 to	
underestimation	of	the	true	decrease	in	SHS	levels	in	hospitality	venues.	
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Exposure	in	the	intervention	group	decreased	significantly	compared	to	the	exposed	
control	 group.	 Surprisingly,	 even	 this	 group	 experienced	 a	 slight	 decrease	 in	
exposure.	This	trend	is	probably	biased	due	to	loss	to	follow‐up.	It	may	even	be	the	
case	that	guests	in	smoking	venues	reduced	their	tobacco	consumption	as	a	result	of	
the	surrounding	debate.	
Opponents	 of	 the	 ban	 had	 predicted	 that	 smoking	 would	 be	 relocated	 to	 other	
places	once	a	smoking	ban	was	in	force,	in	particular	to	homes	and	thereby	children	
would	 be	 more	 prominently	 exposed	 (111).	 Studies	 refuted	 these	 claims	 (112),	
showing	 that	 a	 comprehensive	 smoking	 ban	 actually	 led	 smokers	 to	 be	 more	
considerate	even	in	private	homes	and	to	also	feel	more	disturbed	by	SHS	(113).	
Which	cardio‐respiratory	health	factors	in	non‐smokers	were	affected	by	long‐term	
SHS	exposure?	
We	found	lower	spirometric	outcomes	in	exposed	persons	compared	to	the	average	
Swiss	population	before	the	ban.	This	finding	was	in	line	with	other	studies	(90,	93,	
114).	Several	large‐scale	studies	had	defined	reference	values	based	on	sex,	age	and	
height	 (115‐117).	 Not	 all	 outcomes	 that	 we	 examined	 in	 this	 study	 offer	 such	
reliable	 reference	 values.	 Different	 studies	 on	 FeNO	 offer	 reference	 values,	which	
cover	a	very	wide	range	and	did	not	prove	useful	in	the	cross‐sectional	comparison	
(118‐120).	To	produce	HRV	reference	values	large	scale	studies	are	still	needed	as	
methods	to	date	have	been	diverse	(121).	The	only	study	offering	reference	values	
on	 pulse	 wave	 velocity	 (PWV)	 used	 categories	 with	 wide	 ranges	 (122).	 This	
parameter	 is	 not	 yet	 sufficiently	 explored	 and	 a	 more	 extensive	 assessment	 to	
produce	 reference	 values	 is	 underway	 (A.	 Schmidt‐Trucksäss,	 personal	
communication).	
In	 addition	 to	 comparing	 baseline	 values	 to	 reference	 values	 of	 the	 average	
population,	we	examined	if	outcomes	were	directly	related	to	exposure	assessed	by	
the	MoNIC	badge	at	baseline.	We	assumed	this	measurement	would	correspond	to	
long‐term	 exposure	 and	 found	 an	 association	 with	 FeNO,	 in	 alignment	 with	 a	
previous	 study	 (123).	 As	 FeNO	 is	 known	 to	 be	 more	 erratic	 in	 asthmatics	 we	
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stratified	 for	asthma.	The	effect	 remained	significant	 in	non‐asthmatics	but	due	 to	
small	sample	size	we	could	not	consider	asthmatics	separately.		
Examining	effects	as	continuous	variables	in	linear	regressions	is	an	advantage.	As	
in	comparable	 studies	we	 looked	at	 respiratory	symptoms	as	binary	variables	but	
logistic	 regression	 is	 less	meaningful.	Our	 lack	of	 significant	 results	 in	 respiratory	
symptoms	 is	 probably	 also	 due	 to	 sample	 size	 as	 there	 were	 some	 tendencies,	
according	to	hypothesis,	that	were	not	statistically	significant.		
Was	there	a	dose‐response	relationship	between	current	SHS	exposure	and	cardio‐
respiratory	health	markers?	
In	this	longitudinal	model	we	compared	exposure	to	outcomes	under	consideration	
of	a	within‐subject	correlation.	Several	HRV	parameters	as	well	as	PWV	were	linked	
to	 exposure.	 This	model	 did	 not	 show	 any	 association	when	 using	 spirometry	 or	
FeNO	 as	 outcome.	 Previous	 studies	 assessing	 PM2.5	 as	 an	 exposure	 proxy	 for	 SHS	
evaluated	exposure	and	outcome	separately	without	directly	relating	them	to	each	
other	as	we	did	in	this	model	(93,	124).	A	further	study	examining	serum	cotinine	
asked	participants	about	 the	number	of	hours	 they	were	exposed	but	also	did	not	
try	to	associate	these	numbers	directly	with	health	parameters	(125).		
This	 analysis	 is	 fairly	 unique	 to	 this	 study	 and	 the	 significant	 associations	 in	
cardiovascular	measure	are	an	important	finding.	It	also	emphasizes	the	workplace	
badge	 as	 an	 appropriate	 exposure	 approximation	 and	 highlights	 the	 sensitivity	 of	
both	HRV	and	PWV	in	relation	to	SHS	exposure.	
Did	cardio‐respiratory	health	improve	after	SHS	exposure	cessation	irrespective	of	
exact	exposure?	
This	model	explored	pre/post	changes	in	health	comparing	the	intervention	group	
and	 the	 exposed	 control	 group	without	 considering	 exact	 levels	 of	 exposure.	 Our	
time‐weighted	 exposure	 proxy,	 though	 being	 objective,	 still	 comprised	 some	
assumptions.	 It	 therefore	 made	 sense	 to	 look	 at	 health	 outcomes	 separately.	
Furthermore	this	model	is	that	which	is	most	commonly	used	in	other	studies	and	
results	were	therefore	easier	to	compare.	
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HRV	 parameters	 were	 fairly	 close	 together	 in	 both	 groups	 at	 baseline	 and	
significantly	 diverged	 at	 follow‐up.	What	was	 remarkable	 is	 that	HRV	 parameters	
actually	 decreased	 in	 the	 control	 group	 adding	 to	 the	 effect	 of	 oppositional	
development	between	groups.	PWV	remained	at	a	steady	level	in	the	control	group	
but	was	lower	at	baseline.	The	intervention	group	did	not	reach	such	low	numbers	
even	at	follow‐up	when	PWV	had	improved.	To	the	best	of	our	knowledge	this	was	
the	first	study	to	examine	HRV	and	PWV	before	and	after	a	smoking	ban.	Previous	
studies	looked	at	short	term	effects	of	SHS	on	HRV	in	humans	(126)	or	mice	(127)	
and	 found	diminishing	HRV	parameters	 upon	 SHS	 exposure.	Another	 study	 found	
effects	using	ordinal	categories	derived	from	a	questionnaire	as	a	chronic	exposure	
measure	 and	 a	 24hrs	 Holter	 ECG	 (128).	 The	 length	 of	 a	 recording	 needs	 to	 be	
standardized	within	 a	 study,	 but	 the	 direction	 of	 an	 effect	may	 still	 be	 compared	
between	studies		using	different	ECG	procedures	(129).	It	is	important	to	note	which	
parameters	 showed	 an	 effect,	 if	 they	 were	 time‐domain	 or	 frequency–domain	
measures.	 Also	when	 using	 NO2	 or	 ozone	 as	 exposure	 parameters	 cardiovascular	
effects	 were	 observed	 but	 these	 studies	 applied	 models	 that	 were	 difficult	 to	
compare	to	ours	(128,	130).	
FeNO	decreased	in	the	intervention	group	at	follow‐up	contrary	to	our	expectations	
that	were	based	on	previous	studies	(131,	132).	This	evolvement	was	significantly	
different	 from	 the	 exposed	 control	 group	 that	 experienced	 an	 increase.	 However,	
according	 to	our	medical	advisors	 this	effect,	 though	statistically	significant,	 is	not	
clinically	 relevant.	 Clinical	 relevance	 is	 usually	 predefined	 and	 needs	 to	 be	
distinguished	 from	 statistical	 significance.	 In	 contrast,	 results	 of	 high	 clinical	
relevance	 are	 not	 automatically	 unimportant	 if	 there	 is	 no	 statistical	 significance	
(133).	In	our	case	it	was	unfortunately	the	other	way	around	as	FeNO	seems	to	be	
very	 variable	 and	 highly	 influenced	 by	 a	 number	 of	 personal	 factors	 that	 were	
difficult	to	control	for.	Previous	studies	also	delivered	contradictory	and	confusing	
results.	In	some	studies	sex	had	an	influence	(119,	123),	whereas	in	other	articles	it	
was	atopy	which	was	influential	on	FeNO	levels	(134).	
Previous	 studies	 documented	 improvements	 in	 FVC	 but	 not	 in	 FEV1	 or	 FEF25‐75%	
after	a	smoking	ban	(91,	93).	We	did	not	observe	a	clear	direction	in	lung	function	
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development	one	year	after	 the	ban	even	though	 it	was	below	average	 in	exposed	
subjects	at	baseline.	This	can	be	caused	by	several	factors:	the	study	sample	was	too	
small,	lung	function	takes	longer	to	recover	or	lung	function	does	not	recover	at	all.	
Lung	function	measurements	can	also	be	influenced	by	many	factors	such	as	current	
fitness	 and	 personal	 exertion	 that	 in	 turn	may	 depend	on	 the	 commitment	 of	 the	
study	nurse.	In	our	analysis	the	study	nurse	was	only	marginally	associated	with	the	
outcome	suggesting	a	balanced	behaviour.	
The	 fact	 that	 we	 did	 not	 find	 any	 decrease	 in	 respiratory	 symptoms	 is	 fairly	
surprising	 given	 that	 previous	 studies	 found	 very	 consistent	 results	 (91,	 92,	 124,	
125).	We	based	our	questions	on	the	SAPALDIA3	questionnaire	instead	of	asking	the	
typical	 questions	 usually	 evaluated	 in	 smoking	ban	 studies.	 These	 always	 enquire	
after	teary	eyes	and	irritated	nose	symptoms.	Comparability	is	therefore	limited	and	
our	questions	might	have	been	less	relevant	in	this	context.		
Were	different	regulations	accepted	and	were	they	complied	with?	Which	factors	did	
acceptance	depend	on?	
In	evaluating	the	behaviour	and	acceptance	survey	we	analysed	the	matched	sample	
comprising	71	participants.	In	this	analysis	the	limited	sample	size	was	even	more	
perceptible.	We	 found	 that	non‐smokers	were	more	 in	 favour	of	 the	 smoking	ban	
from	the	start	and	remained	so.	Strikingly	though,	acceptance	grew	in	both	groups	
in	 the	 canton	 of	 BL,	 the	 canton	which	 implemented	 the	most	 comprehensive	 law.	
The	law	in	both	ZH	and	BS	was	full	of	loopholes	and	did	not	experience	high	levels	of	
acceptance.	This	observation	is	in	line	with	studies	from	other	countries	(135,	136).	
In	general,	Swiss	hospitality	workers	continued	to	feel	that	the	ban	was	too	strict.	
Perceived	 annoyance	 in	 private	 and	 smoking	 status	 affected	 acceptance	 whereas	
age,	 sex,	 health	 status	 and	 perceived	 annoyance	 in	 the	 workplace	 were	 not	
significantly	 correlated	with	 acceptance.	 This	 is	 not	 in	 line	with	 a	 previous	 study	
(137)	 and	 may	 well	 be	 a	 coincidental	 finding.	 We	 did	 not	 find	 any	 changes	 in	
smoking	status	or	intention	to	quit	in	the	26	smoking	participants.	A	previous	study	
                                                 
3	SAPALDIA	(Swiss	study	on	Air	Pollution	and	Lung	Disease	in	adults)	is	a	cohort	study	in	the	Swiss	
population,	which	studies	the	effects	of	air	pollution	on	the	respiratory	and	cardiovascular	health	in	
adults.	
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had	reported	clear	increases	in	smokers	intention	to	quit	after	implementation	of	a	
comprehensive	ban	(138).	
A	large	number	of	the	questions	that	we	asked	did	not	give	any	significant	results	or	
even	 tendencies.	 Some	questions	 turned	out	 to	deliver	 a	 very	 trivial	message	 and	
could	have	been	used	as	covariates	or	to	support	a	more	striking	conclusion,	which	
we	did	not	find.	
9.2	 Methodological	issues:	What	are	the	strengths	and	limitations?	
Study	Design		
The	 special	 situation	 in	 Switzerland	with	 heterogeneous	 smoking	 ordinances	 in	 a	
small	 geographical	 area	 served	 as	 an	 unusual	 quasi‐experimental	 setting	 to	
investigate	health	effects	of	low	SHS	exposures.	Bias	from	time	trends	is	unlikely	in	
this	study	because	a	control	group	that	was	not	affected	by	the	implementation	of	a	
new	 smoking	 ordinance	was	 included.	Many	 prior	 smoking	 ban	 studies	were	 not	
able	 to	 include	a	control	group	(139,	140).	 In	 the	cantons	we	worked	 in,	very	 few	
venues	remained	smoking	areas	and	were	 therefore	eligible	 for	 the	control	group.	
Thus,	we	were	 forced	 to	 include	more	 remote	 regions.	This	 in	 turn	made	 it	more	
difficult	to	convince	participants	to	travel	to	the	study	centre.	
The	prospective	 cohort	 study	design	minimized	 recall	 bias.	 It	may	be	more	 costly	
and	 time‐consuming	 but	 within‐subject	 comparisons	 have	 a	 considerably	 higher	
statistical	power	and	are	less	vulnerable	to	confounding	because	each	person	serves	
as	its	own	control.		Exposure	and	health	outcomes	were	measured	at	the	same	time.	
Two	follow‐ups	promised	to	allow	more	accurate	tracking	of	health	changes,	though	
we	could	not	fully	benefit	from	this	due	to	small	sample	sizes	and	merged	follow‐up	
data.	 As	 the	 original	 control	 group	 that	 continued	 to	 be	 exposed	 to	 SHS	was	 too	
small,	we	had	to	include	two	additional	groups	making	the	entire	control	group	very	
heterogeneous.	
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Recruitment	
Recruitment	was	the	biggest	challenge	in	this	study.	It	was	extremely	time	and	
resource	consuming.	We	had	to	extend	it	for	several	months	and	include	further	
control	groups	with	different	eligibility	criteria.	
By	the	time	ethical	clearance	came	through	at	the	end	of	2009	there	remained	only	
4‐5	months	to	recruit	participants	and	perform	baseline	examinations.	Decisions	on	
when	laws	are	implemented	can	be	on	short	notice	and	May	2010	was	unexpectedly	
early	in	this	case.	It	had	been	clear	that	BS	would	already	change	law	in	April	but	BL	
had	planned	 to	 implement	 the	more	 stringent	 cantonal	 law	only	at	 the	end	of	 the	
year	2010.	This	was	preponed	in	order	to	avoid	confusion	by	first	changing	to	the	
national	 law	 in	May	 and	 then	 further	 tightening	 to	 the	 cantonal	 regulation	 seven	
months	 later.	 These	 sudden	 changes	 posed	 unexpected	 time	 constraints	 on	 our	
study	 team.	We	 hired	 a	 second	 study	 nurse	 to	 support	 recruitment	 and	 perform	
baseline	 examinations	 at	 the	 second	 study	 centre.	 Additional	 adjustments	 were	
taken,	but	nevertheless,	the	preconceived	sample	size	could	not	be	reached.	Further	
reasons	are	discussed	in	section	9.3.		
We	were	 obliged	 to	 continue	 recruiting	 the	 control	 group	 after	 the	 ban.	 As	 these	
participants	were	not	 to	experience	any	changes	 in	exposure,	we	did	not	consider	
this	 to	 lead	 to	 any	bias.	But	 recruitment	did	not	 go	more	 smoothly	 as	 there	were	
only	few	smoking	venues	left	and	non‐smoking	employees	turned	out	to	be	a	rarity	
in	 these	 venues.	 Unfortunately	 we	 could	 not	 profit	 from	 the	 “Fümoar	 Club”	 (for	
details	 see	 introduction)	 in	 Basel	 which	 experienced	 a	 large	 influx	 of	 members.	
Hospitality	owners	were	not	inclined	to	participate	in	our	study.	We	also	observed	
some	 peer	 pressure	 in	 some	 venues	 which	 led	 to	 complete	 teams	 declining	 our	
invitation.	
To	 enlarge	 the	 control	 group	 we	 tried	 to	 locate	 persons	 not	 working	 in	 the	
hospitality	sector	but	exposed	to	SHS	on	a	regular	basis	either	at	work	or	in	private	
by	 means	 of	 an	 online	 advertisement.	 Out	 of	 71	 interested	 persons,	 16	 (22.5%)	
could	eventually	be	 included	in	the	study.	The	majority	did	not	respond	again	and	
some	 were	 occasional	 smokers	 and	 therefore	 not	 eligible.	 For	 a	 more	
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comprehensive	 cross‐sectional	 baseline	 survey	 we	 then	 recruited	 hospitality	
workers	who	had	always	worked	in	smoke‐free	venues	such	as	canteens.	There	was	
a	larger	proportion	of	non‐smokers	in	these	venues	and	14	persons	underwent	the	
examination.	
Exposure	Measurements	
We	collected	exposure	data	using	three	different	methods.		
Questionnaires	were	conducted	 in	 two	parts:	an	oral	 interview	and	distributed	on	
paper	to	be	returned	by	post	to	shorten	the	examination	time.	79%	were	returned	
at	 baseline,	 so	 we	 asked	 participants	 at	 follow‐up	 to	 immediately	 fill	 in	 the	
questionnaires	and	got	complete	data	sets.	
Saliva	was	 sampled	 during	 the	medical	 examination.	 Compared	 to	 blood	 samples	
saliva	 can	 be	 obtained	 non‐invasively.	 Urine	 samples	 could	 have	 been	 another	
choice,	 especially	 as	 some	 participants	 expressed	 serious	 problems	 in	 producing	
enough	saliva	 (1ml).	Technical	 issues	at	 the	 lab	 resulted	 in	 further	missing	values	
and	 a	 large	 number	 of	 samples	were	 below	 the	 detection	 limit	 (0.1ng/ml).	When	
sampling	 bodily	 fluids	 to	 determine	 nicotine	 and	 cotinine	 the	 exact	 time	 point	 of	
collection	in	relation	to	the	time	of	exposure	is	crucial.	The	original	plan	in	our	study	
was	 to	 schedule	 medical	 examinations	 immediately	 after	 a	 work	 shift	 but	 this	
turned	out	to	be	impracticable.	Most	participants	only	agreed	to	come	on	their	day	
off	as	they	were	too	tired	or	too	busy	on	their	working	days.	Consequently	the	saliva	
samples	were	not	comparable.		
In	 a	 future	 study	 participants	 may	 have	 to	 be	 asked	 to	 independently	 take	 their	
saliva	 sample	 immediately	 after	 a	 work	 shift	 to	 deliver	 more	 consistent	 and	
comparable	results.		
Two	 MoNIC	 badges	 were	 evaluated	 per	 person,	 one	 from	 the	 workplace	 which	
measured	 ambient	 nicotine	 over	 the	 course	 of	 a	 week	 and	 a	 second	 badge	 that	
participants	wore	on	themselves	for	24	hours.		
The	badge	that	was	placed	at	 the	venue	was	the	easiest	and	most	reliable	method	
because	 we	 could	 easily	 control	 and	 document	 surrounding	 circumstances	
ourselves.	Only	 in	 two	 instances	 the	badge	was	 thrown	away	during	 the	course	of	
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the	 week.	 The	 personal	 badge	 turned	 out	 to	 be	 more	 challenging	 because	
participants	 did	 not	 always	 document	 clearly	where	 they	wore	 the	 badge	 and	 for	
how	 long.	 The	 badge	 protocol	 also	 turned	 out	 to	 be	 too	 superficial	 to	 accurately	
trace	the	number	of	hours	the	badge	was	worn	at	which	place.	Some	badges	were	
handed	in	after	the	medical	examination	because	participants	had	forgotten	them.	It	
was	also	crucial	to	store	the	badge	in	the	plastic	case	and	in	most	cases	participants	
complied	with	 this	 instruction.	 For	 the	 exposed	 non‐hospitality	 group	we	 did	 not	
have	any	workplace	badge	and	were	obliged	to	use	the	personal	badge	as	exposure	
measure.	
The	decrease	in	exposure	according	to	hypothesis	as	measured	by	the	badge	could	
not	 be	 observed	 when	 evaluating	 the	 salivary	 sample	 and	 questionnaire	 data,	
underlining	the	limited	reliability	of	these	two	methods	in	our	study	setting.		
Health	Examinations	
Examining	 many	 objective	 health	 outcomes	 made	 this	 study	 an	 unusually	
comprehensive	 research	project	 in	 the	 field	 of	 low	dose	 SHS	 exposure	 and	health	
effects	 of	 smoking	 bans.	 However,	 this	 also	 made	 the	 medical	 examination	 fairly	
long	and	laborious.		
Hip	 and	 waist	 circumference	 as	 well	 as	 height,	 weight	 and	 blood	 pressure	 were	
straight	forward	measurements	and	served	as	important	covariates	in	analyses.		
The	skin	prick	test	gave	an	objective	insight	on	allergy	prevalence.	With	the	help	of	a	
specialist	 from	 the	allergy	 station	at	 the	university	hospital	we	 selected	 six	of	 the	
most	common	allergens	 in	order	 to	cover	 the	broadest	range	possible.	 In	addition	
we	included	a	positive	and	a	negative	control.	Allergy	prevalence	was	strikingly	high	
in	our	sample	compared	to	the	average	Swiss	population	(68%	vs.	23%)	(141).	
The	 electrocardiograms	 in	 our	 study	 were	 of	 very	 high	 quality	 according	 to	 our	
collaborators	who	 analysed	 the	 recordings.	 Some	were	 slightly	 short	 and	 did	 not	
permit	 utilization	 of	 two	 non‐overlapping	 sequences	 as	 had	 been	 planned,	 so	 a	
single	sequence	was	used	in	these	cases.		
During	the	ECG	participants	 lay	flat	on	their	back	for	ten	minutes	which	served	as	
preparation	time	for	the	PWV	measurements.	From	a	logistic	point	of	view	it	would	
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have	been	an	advantage	to	have	a	mobile	study	centre	as	the	medical	examination	
was	very	extensive	and	required	a	fair	amount	of	personal	interest	and	commitment	
from	 the	 study	 participants.	 Arterial	 stiffness	 would	 not	 have	 been	 possible	 to	
include	 in	 such	a	 setting	as	 the	measuring	device	was	very	bulky,	 cumbersome	 to	
transport	and	fairly	sensitive	to	being	moved.	
Lung	function	measurements	were	performed	with	a	small	portable	device	using	a	
nose	 clip.	 Results	 could	 instantly	 be	 read	 and	 transferred	 to	 a	 specific	 software	
producing	 a	 descriptive	 results	 page	 to	 print	 out	 for	 participants.	 If	 quality	 was	
insufficient	 up	 to	 eight	 spirometries	 had	 to	 be	 performed,	 a	 task	 which	 can	 be	
exhausting	 and	 requires	 some	 personal	 commitment	 on	 behalf	 of	 the	 study	
participant.	Even	though	our	quality	standards	were	slightly	lower	than	for	example	
in	 the	 SAPALDIA	 study,	 we	 had	 to	 exclude	 a	 number	 of	 measurements	 because	
sufficient	quality	was	not	achieved	until	the	end.	This	may	have	caused	bias.	
FeNO	measurements	were	considered	challenging	by	some	of	the	participants	as	in	
this	test	wearing	a	nose	clip	is	not	permitted	but	breath	should	not	go	through	the	
nose.	Air	was	exhaled	into	a	bag	that	needed	to	be	analysed	at	the	hospital	within	12	
hours.	This	was	complied	with	at	all	times.	
Data	Analysis	
Three	statistical	models	were	created	to	analyse	the	data.	The	cross‐sectional	model	
at	baseline	allowed	comparisons	to	reference	values	and	long	term	SHS	exposure.	In	
the	 longitudinal	 analysis	 we	 further	 checked	 for	 association	 of	 exposure	 and	
outcome	in	a	mixed	model	clustering	by	individuals.	In	the	third	model	we	looked	at	
pre/post	 changes	 without	 taking	 exposure	 into	 account	 to	 rule	 out	 exposure	
misclassifications.		
Sample	 size	 was	 found	 to	 be	 the	 major	 limiting	 factor	 when	 analysing	 the	 data.	
When	assessed	as	two	follow‐ups	the	results	were	erratic.	We	therefore	decided	to	
combine	both	follow‐up	measurements	into	one	post‐ban	measure	to	increase	study	
power.	 Unfortunately,	 the	 aim	 of	monitoring	 developments	 of	 health	 outcomes	 in	
more	detail	after	6	and	after	12	months	was	forfeited	with	this	necessary	step.	
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Stratification	was	 restricted	 as	 groups	were	 too	 small.	 This	made	 it	 impossible	 to	
conduct	some	potentially	interesting	analyses.	
9.3	 Hospitality	workers:	Is	this	a	suitable	study	population?	
The	 sample	 of	 the	 medical	 study	 comprised	 92	 non‐smoking	 participants	 at	
baseline,	 56	 at	 first	 follow‐up	 (60.9%)	 and	 48	 at	 second	 follow‐up	 (52.2%).	 The	
matched	sample	of	 the	acceptance	questionnaire	 counted	71	persons.	 Sample	 size	
remained	 below	 expectations	 in	 both	 parts	 of	 our	 study	 despite	 several	
amendments	to	the	recruitment	procedure.		
Sample	size	
Most	smoking	ban	studies	with	hospitality	workers	included	both	smokers	and	non‐
smokers.	An	 Irish	publication	 from	2005	examined	329	bar	workers	out	of	which	
158	 were	 non‐smokers	 (99).	 76%	 came	 back	 at	 follow‐up.	 Participants	 had	 the	
option	 of	 being	 interviewed	 at	 the	workplace	 if	 they	 did	 not	wish	 to	 come	 to	 the	
laboratory.	 From	 a	 371	 Scottish	 sample,	 51%	 participated	 a	 second	 time.	 In	 this	
study,	sampling	and	spirometry	were	performed	at	the	workplace	itself	(124).	Other	
high	impact	studies	also	worked	with	smaller	samples	of	67	or	105	participants	(91,	
125).	An	American	study	examined	urinary	cotinine	in	24	non‐smokers	working	in	
bars	or	restaurants,	and	finding	significant	results	did	not	mention	any	recruitment	
problems	(110).	A	landmark	study	reporting	on	acute	SHS	exposure	and	HRV	used	a	
sample	of	16	adults	but	with	large	effects,	this	can	be	enough	(126).	A	Swiss	study	
comparable	 to	 COSIBAR,	 recruited	 105	 smokers	 and	 non‐smokers	 before	 the	 ban	
and	 performed	 exposure	 and	 lung	 function	 measurements	 at	 the	 workplace.	 66	
(62.9%)	 persons	 agreed	 to	 take	 part	 a	 second	 time	 (90).	 They	 reported	 similar	
problems	to	ours	 in	recruiting.	We	can	conclude	that	our	recruitment	success	was	
not	 exceptionally	 low	 considering	 that	 participants	 had	 to	 sacrifice	 several	 hours	
per	examination.	Our	loss‐to‐follow‐up	rate	was	fair	under	the	circumstances.	
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Hospitality	workers	
In	 the	USA,	hospitality	workers	are	an	occupational	group	with	one	of	 the	highest	
smoking	prevalences	(57,	142).	A	European	study	examining	smoking	prevalences	
in	different	occupations	did	not	stratify	for	waiters	(143,	144).	But	the	numbers	are	
probably	similar.	A	 large	part	of	our	 target	group	was	not	eligible	 for	 the	medical	
part	of	our	study	as	they	were	smokers.	Non‐smokers	who	continued	to	work	in	a	
smoking	environment,	and	could	have	been	included	in	our	exposed	control	group,	
were	 even	 rarer.	 However,	 the	 behaviour	 and	 acceptance	 survey	 that	 included	
smokers	faced	similar	recruitment	problems.	Being	a	smoker	is	generally	associated	
with	a	poorer	response	rate	in	studies	(145).	
When	we	approached	venue	owners	we	experienced	a	very	open	hostility	towards	
the	smoking	ban	which	was	reflected	in	an	extreme	unwillingness	to	participate	in	a	
scientific	 study	 connected	 to	 the	 ban.	 We	 seemed	 to	 blur	 into	 a	 group	 with	 the	
political	 powers	 that	 had	 decided	 to	 enforce	 this	 rule.	 Discussions	 were	 often	
emotional	reflecting	the	venue	owners’	fear	of	 losing	business	due	to	the	new	ban.	
Timing	was	therefore	a	major	disadvantage	in	our	recruitment	process.	When	things	
had	calmed	down	after	the	ban	and	we	tried	to	find	more	members	for	our	control	
group,	it	did	not	get	easier	as	there	were	less	eligible	venues.	
Hospitality	 workers	 are	 a	 vulnerable	 population	 group	 because	 they	 are	 (partly)	
excluded	from	the	law	on	SHS	protection	at	the	workplace	in	many	countries	(76).		
Arguments	often	voiced	in	the	Swiss	debate	that	workers	themselves	have	the	right	
to	 choose	 if	 they	 want	 to	 work	 in	 a	 smoking	 environment	 seem	 absurd.	 The	 job	
market	is	competitive	and	a	person	refusing	to	work	in	the	smoke	would	probably	
not	get	hired	to	work	in	a	venue	with	a	smoking	section.	
We	did	not	offer	any	 incentive	 for	people	 to	participate	apart	 from	a	 free	medical	
examination	and	a	cinema	voucher.	The	fact	that	employees	of	the	hospitality	sector	
work	 in	 shifts	made	 it	 difficult	 to	 schedule	 appointments	 and	 impossible	 to	 have	
everyone	come	straight	after	work	for	a	more	standardized	procedure	as	originally	
planned.		
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The	medical	examination	in	our	study	was	fairly	extensive	taking	almost	three	hours	
at	baseline.	In	addition	participants	were	asked	to	fill	out	a	further	questionnaire	at	
home	and	wear	the	MoNIC	badge	for	24	hours.	This	effort	might	have	been	too	time‐
consuming	for	some.	
Before	 smoking	was	 banned	 in	 aircrafts	 flight	 attendants	were	 highly	 exposed	 at	
their	workplace	and	subject	to	numerous	studies	on	SHS	exposure	and	health	effects	
(146‐148).	Flight	attendants	can	be	considered	a	 subgroup	of	hospitality	workers.	
Negative	 health	 effects	 on	 personnel	 caused	 by	 passive	 smoking	 were	 a	 major	
concern	of	the	labour	union	that	played	a	vital	part	in	banning	smoking	in	aircrafts	
(149).	 Tobacco	 industry	 strategies	 against	 the	 establishment	 of	 smoke‐free	
worksites	failed	in	the	case	of	airlines,	probably	because	their	strongest	argument	of	
economic	losses	was	shown	to	be	obsolete.	
We	concluded	from	our	experience	that	health	issues	were	not	a	prominent	topic	in	
this	occupational	group.	Possibly	there	was	a	selection	bias	in	our	sample	that	may	
have	 consisted	 of	 persons	 more	 interested	 in	 health	 topics	 and	 therefore	 more	
aware	 of	 a	 healthy	 lifestyle	 in	 general.	 Participants	 entering	 a	 study	 tend	 to	 be	
different	 from	those	that	refuse	(150).	At	screening	no	one	had	to	be	excluded	for	
previous	health	 incidents	such	as	 for	example	a	heart	attack.	A	person	working	 in	
the	hospitality	sector	needs	to	be	in	adequate	health	for	this	physically	demanding	
job	suggesting	a	healthy	worker	effect	(151).	
The	 unwillingness	 to	 take	 part	 in	 scientific	 studies	 can	 also	 be	 observed	 in	 other	
population	groups	in	Switzerland,	for	example	in	school	children	who	are	regularly	
asked	 to	 participate	 in	 research	 projects	 (B.	 Bringolf,	 personal	 communication).	
There	 seems	 to	 be	 a	 feeling	 of	 saturation	 of	 requests	 to	 participate	 in	 a	 research	
project	 which	 does	 not	 offer	 a	 clear	 personal	 benefit.	 In	 developing	 countries	
researchers	are	often	met	with	more	enthusiasm	but	 issues	surrounding	informed	
consent	can	be	more	challenging.		
Future	 studies	 need	 to	 simplify	 procedures	 as	 much	 as	 possible	 for	 participants,	
either	 by	 performing	 examinations	 at	 the	 workplace,	 limiting	 their	 length	 or	
reducing	 the	number	of	 follow‐ups	and	avoiding	 repetitive,	 long	questionnaires.	A	
monetary	incentive	may	be	effective	but	does	not	comply	with	ethical	standards	in	
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some	 countries	 (152‐154).	 Furthermore	 it	 is	 important	 to	 increase	 public	
awareness	with	research	(155).	
9.4	 From	research	to	policy:	How	could	our	results	impact	policy‐
making?	
In	the	course	of	 this	study	we	faced	the	extraordinary	opportunity	of	 immediately	
applying	our	study	results	 in	an	on‐going	political	debate.	After	 implementation	of	
the	national	smoking	ban	in	May	2010,	which	served	as	an	external	intervention	for	
the	 study,	 there	were	 two	more	popular	 votes	on	 further	 changes	 to	 the	 smoking	
ban	on	a	cantonal	and	a	national	level.		
The	first	vote	took	place	in	BS	in	November	2011.	It	was	an	initiative	by	the	Basel	
hospitality	association,	mainly	promoted	by	the	aforementioned	“Fümoar	Club”,	 to	
loosen	 the	 cantonal	 law	 to	 the	 level	 of	 the	 national	 law.	 Prior	 to	 this	 vote	 we	
presented	our	first	preliminary	results	on	SHS	exposure	changes	and	effects	on	HRV	
at	 the	 National	 Tobacco	 Conference	 in	 Berne.	 Our	 message	 was	 taken	 up	 with	
interest	 and	 a	 press	 release	 after	 the	 meeting	 included	 a	 recommendation	 from	
Swiss	health	prevention	experts	invoking	our	results	to	reject	the	BS	initiative.	The	
initiative	 was	 indeed	 rejected	 despite	 a	 delusive	 campaign	 by	 the	 hospitality	
association.	 The	 innkeepers	 emphasized	 that	 the	 “Fümoar	Club”	 and	 the	nuisance	
associated	 with	 membership	 cards	 could	 be	 abolished	 if	 the	 initiative	 would	 be	
accepted,	 completely	disregarding	 that	 the	disadvantages	caused	by	 the	club	were	
actually	 self‐imposed	 and	 the	 club	 itself	 legally	 questionable.	 Given	 the	 way	 the	
campaign	was	 led,	 it	 seemed	possible	 that	people	would	actually	be	deceived	 into	
voting	 for	 something	 they	 did	 not	 agree	 with.	 Eventually	 50.23%	 rejected	 the	
initiative	corresponding	to	a	difference	of	only	212	votes	in	such	a	small	canton.	The	
result	seems	coincidental	and	in	fact	underlines	the	division	among	the	population	
regarding	a	complete	smoking	ban	in	hospitality	venues.	
The	 second	 vote	 in	 September	 2012	 was	 a	 national	 initiative	 by	 the	 Swiss	 lung	
association	 attempting	 to	 unify	 the	 regulation	 for	 a	 country‐wide	 comprehensive	
smoking	ban	on	the	 level	of	 the	most	stringent	cantonal	regulations,	only	allowing	
unserved	 smoking	 rooms.	 This	 campaign	 by	 the	 lung	 association	 was	 very	much	
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focused	 on	 health	 protection	 of	 all	 people	 at	 their	 workplace.	 Opponents	 of	 the	
initiative	 covered	 the	whole	 political	 spectrum.	 They	 argued	 that	 the	 current	 law	
was	 still	 very	 new	 and	 venues	 had	 invested	 into	 constructing	 adequate	 smoking	
rooms	 and	 ventilation	 systems	 that	 most	 hospitality	 workers	 were	 smokers	
themselves	 and	 therefore	 did	 not	 need	 any	 protection	 from	 SHS,	 and	 that	
Switzerland	was	 turning	 into	 a	nanny	 state	 full	 of	 regulations	 that	undermine	 the	
personal	 freedom	of	decision	of	 its	citizens.	We	 issued	a	press	release	on	 the	 final	
cardiovascular	 results	 (improvement	 of	 both	 HRV	 and	 PWV)	 at	 the	 beginning	 of	
August	2012	in	the	frame	of	the	Swiss	Public	Health	conference	where	the	study	was	
to	be	presented.	Due	to	the	timeliness	of	the	topic	the	response	was	substantial	and	
many	newspapers	 took	up	 the	subject.	One	 to	 two	months	before	 the	vote	public‐
opinion	 polls	 showed	more	 than	 60%	 to	 be	 in	 favour	 of	 the	 lung	 association	 but	
during	the	last	few	weeks	this	number	dramatically	dropped	leaving	the	initiative	to	
be	clearly	rejected	in	the	end	by	66%.	Only	one	canton	(GE)	accepted	the	initiative.		
This	was	a	dramatic	blow	for	public	health	advocates	in	Switzerland	and	raised	the	
question	whether	the	campaign	was	badly	run	or	if	it	had	been	built	on	the	wrong	
arguments.	 How	 could	 support	 drop	 so	 dramatically	 in	 such	 short	 time?	 Despite	
being	the	most	precious	good	of	every	human	being,	why	does	it	not	seem	attractive	
to	agitate	for	health	in	a	political	discussion	as	opposed	to	personal	freedom?	
The	lung	association	seemed	too	health‐focused	and	were	accused	of	coercion.	The	
new	 law	stated	 that	all	workplaces	 should	be	smoke‐free	and	adversaries	pointed	
out	that	persons	in	single	offices	would	also	be	affected	causing	a	popular	outrage.	
Presumably	 it	 would	 have	 been	 more	 effective	 to	 emphasize	 the	 unification	 and	
simplification	of	the	law	and	the	disproof	of	economic	losses	as	had	been	shown	in	
several	international	studies	(156‐159)	as	well	as	in	Switzerland	itself	(160).		
The	 system	 of	 direct	 democracy	 gives	 people	 a	 unique	 power	 to	 interfere	 with	
political	decisions.	Personal	freedom	of	choice	seems	to	have	a	high	priority	for	the	
Swiss.	 Nevertheless	 this	 smoking	 ban	 debate	 seems	 to	 be	 a	 prime	 example	 of	
manipulation	 of	 the	 people	 by	 a	 non‐transparent	 political	 system	 infiltrated	 by	 a	
powerful	private	lobby.	
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The	federal	government	and	parliament	usually	recommend	rejecting	initiatives	as	
was	 the	 case	with	 this	 initiative.	 Examples	 from	other	 countries	have	 shown	how	
important	 a	 supportive	 government	 is	 when	 it	 comes	 to	 implementation	 of	 a	
smoking	ban.	In	Turkey,	a	country	with	a	high	smoking	prevalence	and	a	long	Shisha	
tradition,	the	prime	minister	and	the	health	minister	collaborated	on	this	topic	and	
established	a	ban	in	short	time	albeit	in	a	different	political	procedure	(161).	
Financial	 arguments	 are	 among	 the	most	 important.	 Ironically	 a	 smoking	ban	has	
been	 shown	 to	 be	 one	 of	 the	 most	 effective	 ways	 of	 decreasing	 health	 costs,	 an	
interesting	fact	for	the	country	with	the	third‐highest	health	expenditure	of	all	OECD	
countries(162).	Health	 costs	 incurred	 by	 active	 and	 passive	 smoking	were	widely	
ignored	in	the	debate.	Although	it	has	been	proven	that	this	is	not	the	case,	there	are	
still	voices	arguing	that	smoking	bans	destroy	small	traditional	venues,	especially	in	
rural	 areas.	 More	 probably	 these	 traditional	 village	 restaurants	 are	 obsolescent	
hospitality	models.		
The	 tobacco	 industry	 has	 been	 very	 successful	 in	 controlling	 tobacco	 policy	 in	
Switzerland	 (27).	 It	 maintains	 strong	 alliances	 to	 both	 advertising	 agencies	 and	
print	media.	 It	 openly	 attacked	 results	 of	 the	 SAPALDIA	 study	 that	 linked	passive	
smoking	to	respiratory	symptoms	in	1995	(163).	Through	scientist	R.	Rylander	from	
Geneva,	 who	 on	 behalf	 of	 the	 tobacco	 industry	 invented	 random	 “confounder	
variables”	such	as	green	vegetables	to	disguise	the	linkage	between	passive	smoking	
and	childhood	bronchitis,	the	industry	successfully	played	for	time	in	implementing	
a	 smoking	 ban	 (164,	 165).	 It	 has	 been	 shown	 that	 the	 industry	 made	 financial	
contributions	to	hospitality	associations	worldwide	(72).	 It	can	easily	be	 imagined	
that	 this	 is	 the	 case	 in	 Switzerland	 considering	 the	 vehement	 opposition	 of	 the	
hospitality	sector	to	any	smoking	ban.	In	addition	the	marketing	law	in	Switzerland	
is	 among	 the	 loosest	 in	 Europe	 even	 though	 constraining	 advertising	 is	 most	
effective	with	youth	and	only	causes	minor	economic	losses	(166,	167).	
The	 tobacco	 industry	 is	 now	 increasingly	 targeting	 developing	 countries	 where	
knowledge	on	negative	health	effects	is	not	yet	widespread	and	infectious	diseases	
are	 more	 pressing.	 But	 more	 and	 more	 industrialized	 countries	 are	 adapting	
stringent	 laws.	 Probably	 even	 in	 Switzerland	 a	 complete	 national	 ban	 is	 only	 a	
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matter	 of	 time.	 The	 women’s	 right	 to	 vote	 also	 took	 longer	 than	 in	 any	 other	
industrialized	country	to	be	adopted	here.	
In	 some	 areas	 the	 debate	 is	 moving	 beyond	 banning	 smoking	 in	 workplaces	 to	
policies	including	full	disclosure	on	smoking	status.	While	the	WHO	has	been	hiring	
only	 non‐smokers	 since	 2008	 (168),	 selected	 employers	 in	 the	 US	 such	 as	 the	
University	of	Pennsylvania	have	started	to	state	in	job	ads	that	smokers	will	not	be	
considered	(169).	They	justify	this	by	economic	reasons	but	this	also	seems	to	open	
the	field	for	a	whole	new	discussion	on	discrimination	and	privacy.	
Obviously	the	indoor	smoking	ban	has	led	to	increased	smoking	in	outdoor	areas	of	
hospitality	 venues.	 Some	 countries	 have	 now	 started	 to	 ban	 smoking	 in	 selected	
outdoor	 areas	 and	 private	 places	 as	 well	 (76).	 The	 initiative	 from	 Geneva	 that	 is	
currently	 collecting	 signatures	 (for	 details	 see	 introduction)	 also	 steers	 in	 this	
direction	 (80).	Time	will	 tell	 if	 it	will	 be	 taken	up	 seriously	 in	 Switzerland	 at	 this	
stage.	 There	 have	 been	 too	 many	 discussions	 during	 the	 past	 few	 years,	 leaving	
people	tired	and	saturated	on	this	topic.	It	will,	no	doubt,	eventually	come	up	again.	
9.5	 Future	tobacco	research:	What	are	key	issues	and	goals?	
Why	still	do	tobacco‐related	health	research?	
Cigarette	 smoking	 is	 probably	 the	 most	 researched	 area	 in	 epidemiology	 (170).	
Research	on	health	effects	of	active	smoking	delivered	first	results	in	the	1940s,	the	
discussion	 on	 passive	 smoking	 emerged	 around	 1980	 and	 the	 first	 smoking	 bans	
were	 implemented	 around	 the	 turn	 of	 the	millennium	as	 a	 result	 of	 serious	 long‐
term	campaigning	by	the	anti‐tobacco	movement	and	unreserved	support	from	the	
WHO.	 So	why	 do	we	 still	 design	 new	 studies	 to	 examine	 health	 effects	 related	 to	
tobacco	 consumption	 when	 it	 has	 been	 repeatedly	 proven	 that	 smoking	
substantially	 raises	 the	 risk	 for	 a	 range	 of	 serious	 illnesses	 and	 delimits	 life	
expectation?	
Interesting	 health	markers	 to	 explore	 tobacco‐induced	 illnesses	 help	 us	 to	 better	
understand	the	exact	pathways	and	complex	interactions	that	lead	to	diseases.	This	
can	 also	 support	 effective	 treatment	 and	 prevention.	 Health	 and	 control	
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interventions	 always	 need	 to	 be	 evaluated	 in	 parallel	 to	 increase	 effectiveness	
(171).	
Study	 results	 should	 be	 reproduced	 as	 statistical	 analyses	 are	 always	 subject	 to	
errors	 and	 every	 study	 has	 some	 limitations.	 With	 a	 powerful	 tobacco	 industry	
constantly	 trying	 to	 undermine	 and	 question	 study	 results	 it	 is	 that	 much	 more	
important	to	produce	undisputable	statements.		
Surprisingly,	 even	 today	 among	 parts	 of	 the	 population	 the	 harmful	 effects	 of	
tobacco	consumption	are	largely	underestimated.	While	people	agree	that	smoking	
is	 unhealthy,	 knowledge	 on	 the	 true	 risk	 and	 wide	 scope	 of	 illnesses	 that	 are	
promoted	 by	 active	 and	 passive	 smoking	 remains	 vague.	 Furthermore	 public	
awareness	 of	 the	 strong	 influence	 the	 tobacco	 industry	 has	 in	 political	 debates,	
through	marketing	schemes	and	by	publishing	 their	own	research	 that	downplays	
scientific	findings,	remains	low	(172).		
For	 these	 reasons	 it	 is	 important	 to	 keep	 the	 topic	 in	 discussion	 and	 continue	 to	
educate	 the	 population	 on	 tobacco‐related	 health	 impairments.	 In	 a	 controversial	
topic	 such	 as	 a	 smoking	 ban,	 cultural,	 political	 or	 even	 climatic	 differences	 are	
willingly	deployed	as	arguments	to	fight	against	following	other	countries	in	terms	
of	smoking	regulations.	Therefore,	studies	from	other	areas	cannot	often	be	used	as	
evidence,	and	instead	it	is	important	to	replicate	study	results	from	other	countries	
locally.	In	the	course	of	this	project	we	observed	how	new	findings	from	a	national	
study	were	 seriously	 taken	up	 in	 the	discussion,	 even	 though	 the	overall	message	
was	 the	 same	 as	 from	 other	 studies:	 exposure	 to	 SHS	 is	 harmful.	 But	 it	 proved	
necessary	to	show	that	this	is	also	the	case	in	Switzerland.	
There	 are	 still	 a	 lot	 of	 prevalence	 studies	 being	 conducted	 examining	 different	
minorities	and	socioeconomic	 influences,	and	studies	on	co‐morbidities,	especially	
psychological,	 and	 their	 influence	on	 smoking	 cessation	 is	 increasing.	 Genetic	 and	
neurological	studies	on	factors	that	promote	addiction	are	frequent	too.		
Regarding	health,	modern	smokeless	 tobacco	products	such	as	 the	e‐cigarette	and	
their	impact	on	health	still	need	to	be	further	investigated.	Third	hand	smoke	which	
refers	to	indirect	exposure	to	tobacco	smoke,	sticking	to	clothes	for	example,	and	is	
inhaled,	ingested	and	dermally	absorbed	is	a	further	topic.		
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Second	hand	smoke	exposure	studies	in	outdoor	locations	such	as	cafés,	bus	stops	
and	 building	 entrances	 have	 been	 done	 but	 assessing	 health	 effects	 of	 these	
exposures	is	challenging.		
Further	topics	related	to	tobacco	research	
The	 international	 anti‐tobacco	movement	has	been	 immensely	 successful	 in	many	
directions	 during	 the	 past	 20	 years.	 	 Advertising	 on	 TV	 and	 in	 public	 places	 has	
disappeared	to	a	large	extent	and	sales	to	minors	have	been	hampered.	In	Australia	
plain	 cigarette	 packaging	 reached	 a	 new	 climax	 in	 2012	with	 a	 drab	 dark	 brown	
colour	 and	 no	 logo	 (173).	 	 Although	most	 developing	 countries	 are	 far	 from	 such	
strict	 rules	 and	 some	 industrialized	 countries	 such	 as	 Switzerland	 are	 still	 in	 the	
middle	 of	 what	 seems	 like	 a	 long	 adaptation	 phase,	 the	 future‐oriented	 research	
community	is	debating	what	its	ultimate	goal	in	this	battle	actually	is.	A	worldwide	
smoking	ban?	Make	tobacco	illegal?	A	non‐hazardous	cigarette?	
Countries	with	more	or	less	comprehensive	smoking	bans	will	certainly	continue	to	
rise	 in	 number.	 The	 question	 remains	 how	 many	 exceptions	 and	 loop	 holes	 will	
continue	to	be	written	into	these	laws.		
Regarding	 policy,	 researchers	 are	 indeed	 discussing	 the	 “end	 game	 of	 tobacco”:	
making	 the	world	 tobacco‐free.	Despite	 there	still	being	many	countries	without	a	
comprehensive	 smoking	 ban	 there	 are	 some	 health	 advocates	 fighting	 for	 a	
complete	prohibition	of	all	tobacco	products.	New	Zealand	and	Finland	are	leaders	
in	this	mission	aiming	for	a	smoke‐free	country	by	2025	and	2040	respectively	(174,	
175)	and	Sweden	is	about	to	follow	their	example	(176).	One	proposed	strategy	to	
achieve	this	is	by	applying	a	“sinking	lid”,	eg.	by	prohibiting	cigarette	sales	to	anyone	
born	after	2000.	However,	this	could	substantially	increase	illicit	trade.		
A	major	goal	is	the	development	of	a	clean	cigarette	with	a	reduced	nicotine	content	
that	 is	 potentially	 harmless	 and	 non‐addictive.	 Banning	 certain	 additives	 such	 as	
menthol	or	clove	is	also	under	discussion.	The	tobacco	industry	missed	the	chance	
to	 develop	 a	 harmless	 cigarette	 being	 too	 focused	 on	 covering	 up	 and	 distorting	
unfavourable	evidence	from	the	scientific	community.	
9	Discussion	
 
142	
 
Studies	of	the	relationship	between	smoking	and	health	risks	have	been	important	
in	 establishing	 the	 basis	 of	 observational	 epidemiological	 studies	 and	 causal	
inferences.	 This	 methodology	 may	 be	 applied	 to	 other	 risk	 factors	 and	 to	 better	
understand	 the	 causality	 of	 NCDs	 (177).	 Parallels	 have	 been	 found	 between	 the	
tobacco	 industries’	 and	 the	 food	 industries'	 strategies,	 so	 lessons	 learned	 from	
tobacco	research	may	apply	in	other	sectors	as	well	(178).	
9.6	 Conclusion	
In	 this	 study	 we	 confirmed	 the	 need	 for	 a	 comprehensive	 smoking	 ban	 in	
Switzerland	to	effectively	protect	hospitality	workers’	cardiovascular	health.	Only	a	
law	without	exceptions	will	be	complied	with	and	well	accepted.	
The	 Swiss	 government	 needs	 to	 free	 itself	 from	 the	 influence	 of	 the	 tobacco	
industry,	 ratify	 the	 Framework	 Convention	 for	 Tobacco	 Control	 and	 start	
implementing	the	recommendations	therein	on	a	national	level	without	exceptions.		
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11 APPENDIX	‐	ARTICLE	5:	Direct	health	costs	of	environmental	
tobacco	smoke	exposure	and	indirect	health	benefits	due	to	
smoking	ban	introduction	
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	 ISEE‐ISES‐ISIAQ	Environment	&	Health	Conference,		
Basel	 	 	 	 	 	 	 	 oral	presentation	
	
Award	
Swiss	School	of	Public	Health+	PhD	Award	2012,	Best	Abstract		
	
Teaching	Activities	
Swiss	TPH:	Key	Issues	in	International	Health;	Tobacco‐	a	burning	public	health	
issue,	December	2012	
ISSW,	University	of	Basel:	Wissenschaftliches	Vorgehen	zur	Beurteilung	der	
Qualität	von	Publikationen	zum	Tabakkonsum	aus	epidemiologischer	Sicht,	April	
2013	
  
	
	
	
	
	
	
	
